UNICEF 2012ed Immunization Summary (English)

IMMUNIZATION SUMMARY
A statistical reference containing

data through 2010
(The 2012 edition)
DISCLAIMER: The data in this
edition supersede all historical
data previously published by
UNICEF and WHO.
Version en franais sur CD-ROM
Versin en espaol en CD-ROM
CD-ROM
inside
IMMUNIZATION SUMMARY
A statistical reference containing

data through 2010
See inside back cover

for CD-ROM
CONTENTS
Introduction................................................................... iv
Annual updates............................................................ vii
Indicative prices....................................................... viii
Trends: Regional progress....................................... xi
Maps: Global indicators........................................... xv
Notes on indicators and data................................. xix
Countries and territories.......................................... xxiii
Afghanistan...............1
Albania......................2
Algeria.......................3
Andorra.....................4
Angola.......................5
Antigua and
Barbuda.................6
Argentina...................7
Armenia.....................8
Australia....................9
Austria.....................10
Azerbaijan...............11
Bahamas..................12
Bahrain....................13
Bangladesh.............14
Barbados.................15
Belarus.....................16
Belgium...................17
Belize ......................18
Benin........................19
Bhutan.....................20
Bolivia......................21
Bosnia and
Herzegovina........22
Botswana.................23
Brazil........................24
Brunei
Darussalam.........25
Bulgaria...................26
Burkina Faso...........27
Burundi....................28
Cambodia................29
Cameroon................30
Canada.....................31
Cape Verde..............32
Central African
Republic..............33
ii
Chad.........................34
Chile.........................35
China........................36
Colombia.................37
Comoros..................38
Congo......................39
Congo, Democratic
Republic of the...40
Cook Islands............41
Costa Rica...............42
Cte dIvoire............43
Croatia.....................44
Cuba.........................45
Cyprus.....................46
Czech Republic.......47
Denmark..................48
Djibouti....................49
Dominica.................50
Dominican
Republic..............51
Ecuador...................52
Egypt........................53
El Salvador..............54
Equatorial Guinea...55
Eritrea......................56
Estonia.....................57
Ethiopia...................58
Fiji............................59
Finland.....................60
France......................61
Gabon......................62
Gambia....................63
Georgia....................64
Germany..................65
Ghana......................66
Greece.....................67
Grenada...................68
Guatemala...............69
Guinea.....................70
Guinea-Bissau.........71
Guyana....................72
Haiti..........................73
Honduras.................74
Hungary...................75
Iceland.....................76
India.........................77
Indonesia.................78
Iran (Islamic
Republic of)........79
Iraq...........................80
Ireland......................81
Israel........................82
Italy..........................83
Jamaica...................84
Japan.......................85
Jordan.....................86
Kazakhstan..............87
Kenya.......................88
Kiribati.....................89
Korea, Democratic
Peoples Republic
of..........................90
Korea, Republic
of..........................91
Kuwait......................92
Kyrgyzstan...............93
Lao Peoples
Democratic
Republic..............94
Latvia.......................95
Lebanon...................96
Lesotho....................97
Liberia......................98
Libya........................99
Lithuania................100
Luxembourg..........101
Madagascar...........102
Malawi...................103
Malaysia................104
Maldives................105
Mali........................106
Malta......................107
Marshall Islands...108
Mauritania.............109
Mauritius...............110
Mexico...................111
Micronesia
(Federated
States of)...........112
Moldova................113
Monaco..................114
Mongolia...............115
Montenegro..........116
Morocco................117
Mozambique.........118
Myanmar...............119
Namibia.................120
Nauru.....................121
Nepal.....................122
Netherlands...........123
New Zealand.........124
Nicaragua..............125
Niger......................126
Nigeria...................127
Niue.......................128
Norway..................129
occupied Palestinian
territory.............130
Oman.....................131
Pakistan.................132
Palau......................133
Panama..................134
Papua New
Guinea...............135
Paraguay...............136
Peru........................137
Philippines.............138
Poland....................139
Portugal.................140
Qatar......................141
Romania................142
Russian
Federation.........143
Rwanda..................144
Saint Kitts and
Nevis.................145
Saint Lucia............146
Saint Vincent
and the
Grenadines.......147
Samoa...................148
San Marino...........149
Sao Tome and
Principe.............150
Saudi Arabia.........151
Senegal..................152
Serbia....................153
Seychelles.............154
Sierra Leone..........155
Singapore..............156
Slovakia.................157
Slovenia.................158
Solomon Islands...159
Somalia.................160
South Africa..........161
Spain......................162
Sri Lanka...............163
Sudan....................164
Suriname...............165
Swaziland..............166
Sweden..................167
Switzerland...........168
Syrian Arab
Republic............169
Tajikistan...............170
Tanzania, United
Republic of........171
Thailand.................172
The former Yugoslav
Republic of
Macedonia........173
Timor-Leste...........174
Togo.......................175
Tonga.....................176
Trinidad and
Tobago..............177
Tunisia...................178
Turkey....................179
Turkmenistan........180
Tuvalu....................181
Uganda..................182
Ukraine..................183
United Arab
Emirates............184
United Kingdom...185
United States........186
Uruguay.................187
Uzbekistan.............188
Vanuatu.................189
Venezuela
(Bolivarian
Republic of)......190
Viet Nam...............191
Yemen...................192
Zambia...................193
Zimbabwe.............194
Glossary of acronyms............................................... 195
iii
INTRODUCTION
Tracking, evaluating and sharing information provides a vital tool for understanding immunization
coverage. Statistics on levels and trends are used
to monitor the performance of services at local,
national and international levels. They guide campaigns to eradicate polio, control measles and
eliminate neonatal tetanus. They identify areas of
weak system performance and reveal areas where
focused attention and extra resources may be
required. And, when deciding whether to introduce
a vaccine, immunization levels and trends are one
important consideration.
The numbers for a single vaccine can provide vital
information for national and global action. Coverage
levels for the diphtheria and tetanus toxoid with
pertussis vaccine (DTP), for example, are considered to be a good indicator of health system performance. In addition, some funding agencies, such as
the Global Alliance for Vaccines and Immunization
(GAVI Alliance), often consider immunization coverage levels when reviewing applications for financial
and technical support, although coverage estimates
alone are insufficient to constitute a sole criterion for
determining whether a national immunization programme has achieved certain performance levels.
This reference book, jointly produced by the United
Nations Childrens Fund (UNICEF) and the World
Health Organization (WHO), presents detailed statistics on the performance of national and district-level
immunization systems in 194 countries and territories. It provides an overview of key aspects, including:
Basic indicators from WHO and UNICEF, the
United Nations Population Division and the World
Bank for each country or territory.
Trends in national and territorial coverage for
eight major antigens.
District-level performance in achieving coverage
with DTP and measles vaccines.
iv
Measles control activities, including coverage

achieved through routine services and information on national measles campaigns.
The most current immunization schedule
reported by each country or territory.
A copy of the most recent data collection form can
be found on the CD-ROM on the inside back cover
of this booklet. Background documentation and data
can also be downloaded, along with further information and electronic copies of this book, from the
following websites:
UNICEF: http://www.childinfo.org/immunization.html
WHO: http://www.who.int/immunization_monitoring/
data/en/
ANNUAL UPDATES
Table 1: Indicative budget prices for

major antigens, 2012
The prices listed in the table below are subject to change.
UNICEF Supply Division provides this information for
preliminary budget planning only. Full names of these
vaccines appear in the Glossary of acronyms, p. 195.
Vaccine (doses per vial)
BCG
DT
DTP
DTPHep
DTPHepHib
DTPHib
HepB
Hib
Influenza
MCV
MenAC
MMR
MR
OPV
bOPV
mOPV
Pneumococcal
Rotavirus
Td
TT
Yellow fever
BCG-20
DT-10
DTP-10
DTP-20
DTP-HepB-10 GAVI
DTP-HepB-Hib-1 (Liquid) non-GAVI
DTP-HepB+Hib-2 (Liquid + Lyophilized) non-GAVI
DTP-HepB-Hib-1 (Liquid) GAVI
DTP-HepB-Hib-10 (Liquid) GAVI
DTP-HepB+Hib-2 (Liquid + Lyophilized) GAVI
DTP-Hib-10 (Liquid) GAVI/non-GAVI
DTP+Hib-1 (Lyophilized) non-GAVI
DTP+Hib-10 (Lyophilized) GAVI
DTP+Hib-10 (Lyophilized) non-GAVI
HepB-1
HepB-2
HepB-6
HepB-10
HepB-1 adult (1 ml)
HepB-10 adult (10 ml)
Hib-1 (Liquid) non-GAVI*
Hib-1 (Lyophilized)
Influenza-10
Influenza-20
Mea-10
Meningitis AC-10*
MMR-1 (L-Zagreb strain)
MMR-1 (Urabe strain)
MMR-10 (Urabe & strain)
MR-10
OPV-10
OPV-20
bOPV-20
mOPV1-20
mOPV3-20
Pneumococcal-1** GAVI (13-val)
Pneumococcal-2** GAVI (10-val)
Pneumococcal-1 non GAVI (13-val)
Pneumococcal-2 non GAVI (10-val)
Rotavirus
Td-10
TT-10
TT-20
YF-5
YF-10
* Subject to availability.
** Vaccine prices to suppliers are initially US$7.00, however, AMC donors will pay
a portion of the price so that countries pay in 2012 a maximum of US$3.50.
viii
Recommended budget price, 2012

(US$ per dose)
(US$ per dose)
2.14
1.05
1.78
2.82
6.20
3.10
5.50
2.94
17.50
5.90
32.50
2.80
not available
34.00
0.40
0.58
2.04
2.10
0.37
1.90
3.65
3.40
5.50
45.00
2.44
11.50
1.95
3.10
4.50
16.50
9.30
5.36
1.78
2.90
2.90
3.10
3.10
3.50
7.00
20.00
30.00
TBD
0.99
0.85
1.03
3.30
10.78
0.1070
0.1050
0.1780
0.1410
0.6200
3.1000
2.7500
2.9400
1.7500
2.9500
3.2500
2.8000
not available
3.4000
0.4000
0.2900
0.3400
0.2100
0.3700
0.1900
3.6500
3.4000
5.5000
4.5000
0.2440
1.1500
1.9500
3.1000
0.9000
1.6500
0.9300
0.5360
0.1780
0.1450
0.1450
0.1550
0.1550
3.5000
3.5000
20.0000
15.0000
TBD
0.0990
0.0850
0.0514
0.6600
1.0780
ix
Table 2: Indicative budget price for

immunization devices, 2012
These prices are subject to change. UNICEF Supply Division
provides this information for preliminary budget planning only.
Device (box of 100,

unless otherwise stated)
BCG autodisable syringe, 0.05 ml
5.50
BCG autodisable syringe, 0.1 ml
5.29
Autodisable syringe, 0.5 ml
4.60
Reconstitution syringe, 2 ml, with needle
2.71
Re-use prevention feature syringe, 2 ml,

with fixed needle
5.70
3.50
Re-use prevention feature syringe, 5 ml,

with fixed needle
6.60
Re-use prevention feature syringe with SIP,

5 ml, with fixed needle
Recommended budget
price, 2012 (US$ per box)
18.00
4.75
Re-use prevention feature syringe with SIP,

10 ml, with fixed needle
20.00
Safety box, 5 litre (box of 25)
14.50
TRENDS: REGIONAL
PROGRESS TOWARDS
MDG4, 1980 - 2010
Note: The list of countries and territories in MDG regions appears

online at the United Nations Statistics Division website Millennium
Development Goals Indicators <http://mdgs.un.org/unsd/mdg/
Host.aspx?Content=Data/regionalGroupings>
xii
Global
MDG regions
Caucasus and Central Asia
Developed countries
Eastern Asia
Latin America
Caribbean
Northern Africa
Oceania
South-eastern Asia
Southern Asia
Sub-Saharan Africa
Western Asia
UNICEF regions
Central and Eastern Europe and CIS
East Asia and Pacific
Eastern and Southern Africa
Industrialised Countries
Latin America and the Caribbean
Middle East and North Africa
South Asia
West and Central Africa
WHO regions
African
American
Eastern Mediterranean
European
South East Asian
Western Pacific
MCV coverage
92
93
99
96
76
95
59
88
78
73
86
96
94
77
93
94
89
77
68
73
94
83
94
79
96
94
94
99
94
76
96
59
91
78
75
85
96
95
79
93
93
90
77
71
76
93
85
95
79
97
2010
84
2009
85
2008
70
94
83
94
78
95
96
93
76
93
95
87
77
62
93
94
97
96
76
92
58
88
78
69
86
83
2007
68
94
81
94
78
92
96
91
76
93
94
87
76
59
93
94
94
96
75
96
63
86
77
67
83
82
2006
66
94
80
94
75
92
96
90
73
93
95
86
73
59
93
94
93
96
76
96
68
85
74
66
82
81
2005
63
93
80
93
70
88
95
85
69
93
93
86
68
56
94
94
87
94
77
95
66
84
69
63
83
78
2004
62
94
76
92
67
88
92
85
71
92
94
86
64
52
94
93
87
95
78
93
63
84
65
61
82
76
2003
59
94
73
91
64
86
91
84
68
92
95
85
60
49
94
93
86
96
77
93
66
81
62
58
79
74
2002
56
93
73
91
61
86
92
83
68
91
93
85
58
44
91
92
86
94
78
93
65
80
59
56
82
73
2001
56
93
73
92
62
86
94
83
67
91
94
85
58
44
93
92
85
95
78
94
61
80
59
55
86
73
2000
56
92
72
91
62
85
93
83
64
91
93
86
57
46
93
92
84
94
76
93
66
80
59
55
86
72
1999
52
92
71
90
61
84
91
83
64
90
92
85
56
40
91
91
84
93
75
92
67
81
58
51
85
71
1998
55
91
70
88
59
83
90
82
67
89
90
85
54
41
91
90
82
91
76
93
64
81
56
53
84
71
1997
54
90
68
88
61
83
89
82
66
90
89
83
57
40
91
90
82
90
74
92
56
82
58
53
78
71
1996
54
86
69
86
69
84
85
83
67
90
84
84
64
41
89
90
83
85
75
92
39
82
65
53
76
73
1995
55
86
66
84
72
81
82
78
64
88
85
81
69
44
86
88
80
86
74
89
52
75
70
54
73
73
1994
56
84
67
83
69
77
81
75
66
86
82
80
66
44
77
86
76
83
73
89
47
75
67
54
74
71
1993
52
83
67
83
63
80
82
79
60
82
82
80
59
41
81
83
82
83
70
88
42
74
61
50
74
70
1992
51
83
67
81
56
85
81
82
57
81
83
79
53
41
77
82
87
84
67
87
73
72
55
49
72
69
1991
54
82
66
78
50
89
83
85
58
82
80
78
47
47
83
92
81
68
87
73
71
48
52
73
68
1990
58
80
66
79
59
94
85
89
61
83
76
79
56
50
84
98
77
64
84
70
70
57
56
77
72
1989
56
76
65
76
47
90
83
85
58
84
70
78
44
50
84
95
70
63
85
58
63
46
54
73
67
1988
50
74
62
72
35
88
84
82
53
81
66
73
33
43
82
94
66
60
83
52
55
35
48
70
62
1987
46
66
53
69
27
73
80
67
51
74
60
61
25
37
78
76
60
62
75
44
47
27
43
62
53
1986
42
68
50
65
16
61
78
56
48
75
61
58
14
32
77
63
62
55
71
42
41
16
39
60
46
1985
35
68
47
61
6
78
89
67
42
72
60
55
6
24
80
87
61
51
66
36
26
9
32
54
47
1984
26
62
34
57
3
73
89
60
38
70
52
33
5
15
79
82
53
35
37
25
15
6
25
45
41
1983
21
59
27
52
1
66
89
53
34
66
48
29
3
9
76
76
49
33
32
8
8
4
20
41
37
1982
14
59
23
44
0
5
85
1
20
61
48
30
1
9
71
1
50
23
28
3
2
3
14
39
20
1981
12
59
17
40
0
4
82
1
17
59
49
23
0
8
70
1
51
17
22
5
0
3
12
28
19
6
51
15
30
0
5
73
1
8
52
42
20
0
4
63
1
43
20
22
4
0
2
6
17
16
1980
xiii
Global
MDG regions
Caucasus and Central Asia
Developed countries
Eastern Asia
Latin America
Caribbean
Northern Africa
Oceania
South-eastern Asia
Southern Asia
Sub-Saharan Africa
Western Asia
UNICEF regions
Central and Eastern Europe and CIS
East Asia and Pacific
Eastern and Southern Africa
Industrialised Countries
Latin America and the Caribbean
Middle East and North Africa
South Asia
West and Central Africa
WHO regions
African
American
Eastern Mediterranean
European
South East Asian
Western Pacific
DTP3 coverage
94
95
99
94
78
97
67
88
77
75
86
95
94
77
95
93
90
76
72
76
93
85
96
77
97
94
95
99
94
79
97
62
88
77
77
86
95
94
80
95
93
91
76
72
77
93
87
96
77
96
2010
85
2009
85
2008
72
93
81
96
76
95
95
92
78
95
92
90
75
65
93
95
97
93
78
97
58
86
75
72
85
83
2007
70
93
83
96
75
92
96
90
77
95
93
88
74
62
92
96
93
94
79
97
65
86
75
70
83
82
2006
67
94
82
95
71
92
94
89
75
95
93
88
71
58
92
96
93
94
79
97
66
82
72
67
82
80
2005
65
94
82
95
72
88
94
85
74
96
93
88
71
55
93
96
87
94
78
96
66
82
72
65
84
79
2004
63
93
77
94
70
88
92
85
73
96
92
87
67
51
91
96
87
93
76
95
67
82
68
62
82
77
2003
59
93
75
91
67
87
87
84
70
96
92
86
64
46
92
95
86
94
71
94
72
81
65
58
76
75
2002
56
92
75
93
64
85
91
82
70
95
91
85
62
43
93
95
86
92
77
94
66
76
63
56
80
74
2001
56
91
75
94
65
86
93
83
69
94
90
87
63
41
93
95
86
91
73
96
61
79
64
55
85
74
2000
55
92
73
93
67
85
93
83
66
92
91
87
64
44
93
93
85
92
73
95
65
79
65
55
84
74
1999
53
91
71
93
67
84
91
82
65
93
89
85
64
40
93
94
84
90
73
93
66
79
65
52
82
74
1998
52
88
69
92
69
83
90
82
65
92
86
83
65
38
93
92
83
87
71
92
65
80
66
51
82
73
1997
50
86
67
91
67
83
88
82
66
91
83
82
62
32
91
91
83
84
70
90
53
81
63
49
77
72
1996
51
85
66
89
69
83
85
81
66
94
82
83
64
34
90
93
83
82
68
91
63
79
65
50
76
72
1995
54
86
68
87
71
80
82
79
67
91
83
81
68
38
87
90
80
84
70
89
68
76
69
52
74
73
1994
55
84
60
88
70
84
85
82
66
91
80
79
64
41
73
91
85
81
71
86
67
76
65
53
79
73
1993
50
81
62
81
64
86
75
83
61
87
78
81
59
36
60
87
88
79
70
85
65
74
60
48
78
70
1992
50
79
63
85
60
88
80
85
56
88
77
80
55
40
81
86
91
78
68
84
65
73
57
48
75
70
1991
49
80
65
85
61
92
79
87
57
89
78
78
57
37
86
94
78
68
81
73
74
59
48
74
71
1990
57
74
71
86
70
94
75
89
62
89
68
84
67
49
83
96
68
68
87
73
75
68
55
84
75
1989
51
72
65
85
53
92
74
87
55
90
64
81
49
42
84
95
64
68
87
61
69
50
49
80
68
1988
46
72
62
84
41
90
78
83
52
89
62
76
38
36
84
94
62
71
86
58
61
40
44
75
64
1987
43
69
53
84
33
72
80
68
51
89
59
65
29
31
85
75
59
65
82
54
54
31
40
71
56
1986
37
65
51
79
25
74
75
68
44
88
56
63
21
25
85
78
56
65
75
48
49
23
33
60
52
1985
32
64
46
71
20
73
81
65
40
80
56
57
19
20
82
78
56
50
73
45
38
20
29
55
49
1984
24
65
36
69
17
67
79
57
37
82
56
40
16
13
83
73
57
45
49
42
24
17
24
50
44
1983
18
60
28
61
14
55
79
46
31
76
49
33
13
7
79
58
50
43
42
36
20
14
18
40
38
1982
12
57
24
60
12
12
81
8
18
74
47
31
11
6
79
3
47
43
36
35
18
12
12
39
25
1981
11
54
19
59
7
11
84
8
17
72
42
25
6
5
78
3
43
36
30
37
17
7
11
40
23
5
50
18
44
7
8
76
6
9
62
37
24
5
1
69
1
37
32
29
36
15
7
5
28
20
1980
MAPS: GLOBAL INDICATORS
xvi
Source: WHO/UNICEF coverage estimates,

1980-2010, July 2011
90% (126 countries or 65%)
80-89% (24 countries or 12%)
50-79% (41 countries or 21%)
<50% (2 countries or 1%)
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of
its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate
border lines for which there may not yet be full agreement.
Map 1: Immunization coverage with measles-containing vaccines in infants, 2010
xvii
*155 developing countries and economies

in transition per UN World Economic &
Social Survey, 2010 classification
Source: WHO/UNICEF coverage estimates,

1980-2010, July 2011
Not applicable (32 countries)
(DTP3 estimated coverage for 2010

16 countries 90%; 4 countries <90%)
No data (20 countries or 13%)
No (89 countries or 57%)
Yes (46 countries or 30%)
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory,
city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps
represent approximate border lines for which there may not yet be full agreement.
Map 2: Developing and transition countries and territories* with all districts achieving at least 80% DTP3
coverage, 2010
NOTES ON INDICATORS
AND DATA
Basic indicators
Births The number of children born each year.
Surviving infants The number of children who have survived beyond
their first year of life.
For both births and surviving infants, figures are rounded to the nearest thousand. Where populations are small and birth rates are low,
the figure shown is 0. In countries or territories where the numbers
of births and surviving infants are very close, rounding to the nearest
thousand may cause the figures to appear equal. In places where the
birth rate is declining, it is possible for the number of surviving infants
to exceed births because the former were born in the previous year.
Infant mortality rate The probability of dying between birth and
exactly one year of age. The infant mortality rate is expressed as the
number of infant deaths per 1,000 live births.
Under-five mortality rate The probability of dying between birth and
exactly five years of age. The under-five mortality rate is expressed as
the number of deaths of children under age five per 1,000 live births.
Gross national income per capita (PPP, US$) Gross national income
(GNI) is the sum of value added by all resident producers, plus any
product taxes (less subsidies) not included in the valuation of output,
plus net receipts of primary income (compensation of employees and
property income) from abroad. GNI per capita is gross national income
divided by mid-year population. GNI per capita in US dollars is converted using the World Bank Atlas method. Purchasing power parity (PPP)
is a criterion for an appropriate exchange rate between currencies. It
indicates that a representative basket of goods in one country would
cost the same as in another country if the currencies are exchanged at
that rate. Actual exchange rates vary from the PPP levels for such reasons as the demand for imports or investments between countries.
Percentage of routine EPI vaccines financed by government The
immunizations in the Expanded Programme on Immunization (EPI)
include those against tuberculosis, diphtheria, tetanus and pertussis
(DTP), polio and measles, as well as protecting newborn children and
their mothers against tetanus by vaccination of pregnant women. In
some countries, other vaccines (e.g., against hepatitis B, Haemophilus
influenzae type B or yellow fever) may be included.
National coverage rates (WHO/UNICEF estimates)

UNICEF and WHO conduct an annual review of national or territorial
immunization reports to determine the most accurate levels of coverage. The resulting estimates are based on reported (administrative) data,
household surveys and government estimates as reported annually in
the WHO/UNICEF Joint Reporting Form on Immunization, as well as
data from the scientific and technical literature. As an essential part of
this review, UNICEF and WHO consult and collaborate with national and
territorial authorities. Prior to public release, the draft estimates are sent
to the authorities of each country or territory for their review and subsequent revisions as necessary. The vaccines included in this section are:
xx
BCG bacille Calmette-Gurin (vaccine against tuberculosis)

DTP1 first dose of diphtheria and tetanus toxoid with pertussis vaccine
DTP3 third dose of diphtheria and tetanus toxoid with pertussis vaccine
HepB3 third dose of hepatitis B vaccine
Hib3 third dose of Haemophilus influenzae type B vaccine
MCV measles-containing vaccine
Pol3 third dose of polio vaccine
PAB protection at birth against tetanus
Coverage for DTP1 should be at least as high as DTP3. Cases where
DTP1 coverage is less than DTP3 coverage reflect deficiencies in data
collection and reporting. UNICEF and WHO are working with national
systems to eliminate these discrepancies. Because DTP and Hib vaccines are dispensed on the same schedule, the coverage levels for
DTP3 and Hib3 should be similar. More information on the estimation
method can be found on the following websites:
UNICEF: http://www.childinfo.org/Immunization.html
WHO: http://www.who.int/immunization_monitoring/routine/
immunization_coverage/en/index4.html
District coverage (as reported)

The disaggregation of immunization statistics to the district level
assists efforts to ensure an equitable distribution of immunization for
all children. The data shown in this section reflect reported (administrative) coverage levels and give an indication of district-level performance. The data are reported through the annual WHO/UNICEF Joint
Reporting Form on Immunization.
Number of districts in country The total number of districts in a
country or territory; this figure may vary from year to year.
Percentage of districts reporting The proportion of districts that
report data through the annual WHO/UNICEF Joint Reporting Form
on Immunization.
DTP3 The proportion of districts achieving each of three coverage
ranges for DTP3. In some cases, not all districts are able to report
coverage levels; consequently, the sum of the three categories may
not be 100 per cent.
MCV The proportion of districts achieving coverage of 90 per cent
or higher for measles-containing vaccine.
DTP1-DTP3 drop-out rate The percentage of children who do not
receive all three doses of DTP after receiving an initial dose, compared
with all children who receive the initial dose of DTP. When a given
districts drop-out rate is less than 10 per cent, children who receive
an initial DTP dose are highly likely to receive all three required doses,
indicating a high level of health-care assistance and performance.
The key indicator given in this reference is the proportion of districts
categorized as high-performing, i.e., those with drop-out rates of less
than 10 per cent.
xxi
Measles control activities (as reported)

Measures such as introducing two rather than one dose of the measles vaccine into the national immunization schedule and conducting
supplementary immunization activities to fill in the gaps in routine
vaccination delivery systems are necessary to prevent measles outbreaks. This section presents data on:
MCV2 routine coverage in 2010: the level of coverage by the second
dose of the measles-containing vaccine, as reported in the annual
WHO/UNICEF Joint Reporting Form on Immunization.
Most recent national measles campaign: the year, target age group
and coverage level of the most recent national measles campaign (as
opposed to a rollover campaign, implemented in several subnational
stages over a period of time).
Immunization schedule
Updated immunization schedules are submitted through the annual
WHO/UNICEF Joint Reporting Form on Immunization. The notations
used in each table may vary slightly because there is no standard
format for reporting immunization schedules.
Note: In all instances, an ellipsis indicates that data are not available.
DATA SOURCES
Births, surviving infants, total population: United Nations
Population Division.
Infant mortality rate, under-five mortality rate: The State of the
Worlds Children 2011, UNICEF, New York, 2010.
Gross national income per capita: The World Bank.
National coverage: WHO/UNICEF Review of National Immunization
Coverage 1980-2010, July 2011.
Percentage of routine EPI vaccines financed by government,
district coverage, measles control activities and immunization
schedules: WHO/UNICEF Joint Reporting Form on Immunization,
data collected in 2011.
xxii
COUNTRIES AND
TERRITORIES
Afghanistan
2010
Births........................................................................................................................ 1,385,000
Surviving infants.................................................................................................... 1,205,000
Total population................................................................................................... 31,412,000
Infant mortality rate (per 1,000 live births).................................................................... 103
Under-five mortality rate (per 1,000 live births)............................................................ 149
Gross national income per capita (PPP, US$)................................................................ 970
Percentage of routine EPI vaccines financed by government........................................... 2
National coverage rates (%) (WHO/UNICEF estimates, 2010)

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
68
64
66
60
60
57
30
31
30
17
...
DTP1
86
84
85
84
81
80
48
44
50
37
22
DTP3
66
63
64
63
58
58
24
20
25
15
HepB3
66
63
64
63
...
...
...
...
...
...
...
Hib3
66
63
...
...
...
...
...
...
...
...
...
MCV
62
60
59
55
53
50
27
41
20
14
11
Pol3
66
63
64
63
58
58
24
20
25
15
PAB
79
89
83
84
95
96
32
13
13
13

2010 2009
Number of districts in country

Percentage of districts reporting
329
329
98
97
11
12
DTP3: proportion of districts with coverage (%) between 50-79%
29
29
58
56
MCV: proportion of districts with coverage at 90% or above (%)
34
26
DTP1DTP3 drop-out rate: proportion of districts that

have achieved a rate of less than 10% (%)
50
54
below 50%
at 80% or above

46
MCV2 routine coverage in 2010 (%)

year
2009
Most recent national measles campaign
target age group
coverage (%)
9-36 m
110
BCG birth
DTwPHibHep
Measles
6, 10, 14 weeks
9, 18 months
OPV

TT
birth; 6, 10, 14 weeks;

9 months
1st contact; +1, +1 year (CBAW)
Albania
2010
Births............................................................................................................................. 41,000
Surviving infants......................................................................................................... 40,000
Total population..................................................................................................... 3,204,000
Infant mortality rate (per 1,000 live births)...................................................................... 16
Under-five mortality rate (per 1,000 live births).............................................................. 18
Gross national income per capita (PPP, US$)............................................................. 8,840
Percentage of routine EPI vaccines financed by government....................................... 100

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
97
99
98
97
98
93
97
94
92
93
DTP1
99
99
99
98
98
99
98
98
97
98
97
DTP3
99
98
99
98
97
98
97
97
94
96
94
HepB3
99
98
99
98
98
98
96
88
...
...
...
Hib3
99
98
...
...
...
...
...
...
...
...
...
MCV
99
97
98
97
95
97
95
91
88
96
90
Pol3
99
98
99
99
97
97
97
98
89
94
92
PAB
87
87
87
87
87
86
86
90
30
...
...

2010 2009

36
36
100
100
100
100
100
100

100
94
below 50%

at 80% or above

99

year
2000
target age group
coverage (%)
12 m-14 y
99
BCG birth
MMR
DT
6 years
OPV
DTwP
2 years
Td
14 years
2, 4, 6 months
TT
1st contact; +1 month
DTwPHibHep
HepB birth
1, 5 years
2, 4, 6 months; 2, 6 years
Algeria
2010
Births........................................................................................................................... 714,000
Surviving infants....................................................................................................... 698,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
98
97
93
99
86
...
DTP1
99
98
97
98
98
94
92
96
96
88
...
DTP3
95
95
93
95
95
88
86
88
89
69
...
HepB3
95
94
91
90
80
83
...
...
...
...
...
Hib3
95
95
93
...
...
...
...
...
...
...
...
MCV
95
92
88
92
91
83
80
89
83
68
...
Pol3
95
94
92
95
95
88
86
88
89
69
...
PAB
90
71
71
70
70
69
64
44
75
...
...

2010 2009

271
464
77
100
...
...
71
...
50
...

94
...
below 50%

at 80% or above

...

year
2007
target age group
coverage (%)
unknown
91
BCG birth
HepB
birth; 1, 5 months
DT
Measles
9 months; 6 years
6 years
DTwPHib
3, 4, 5, 18 months
Influenza
high-risk groups
OPV

Td
birth; 3, 4, 5, 18 months;
6 years
11-13, 16-18 years
Andorra
2010
Births................................................................................................................................... ...
Surviving infants............................................................................................................... ...
Total population................................................................................................................ ...
Infant mortality rate (per 1,000 live births)........................................................................ 3
Under-five mortality rate (per 1,000 live births)................................................................ 4
Gross national income per capita (PPP, US$)................................................................. ...

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
98
97
99
99
...
...
...
...
DTP3
99
99
99
96
93
98
98
...
...
...
...
HepB3
96
96
94
91
84
79
84
...
...
...
...
Hib3
98
97
98
95
93
97
90
...
...
...
...
MCV
99
98
98
94
91
94
97
...
...
...
...
Pol3
99
99
99
96
93
98
95
...
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
DTaP
DTaPHibHepIPV
DTaPHibIPV
5, 15 years
2, 6 months
4, 18 months
HepB birth
MenC_conj
MMR
Pneumo_conj
2, 4, 18 months
15 months; 5 years
3, 5, 15 months
Angola
2010
Births........................................................................................................................... 795,000
Percentage of routine EPI vaccines financed by government......................................... 29

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
93
83
87
88
65
61
56
60
48
28
...
DTP1
97
93
99
94
66
62
44
48
48
28
...
DTP3
91
73
81
83
44
47
31
24
24
...
HepB3
91
73
81
83
...
...
...
...
...
...
...
Hib3
91
73
81
83
...
...
...
...
...
...
...
MCV
93
77
79
88
48
45
41
46
38
44
...
Pol3
92
73
75
83
44
46
33
28
23
13
...
PAB
75
88
79
78
77
75
60
48
34
19
...

2010 2009
164
164
100
99
16
33
23
26
60
40
53
34

29
28
below 50%
at 80% or above

0

year
2009
target age group
coverage (%)
9-59 m
101
BCG birth
DTwPHibHep
Measles
OPV
2, 4, 6 months
9 months
birth; 2, 4, 6 months
TT

Vitamin A
Yellow fever
1st contact pregnancy; +1,

+6 months; +1, +1 year
6, 9 months
9 months; travellers
Antigua and Barbuda

2010
Births................................................................................................................................... ...
Gross national income per capita (PPP, US$)........................................................... 15,380
Percentage of routine EPI vaccines financed by government........................................ ...

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
99
99
99
98
99
99
99
77
DTP3
98
99
99
99
99
99
95
99
99
99
54
HepB3
98
98
98
97
99
99
...
...
...
...
...
Hib3
98
94
97
99
99
99
...
...
...
...
...
MCV
98
99
99
99
99
99
95
93
89
69
...
Pol3
99
98
99
98
99
98
96
99
99
99
36
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

...
100
...
...
...
100
...
100
...
...
...

...
year
...
target age group
...
coverage (%)
...
DT
DTwP
DTwPHibHep
5 years
18 months
2, 4, 6 months
HepB
1st contact; +1, +5 months
(adults)
Influenza
MMR
OPV
Td

6-35 months
1, 5, 15 years
2, 4, 6, 18 months; 5 years
1st contact; +1.5, +6 months;
+10 years
Argentina
2010
Births........................................................................................................................... 694,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
99
99
90
62
DTP1
98
94
97
98
98
98
94
95
95
86
69
DTP3
94
87
92
96
94
94
83
85
87
66
44
HepB3
94
92
89
92
90
85
...
...
...
...
...
Hib3
94
87
92
96
94
94
83
...
...
...
...
MCV
99
99
97
98
97
99
91
99
93
54
61
Pol3
96
96
94
94
94
95
88
90
90
73
33
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
511
511
100
99
29
23
68
70
64
64

...
...
below 50%
at 80% or above

98

year
target age group
coverage (%)
2008
19-36 y
77
BCG
DTwP
DTwPHib
DTwPHibHep
HepA
HepB
Hib
Influenza
IPV
MenC_conj
1 week
6 years
18 months
2, 4, 6 months
1 year
birth; 11 years (catch up)
high-risk groups
<2 years; >65 years
high-risk groups
(if indicated)
MMR
1, 6 years
MR post-partum
OPV
Pneumo_conj
high-risk groups
Pneumo_ps
high-risk groups
Td
pregnancy; adults
Tdap
11 years; health workers (if indicated)
Typhoid military
Varicella
high-risk groups
Yellow fever
1 year (high-risk areas)
Armenia
2010
Births............................................................................................................................. 47,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
95
99
98
94
91
94
97
84
...
...
...
DTP1
98
97
96
96
95
96
97
98
...
...
...
DTP3
94
93
89
88
87
90
93
98
...
...
...
HepB3
94
93
89
85
78
91
55
...
...
...
...
Hib3
48
...
...
...
...
...
...
...
...
...
...
MCV
97
96
94
92
92
94
92
96
...
...
...
Pol3
96
94
91
90
87
92
96
93
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

51
51
100
100
100
98
100
96
96
96

97

year
2009
target age group
coverage (%)
28-45 y
67
BCG birth
MMR
DTwP
OPV

DTwPHibHep
18 months
6, 10, 14 weeks
HepB birth
Td
1, 6 years
6, 10, 14 weeks; 18 months;
6 years
6, 16, 26, 36, 46, 56 years
Australia
2010
Births........................................................................................................................... 303,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
97
97
97
97
97
97
96
95
98
87
58
DTP3
92
92
92
92
92
92
90
86
95
68
33
HepB3
92
92
94
94
95
95
...
...
...
...
...
Hib3
92
92
94
94
95
94
90
...
...
...
...
MCV
94
94
94
94
94
94
91
87
86
68
...
Pol3
92
92
92
92
92
92
90
86
72
94
17
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

100
100
100
100
100
100
...
...

...
year
...
target age group
...
coverage (%)
...
DTaP
15-17 years
DTaPHepIPV
2, 4, 6 months (subnational)
DTaPHibHepIPV
2, 4, 6 months
DTaPIPV
4 years
HepA
12-24, 18-24 months (subnational)
HepB
birth; 2, 4, 6 months;

1, 10-13 years (subnational)
HepBHib
Hib
2, 4, 6, 12 months (subnational)
HPV
12-13 years (females)
Influenza
65 years (subnational);

high-risk groups
MenC_conj
1 year (subnational)
MMR
1, 4 years
Pneumo_conj
2, 4, 6 months
Pneumo_ps
18-24 months; 15-49 years;
50 years (subnational)
Rotavirus
2, 4, 6 months (subnational, 3rd

dose depending on vaccine)
Varicella 18 months; 10-13 years (subnational)
Austria
2010
Births............................................................................................................................. 74,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
90
90
DTP1
93
93
97
99
99
99
99
96
96
96
96
DTP3
83
83
83
85
83
86
81
90
90
90
90
HepB3
83
83
83
85
83
86
33
...
...
...
...
Hib3
83
83
83
85
83
86
72
...
...
...
...
MCV
76
76
83
79
80
75
75
60
60
40
...
Pol3
83
83
83
85
83
86
71
90
90
90
90
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
121
121
...
...
...
...
...
...
...
...
...

...
100

below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
DTaPHibHepIPV birth-1 year (3 doses);

1-2 years
HepB
HPV

MMR

10
12-13 years (booster)

9 years (females, 3 doses,
private sector)
1-2 years (2 doses); (catch up
at any age)
Pneumo_conj
birth-1 year (3 doses);

1-2 years (high-risk
groups)
Rotavirus

7 weeks-6 months (2 or 3
doses depending
on vaccine)
Azerbaijan
2010
Births........................................................................................................................... 182,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
81
81
81
81
82
81
81
76
...
...
...
DTP1
80
79
80
80
80
78
82
79
...
...
...
DTP3
72
73
74
74
74
72
75
74
...
...
...
HepB3
49
49
49
49
45
48
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
67
67
66
66
65
67
67
64
...
...
...
Pol3
78
78
80
79
79
79
76
71
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

64
64
100
100
100
100
95
100
100
100

98

year
2006
target age group
coverage (%)
23-35 y
95
BCG
DT
4-7 days
MMR
6 years
OPV
DTwP
2, 3, 4, 18 months
HepB
birth; 2, 4 months
Vitamin A
1, 6 years
4-7 days; 2, 3, 4, 18 months
12, 18 months; 6 years
11
Bahamas
2010
Births............................................................................................................................... 5,000
Surviving infants........................................................................................................... 5,000
Total population........................................................................................................ 343,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
98
95
99
99
95
95
95
61
DTP3
99
96
93
95
95
93
99
87
86
86
36
HepB3
98
95
90
93
96
93
...
...
...
...
...
Hib3
98
96
94
95
95
93
90
...
...
...
...
MCV
94
98
90
96
88
85
93
90
86
79
...
Pol3
97
97
93
95
94
93
91
86
82
84
35
PAB
90
90
90
90
92
90
85
79
71
...
...

2010 2009
31
31
...
...
...
...
...
...
...

...
100

below 50%
at 80% or above

47

year
target age group
coverage (%)
2007
4-40 y
21
DT
DTaPHepIPV
DTaPHibHepIPV
DTaPHibIPV
DTwP
DTwPHib
DTwPHibHep
HepB
12
4-5 years
4, 6 months
4, 6 months
4, 6 months
4, 6 months
15 months
2, 4, 6 months
high-risk groups
2,
2,
2,
2,
Hib
2, 4, 6 months
Influenza
high-risk groups
IPV
2, 4, 6 months; 4-5 years

(subnational)
MMR
1, 4-5 or 11 years (catch up)
OPV
Pneumo_conj
2, 4, 6 months;

high-risk groups
Td
10 years
Bahrain
2010
Births............................................................................................................................. 23,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
98
98
97
99
99
98
98
97
96
89
DTP3
99
98
98
97
98
98
97
95
94
90
72
HepB3
99
98
98
97
98
98
97
95
...
...
...
Hib3
99
97
97
97
97
98
97
...
...
...
...
MCV
99
99
99
99
99
99
98
95
87
78
45
Pol3
99
97
97
97
98
98
97
95
94
90
72
PAB
94
94
99
96
93
97
84
59
48
34

2010 2009

...
100
...
...
...
100
...
100
...

100
...
below 50%

at 80% or above

98

year
...
target age group
...
coverage (%)
...
BCG
birth (high-risk groups)
DT
2, 4, 6, 18 months (pertussis
contraindication)
DTaP
5 years
DTaPHibHepIPV
2 months
DTwPHibHep
4, 6, 18 months
HepA
18 months; 2 years or

12-13 years (catch up); travellers
HepB
birth; 1 month (high-risk groups)
Hib
high-risk groups
Influenza
6 months (high-risk groups);

>50 years; travellers
IPV

(high-risk groups)
MenACWY
2 years (high-risk groups); travellers
MMR
1, 5 years
OPV
Pneumo_conj
2, 4, 6 months; 1 year
Pneumo_ps
65 years; high-risk groups
Rotavirus
2, 4 months
Td
>12 years (post-trauma,

pregnancy, pilgrims)
Tdap
13 years
Typhoid travellers
Varicella
high-risk groups; health workers
Yellow fever
travellers
13
Bangladesh
2010
Births........................................................................................................................ 3,038,000
Total population................................................................................................. 148,692,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
94
94
90
92
96
97
95
93
86
...
DTP1
98
97
95
97
95
96
88
87
86
20
...
DTP3
95
96
95
95
93
96
83
69
69
...
HepB3
95
96
95
95
94
45
...
...
...
...
...
Hib3
95
96
...
...
...
...
...
...
...
...
...
MCV
94
98
96
95
92
94
72
79
65
...
Pol3
95
96
95
95
93
96
84
69
69
...
PAB
93
93
91
91
92
89
89
85
70

2010 2009

64
64
100
100
...
20
20
80
80
52
69
100
100
below 50%
at 80% or above


...

year
2010
target age group
coverage (%)
9 m-5 y
100
BCG birth
OPV
DTwPHibHep
TT

Measles
6, 10, 14 weeks
38 weeks
Vitamin A
14
6, 10, 14, 38 weeks

15 years; +1, +6 months;
+1, +1 year
38 weeks
Barbados
2010
Births............................................................................................................................... 3,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
95
93
85
93
94
97
93
97
97
94
82
DTP3
86
93
85
93
84
92
93
93
91
83
60
HepB3
86
93
85
93
84
92
...
...
...
...
...
Hib3
86
93
85
93
84
92
...
...
...
...
...
MCV
85
94
94
75
92
93
94
92
87
88
41
Pol3
90
93
85
93
85
91
86
93
90
88
99
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
...
...
...
...
...
...

...
100
below 50%
at 80% or above

96

year
...
target age group
...
coverage (%)
...
BCG
5 years
DT
5-7 years
DTwP
18 months; 4.5 years
DTwPHibHep
3, 4, 6 months
HepB adults
Influenza
high-risk groups
(subnational)
IPV
2, 4, 6, 18 months; 4.5, 10-11

years (high-risk groups)
MMR
1, 3-5 years
OPV
2, 4, 6, 18 months; 4.5,

10-11 years
Pneumo_conj
2, 4, 6 months
Td
10-11 years
Varicella 18 years (high-risk groups)
Yellow fever
1 year; travellers
15
Belarus
2010
Births........................................................................................................................... 106,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
98
98
98
99
99
99
96
...
...
...
DTP1
99
98
98
99
99
99
99
98
...
...
...
DTP3
98
96
97
95
99
99
99
96
...
...
...
HepB3
96
98
98
91
98
99
70
...
...
...
...
Hib3
19
...
...
...
...
...
...
...
...
MCV
99
99
99
99
97
99
98
93
...
...
...
Pol3
99
98
98
90
97
98
99
96
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
130
119
100
100
below 50%
100
100
100
100

100
...
at 80% or above

99

year
...
target age group
...
coverage (%)
...
BCG
3-5 days; 7, 14 years
IPV
Dip
11 years
MMR
DT
6 years
OPV
3, 4, 5 months
1, 6 years
DTwP
3, 4, 5, 18 months
Td
HepB
birth; 1-5 months
TT outbreaks
Hib
Influenza
16
high-risk groups
Yellow fever
16 years
high-risk groups
Belgium
2010
Births........................................................................................................................... 122,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
99
99
97
97
97
97
98
98
DTP3
99
99
99
99
99
97
95
94
93
95
95
HepB3
97
97
98
94
94
77
60
...
...
...
...
Hib3
97
97
98
98
98
95
86
13
...
...
...
MCV
94
94
93
92
92
88
82
85
85
82
...
Pol3
99
99
99
99
99
97
96
92
95
97
99
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

43
43
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
DTaPHibHepIPV
DTaPIPV
HepB
2, 3, 4, 15 months
5-7 years
10-13 years (catch up)
HPV
10-13 years (females,
subnational)
MenC_conj
MMR
15 months
12 months; 10-13 years
Pneumo_conj

Rotavirus

Td
Tdap
2, 4, 12 months;
high-risk groups
>2 years
2, 3, 4 months (3rd dose
depending on vaccine)
every 10 years
14-16 years
17
Belize
2010
Births............................................................................................................................... 8,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
99
98
99
97
96
96
92
93
81
71
DTP1
99
99
98
98
98
98
97
94
97
81
72
DTP3
96
97
94
96
98
96
91
83
91
58
47
HepB3
96
97
94
96
98
96
76
...
...
...
...
Hib3
96
97
94
96
98
96
...
...
...
...
...
MCV
98
97
96
96
99
95
96
83
86
49
21
Pol3
96
98
94
97
98
96
91
83
86
61
44
PAB
88
88
88
87
85
87
85
87
88
88
...

2010 2009


below 50%

at 80% or above

100
100
100
100
67
100
100
83

91

year
2010
target age group
1-2 y
coverage (%)
95
BCG birth
DT


(pertussis contraindication)
DTwP
DTwPHibHep
4-5 years
2, 4, 6 months
HepB
2, 4, 6 months (pertussis
contraindication);

high-risk groups
Influenza

6-24 months (2 doses); >65

years; health workers;
high-risk groups
IPV
(HIV-exposed)
MMR
OPV
Vitamin A 6, 12, 18, 24, 30, 36 months

Yellow fever
18
1, 2 years
>1 year (travellers)
Benin
2010
Births........................................................................................................................... 350,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
97
97
97
97
99
88
92
85
92
27
...
DTP1
94
94
91
99
99
84
89
82
86
36
...
DTP3
83
83
78
82
74
70
78
67
74
17
...
HepB3
83
83
78
82
74
70
...
...
...
...
...
Hib3
83
83
78
82
74
35
...
...
...
...
...
MCV
69
72
66
70
66
61
70
65
79
23
...
Pol3
83
83
79
82
76
73
78
68
74
16
...
PAB
92
92
92
93
95
95
87
82
48
...
...

2010 2009

77
77
100
100
91
91
65
75

69
77
below 50%

at 80% or above

...

year
2008
target age group
coverage (%)
9-59 m
102
BCG birth
Pneumo_conj
DTwPHibHep
TT

Measles
OPV
6, 10, 14 weeks
9 months
birth; 6, 10, 14 weeks
6, 10, 14 weeks

Vitamin A
6 months
Yellow fever
9 months
19
Bhutan
2010
Births............................................................................................................................. 15,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
96
94
99
94
92
92
97
98
99
54
43
DTP1
94
97
97
98
98
97
99
95
98
66
25
DTP3
91
93
96
95
95
95
92
87
96
41
HepB3
91
93
96
95
95
95
98
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
95
94
99
95
90
93
78
85
93
44
21
Pol3
92
93
96
93
96
95
98
86
96
41
PAB
89
89
89
84
85
85
85
78
63
...

2010 2009

20
20
100
100
10
15
90
85
75
75
100
100
below 50%
at 80% or above


85

year
2006
target age group
coverage (%)
9 m-44 y
98
BCG birth
MR
DT
OPV
DTwPHep
HPV

20
2 years
6, 10, 14 weeks
12-18 years; +2, +6 months
(females)
TT

Vitamin A
9, 24 months
1st contact pregnancy;
+1 month
6, 12, 18, 24, 30, 36 months
Bolivia
2010
Births........................................................................................................................... 263,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
90
88
86
86
87
88
92
87
65
24
30
DTP1
87
87
87
85
87
93
92
84
66
58
32
DTP3
80
85
83
82
83
85
75
64
41
33
11
HepB3
80
85
83
82
83
85
77
...
...
...
...
Hib3
80
85
83
82
83
85
77
...
...
...
...
MCV
79
86
87
83
88
89
84
58
53
21
13
Pol3
80
84
82
82
82
84
74
64
50
30
14
PAB
74
74
74
71
71
70
67
57
23
...
...

2010 2009
337
327
100
99
13
11
41
39
46
49
30
38

81
92
below 50%
at 80% or above

...

year
2003
target age group
1-4 y
coverage (%)
95
BCG birth
OPV
DTwPHep
2, 4, 6 months
Rotavirus
DTwPHibHepIPV
2, 4, 6 months
Td

Influenza
MMR
high-risk groups
12-23 months
2, 4, 6 months
2, 4 months
1st contact; +1, +6 months;
+1, +1 year
Vitamin A
Yellow fever
6-11 months
12-23 months
21
Bosnia and Herzegovina

2010
Births............................................................................................................................. 32,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
97
97
96
98
97
95
93
64
...
...
...
DTP1
95
95
95
96
94
95
90
78
...
...
...
DTP3
90
90
91
95
87
93
85
55
...
...
...
HepB3
90
90
88
94
90
93
...
...
...
...
...
Hib3
80
80
83
83
82
50
...
...
...
...
...
MCV
93
93
84
96
85
90
80
53
...
...
...
Pol3
90
90
92
95
91
95
87
69
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

18
10
100
100
11
10
89
90
72
60

89
90
below 50%
at 80% or above

90

year
...
target age group
...
coverage (%)
...
BCG
DT
DTaP

DTaPIPV
DTPHibIPV
22
birth (subnational)
3, 4, 6 months; 5 years
(subnational)
HepB
Hib
MMR
OPV

birth; 1, 6 months
2-3, 3-5, 18 months; 2 years
1, 6 years (subnational)
3, 4, 5-6, 18-24 months; 5-6,
Td
TT
18 years (subntional)
Botswana
2010
Births............................................................................................................................. 47,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
96
93
97
92
DTP1
98
98
98
98
98
98
98
98
99
98
89
DTP3
96
96
96
96
96
96
97
95
92
84
71
HepB3
93
93
93
93
93
92
86
73
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
94
94
94
94
94
93
91
89
87
85
63
Pol3
96
96
96
96
96
96
97
94
90
85
46
PAB
92
92
85
84
84
83
80
72
59
39
...

2010 2009

24
24
100
100
92
96
58
58

75
54
below 50%

at 80% or above

...

year
2009
target age group
coverage (%)
unknown
115
BCG birth
OPV
DTwP
2, 3, 4, 18 months
HepB
birth; 2, 9 months
TT


Measles
9 months
Vitamin A

9-12, 18, 24, 30, 36, 42

months; birth-6 months
if not breastfed
23
Brazil
2010
Births........................................................................................................................ 3,023,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
99
79
63
56
DTP1
99
99
99
98
98
97
99
85
86
86
62
DTP3
98
98
98
97
97
96
98
81
66
66
37
HepB3
96
99
96
99
99
92
94
10
...
...
...
Hib3
99
99
99
98
97
96
90
...
...
...
...
MCV
99
99
99
99
99
99
99
87
78
67
57
Pol3
99
99
99
99
99
98
99
79
58
52
69
PAB
92
92
92
92
92
67
92
78
63
...
...

2010 2009
5,565 5,565

below 50%
100
100
11
89
92
71
81

83
85
at 80% or above

53

year
target age group
coverage (%)
2008
20-39 y
94
BCG
birth; high-risk groups
DT
contraindication)
DTaP
2, 4, 6 months (high-risk groups)
DTwP
DTwPHibHep
2, 4, 6 months
DtwPHib
2, 4, 6 months
HepA
12, 18 months (high-risk groups)
HepB
birth; 1, 6 months; high-risk groups
Hib
2, 4, 6, 15 months (high-risk groups)
Influenza
6 months-9 years (2 doses); 60 years
IPV
24
MenAC
2 years (if indicated, subnational)
MenC_conj
3, 5 months; >1 year;

high-risk groups
MMR
1, >4 years; adolescents; adults
OPV
2, 4, 6, 15 months
Pneumo_conj
2, 4, 6, 15 months
Pneumo_ps
>2, 7, >60 years (high-risk groups)
Rotavirus
35, 97 days
Td
>7 years (4 doses)
Typhoid
2 years (2 doses, high-risk groups)
Varicella
12, 14 months (high-risk groups)
Yellow fever
9 months; 10 years (subnational)
Brunei Darussalam
2010
Births............................................................................................................................... 8,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
95
99
99
96
99
96
99
99
91
95
99
DTP1
98
99
99
99
99
99
99
99
97
96
96
DTP3
95
99
98
99
97
94
99
99
93
88
89
HepB3
96
96
96
97
99
99
99
99
96
...
...
Hib3
95
99
98
99
97
94
...
...
...
...
...
MCV
94
99
99
97
97
98
99
99
99
98
73
Pol3
99
99
98
95
94
93
99
99
92
88
89
PAB
95
65
65
64
64
64
77
69
40
51
...

2010 2009


below 50%

at 80% or above

100
100
100
100
100
100
75
...

93

year
...
target age group
...
coverage (%)
...
BCG birth
Influenza seasonal
DT
MMR
DTwPHib
HepB
5 years
2, 3, 4 months
OPV
1, 3 years
2, 3, 4 months
birth; 1, 6 months
25
Bulgaria
2010
Births............................................................................................................................. 76,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
98
98
98
98
98
98
99
99
99
99
DTP1
96
96
97
96
97
97
95
98
99
99
98
DTP3
94
94
95
95
95
96
93
96
99
99
98
HepB3
95
96
96
95
96
96
94
95
...
...
...
Hib3
91
...
...
...
...
...
...
...
...
...
...
MCV
97
96
96
96
96
96
89
94
99
99
98
Pol3
96
94
96
95
96
97
94
97
99
99
99
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

28
28
100
100
96
100
100
100
82
96

...

year
2009
target age group
coverage (%)
13 m-30 y
...
BCG

birth; 7 months; 7, 11, 17 years

(after Mantoux test negative)
DT
2, 3, 4, 24 months (pertussis
contraindication)
DTaPHibIPV
DTaPIPV
DTwP
26
2, 3, 4, 16 months
6 years
2, 3, 4, 24 months
HepB
Influenza
birth; 1, 6 months
>65 years; high-risk groups
IPV
2, 3, 4, 16 months
MMR
13 months; 12 years
Pneumo_conj
2, 3, 4, 12 months
Rabies post-exposure
Td
12, 17, 25, 35, 45, 55 years
Burkina Faso
2010
Births........................................................................................................................... 713,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
80
72
95
33
...
DTP1
98
98
98
96
93
89
97
79
92
35
...
DTP3
95
95
95
88
81
82
63
34
66
...
HepB3
95
95
95
88
76
...
...
...
...
...
...
Hib3
95
95
95
88
76
...
...
...
...
...
...
MCV
94
94
94
94
88
84
59
43
79
38
...
Pol3
94
94
94
94
94
94
64
35
66
10
...
PAB
85
85
79
80
76
72
57
64
55
...

2010 2009

63
63
100
100
100
100
100
81

100
100
below 50%

at 80% or above

...

year
2007
target age group
coverage (%)
9-59 m
102
BCG birth
OPV
DTwPHibHep
TT
Measles
1, 2, 3 months
9 months
1st contact pregnancy; +1 month
Yellow fever
9 months
27
Burundi
2010
Births........................................................................................................................... 283,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
93
98
99
97
98
89
85
92
97
52
...
DTP1
99
99
97
99
99
96
88
86
95
61
...
DTP3
96
94
92
99
92
87
80
73
86
36
...
HepB3
96
94
92
99
92
87
...
...
...
...
...
Hib3
96
94
92
99
92
87
...
...
...
...
...
MCV
92
91
84
88
92
87
76
80
74
32
...
Pol3
94
96
89
93
88
82
71
73
97
58
...
PAB
94
94
78
76
66
65
51
61
67
21
...

2010 2009


below 50%
45
43
100
100
91
91
56
72

93
91
at 80% or above

...

year
2010
target age group
coverage (%)
6 m-14 y
99
BCG birth
OPV
DTwPHibHep
TT
Measles
28
6, 10, 14 weeks
9 months
Vitamin A

1st contact
9, 18, 24, 30, 36, 42 months
Cambodia
2010
Births........................................................................................................................... 318,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
94
96
98
90
87
87
81
69
52
33
...
DTP1
93
99
95
87
85
85
78
55
63
47
...
DTP3
92
94
91
82
80
82
59
39
38
23
...
HepB3
92
92
91
82
80
...
...
...
...
...
...
Hib3
92
...
...
...
...
...
...
...
...
...
...
MCV
93
92
89
79
78
79
65
62
34
29
...
Pol3
92
95
91
82
80
82
62
39
38
26
...
PAB
91
91
87
87
84
81
58
45
11
...

2010 2009

77
77
100
100
14
10
86
88
51
49

96
90
below 50%
at 80% or above

...

year
2007
target age group
coverage (%)
9-59 m
104
BCG birth
Measles
DTwPHibHep
OPV
6, 10, 14 weeks
HepB birth
JE
TT

9 months
6, 10, 14 weeks
10 months (subnational)
Vitamin A
6-59 months (2 doses)
29
Cameroon
2010
Births........................................................................................................................... 710,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
96
92
99
94
98
90
78
62
76
54
...
DTP1
92
88
93
90
87
85
82
71
70
52
...
DTP3
84
80
84
82
81
80
62
46
48
33
...
HepB3
84
80
84
82
81
79
...
...
...
...
...
Hib3
84
80
...
...
...
...
...
...
...
...
...
MCV
79
74
80
74
73
68
49
46
56
39
...
Pol3
83
79
82
81
78
79
57
46
54
35
...
PAB
91
91
86
83
81
76
54
20
19
10
...

2010 2009
179
173
100
100
31
43
65
51
28
17

68
66
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG birth
DTwPHibHep
Measles
OPV
30
6, 10, 14 weeks
9 months
TT


+1, +2 years
Vitamin A 6 months; +every 6 months

until 59 months; post-partum
Yellow fever
9 months
Canada
2010
Births........................................................................................................................... 383,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
92
92
92
98
98
98
97
97
96
...
...
DTP3
80
80
80
94
94
94
92
87
88
...
...
HepB3
17
17
17
14
14
14
...
...
...
...
...
Hib3
80
80
80
87
94
90
86
...
...
...
...
MCV
93
93
93
94
94
94
96
96
89
...
...
Pol3
80
80
80
90
94
92
88
89
88
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
13
...
100
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG
high-risk groups
DTaPIPV
4-6 years
DTPHibIPV
2, 4, 6, 18 months
HepA
high-risk groups
HepB
1st contact; +1, >+2 months
HPV

(females)
Influenza
6-23 months; >65 years;

high-risk groups
MenC_conj
2, 4, 6 months or

2, 4, 12 months
MMR
12, 18 months or 4-6 years
Pneumo_conj
2, 4, 6, 12-15 months
Pneumo_ps
65 years
Td
every 10 years as booster
Tdap
14-16 years
Varicella
1 year; high-risk groups
(recommended)
31
Cape Verde
2010
Births............................................................................................................................. 10,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
96
94
97
64
...
DTP1
99
99
99
99
98
97
94
90
96
64
...
DTP3
99
99
99
98
96
95
90
88
88
39
...
HepB3
98
98
98
96
95
93
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
96
96
96
95
94
92
86
85
79
54
...
Pol3
99
99
99
98
97
95
90
89
87
39
...
PAB
92
78
78
77
74
70
60
30
75
...
...

2010 2009
22
22
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...

year
2009
target age group
coverage (%)
9-59 m
87
BCG birth
Measles
DTwP
MMR subnational
6, 10, 14 weeks; 15 months
DTwPHibHep subnational
HepB
birth; 6, 14 weeks
OPV

TT

32
9 months

15 months
Central African Republic

2010
Births........................................................................................................................... 154,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
74
74
74
74
74
74
66
94
96
34
17
DTP1
64
64
64
64
64
64
60
77
95
44
35
DTP3
54
54
54
54
54
54
37
53
82
20
13
HepB3
54
54
...
...
...
...
...
...
...
...
...
Hib3
54
54
...
...
...
...
...
...
...
...
...
MCV
62
62
62
62
62
62
36
46
82
23
12
Pol3
47
47
47
47
47
47
38
51
82
20
13
PAB
86
86
86
54
52
48
36
34
69
24

2010 2009

24
24
100
100
21
25
67
38
13
38
21

...
below 50%
at 80% or above

...

year
2008
target age group
coverage (%)
6-59 m
102
BCG birth
DTwPHibHep
Measles
OPV
6, 10, 14 weeks
9 months
6, 10, 14 weeks
TT


+1, +1 year
Vitamin A
Yellow fever
>6, >12 months

9 months
33
Chad
2010
Births........................................................................................................................... 503,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
52
40
25
40
53
39
49
43
59
15
...
DTP1
71
66
65
64
69
53
45
41
44
21
...
DTP3
59
51
19
46
53
34
36
18
20
...
HepB3
59
51
17
...
...
...
...
...
...
...
...
Hib3
59
51
17
...
...
...
...
...
...
...
...
MCV
46
49
27
39
45
32
28
26
32
...
Pol3
63
56
30
54
61
45
30
18
20
...
PAB
60
60
58
60
60
61
39
65
14
...
...

2010 2009

61
61
100
100
11
21
34
26
54
52
41
30

26
15
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG birth
OPV
DTwPHibHep
TT

Measles
6, 10, 14 weeks
9 months
Yellow fever
34

9 months
Chile
2010
Births........................................................................................................................... 245,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
95
95
99
98
98
95
93
97
94
96
96
DTP1
93
94
96
98
95
92
98
97
98
99
97
DTP3
92
94
95
96
94
91
91
94
95
99
93
HepB3
92
94
95
92
95
...
...
...
...
...
...
Hib3
92
94
95
96
94
91
91
...
...
...
...
MCV
93
93
96
92
91
90
97
97
97
92
94
Pol3
92
94
95
95
94
92
91
94
95
99
93
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
340
340
100
100
12
12
86
86
62
62

90
90
below 50%
at 80% or above

...

year
target age group
coverage (%)
2007
19-29 y
92
BCG birth
MMR
DT
7 years
OPV
DTwP
4 years
Pneumo_conj 2, 4, 6 months (high-risk

groups)
DTwPHibHep
Influenza
2, 4, 6, 18 months
adults; high-risk groups
Pneumo_ps
1, 6 years
2, 4, 6, 18 months
65 years
35
China
2010
Births...................................................................................................................... 16,486,000
Surviving infants.................................................................................................. 16,143,000
Total population.............................................................................................. 1,341,335,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
97
94
92
86
84
79
99
64
...
DTP1
99
99
99
99
99
95
94
93
98
92
...
DTP3
99
99
97
93
93
87
85
80
97
78
...
HepB3
99
99
95
92
91
84
60
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
99
99
97
94
93
86
84
80
98
88
...
Pol3
99
99
99
94
94
87
86
82
98
87
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
3,092 3,118

below 50%
98
97
98
99
97
93

88
100
at 80% or above

99

year
2010
target age group
coverage (%)
8 m-4 y
97
BCG birth
MenA
DT
MenAC
6 years
DTaP
3, 4, 5, 18 months
HepA
18 months
HepB
birth; 1, 6 months
JE
8 months; 2 years
36
MMR
MR
OPV

3, 6 years
18 months
8 months
Colombia
2010
Births........................................................................................................................... 914,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
84
90
93
93
96
94
91
99
95
76
45
DTP1
96
97
97
97
97
97
92
95
96
82
39
DTP3
88
92
92
93
93
93
79
85
88
61
16
HepB3
88
92
92
93
93
93
78
71
...
...
...
Hib3
88
92
92
93
93
93
65
...
...
...
...
MCV
88
95
92
95
95
94
80
82
82
51
13
Pol3
88
92
92
93
94
93
82
87
93
62
16
PAB
79
78
78
78
77
77
70
64
45

2010 2009
1,123 1,123
100
100
10
41
34
49
57
32
47

91
...
below 50%
at 80% or above

73

year
2010
target age group
1-8 y
coverage (%)
94
BCG birth
DT
DTwP
18 months; 5 years
DTwPHibHep
2, 4, 6 months
HepA
1 year (high-risk groups)
HepB birth
Influenza
6-23 months; +1 month;

18-23 months; >60 years
IPV
(immunocompromised)
MMR
1, 5 years
OPV
Pneumo_conj 2, 4, 12 months (subnational);

high-risk groups (subnational)
Rotavirus
2, 4 months
Td 1st contact; +1, +6 months; +1, +1 year

(CBAW and pregnancy)
Yellow fever
1 year; high-risk areas;
travellers
37
Comoros
2010
Births............................................................................................................................. 28,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
76
80
81
77
84
80
90
95
99
77
...
DTP1
81
89
85
79
78
77
85
91
97
75
...
DTP3
74
83
81
75
69
68
70
75
94
51
...
HepB3
81
83
81
75
69
68
...
...
...
...
...
Hib3
81
38
...
...
...
...
...
...
...
...
...
MCV
72
79
76
65
66
67
70
69
87
18
...
Pol3
82
84
81
75
69
67
70
78
94
53
...
PAB
85
83
83
89
88
91
57
67
78
13
...

2010 2009

17
17
100
100
59
35
35
65
18
29

53
65
below 50%
at 80% or above

...

year
2010
target age group
coverage (%)
9-47 m
84
BCG birth
OPV
DTwPHibHep
TT

Measles
6, 10, 14 weeks
9 months
Vitamin A
38

6 months
Congo
2010
Births........................................................................................................................... 142,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
95
90
93
86
84
73
50
58
90
89
92
DTP1
90
92
93
80
81
73
58
74
92
77
67
DTP3
90
91
89
80
79
65
33
50
79
54
42
HepB3
90
91
89
80
...
...
...
...
...
...
...
Hib3
90
91
...
...
...
...
...
...
...
...
...
MCV
76
76
79
67
66
56
34
38
75
67
49
Pol3
90
91
89
80
79
65
31
50
80
73
42
PAB
83
82
82
82
81
75
67
73
60
...
...

2010 2009

30
30
100
100
33
20
63
80
17
27

93
80
below 50%
at 80% or above

...

year
2010
target age group
coverage (%)
unknown
82
BCG birth
OPV
DTwPHibHep
TT
Influenza
Measles
2, 3, 4 months
high-risk groups
9 months
1st contact pregnancy; +1 month
Vitamin A
9 months
Yellow fever
9 months
39
Congo, Democratic Republic of the

2010
Births........................................................................................................................ 2,873,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
85
84
77
80
72
72
57
34
65
57
57
DTP1
67
81
73
77
71
68
49
47
60
62
...
DTP3
63
77
68
72
62
60
40
23
35
37
...
HepB3
63
77
68
72
...
...
...
...
...
...
...
Hib3
63
77
...
...
...
...
...
...
...
...
...
MCV
68
67
61
66
63
61
46
27
38
40
18
Pol3
72
74
61
71
62
60
42
24
34
34
15
PAB
77
85
75
70
66
67
45
42
53
37
...

2010 2009
508
508
100
100
42
17
48
78
44
42

44
71
below 50%
at 80% or above

...

year
2007
target age group
coverage (%)
6-59 m
101
BCG birth
DTwPHibHep
Measles
OPV
40
6, 10, 14 weeks
9 months
TT


Vitamin A 6 months; +every 6 months

until 59 months
Yellow fever
9 months
Cook Islands
2010
Births................................................................................................................................... ...

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
96
99
99
29
DTP1
99
99
99
99
99
99
99
97
97
92
65
DTP3
99
82
99
99
99
99
92
93
93
78
40
HepB3
99
82
99
99
99
99
98
85
71
...
...
Hib3
99
82
...
...
...
...
...
...
...
...
...
MCV
99
78
95
98
99
99
76
96
67
76
...
Pol3
99
82
99
99
99
99
92
93
83
91
39
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

39
100
100
100
100
100
...

100
below 50%

at 80% or above

98

year
target age group
coverage (%)
2006
1-35 y
90
BCG birth
MR
12, 18 months
DTwP
OPV
6, 10, 14 weeks
DTwPHibHep
18 months; 5 years
6, 10, 14 weeks
HepB birth
Td
16 years
TT
1, 3, 5 months; 4, 11 years;
pregnancy
41
Costa Rica
2010
Births............................................................................................................................. 73,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
77
81
90
91
87
88
92
99
92
82
80
DTP1
96
91
90
90
89
97
90
95
98
96
95
DTP3
88
86
90
89
89
91
88
85
95
90
86
HepB3
89
87
89
89
88
90
89
...
...
...
...
Hib3
90
87
87
88
88
89
92
...
...
...
...
MCV
83
81
89
90
90
89
82
91
90
78
60
Pol3
93
80
89
89
89
91
80
86
95
88
86
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

81
81
100
100
14
14
86
84
59
49
100
83
below 50%
at 80% or above


79

year
2002
target age group
1-4 y
coverage (%)
86
BCG birth
DTaPHibIPV
2, 4, 6, 15 months
DTaPIPV
4 years
DTwP
DTwPHibHep
2, 6 months
H1N1
high-risk groups
HepB
birth; 2, 6 months;

high-risk groups
Hib
4, 15 months
42
Influenza 6 months-3 years (high-risk

groups); >65 years
IPV
MMR
OPV
2, 4, 6 months
Pneumo_conj
2, 4, 6, 15 months
Pneumo_ps
high-risk groups
Rabies
high-risk groups
Td
7 years; +every 10 years
Varicella
15 months
Cte dIvoire
2010
Births........................................................................................................................... 673,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
91
95
91
94
77
85
80
69
62
29
...
DTP1
95
95
89
93
95
83
85
64
77
50
...
DTP3
85
81
74
76
77
76
65
52
54
25
...
HepB3
85
81
74
76
77
76
...
...
...
...
...
Hib3
85
81
...
...
...
...
...
...
...
...
...
MCV
70
67
63
67
73
84
68
57
56
31
...
Pol3
81
77
58
75
76
87
66
46
56
16
...
PAB
82
92
92
74
75
75
76
36
36
...
...

2010 2009

83
83
100
100
35
42
64
57
47
25
below 50%
at 80% or above


...

year
2008
target age group
coverage (%)
9-59 m
95
BCG birth
DTwPHibHep
Measles
OPV
6, 10, 14 weeks
9 months
TT


Vitamin A
6, 12, 18, 24, 30, 36 months
Yellow fever
9 months
43
Croatia
2010
Births............................................................................................................................. 43,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
98
98
99
...
...
...
DTP1
98
98
98
98
98
98
97
96
...
...
...
DTP3
96
96
96
96
96
96
93
90
...
...
...
HepB3
97
97
97
95
...
...
...
...
...
...
...
Hib3
96
96
96
96
96
96
...
...
...
...
...
MCV
95
95
98
96
95
96
93
92
...
...
...
Pol3
96
96
96
96
96
96
94
90
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
21
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG
birth; 13 years
DTaP
4 years
DTaPHibIPV
HepB
44
birth; 2, 6 months
IPV
MMR
Td
6, 14 years
1, 7 years
6, 14, 19 years; >60 years
Cuba
2010
Births........................................................................................................................... 112,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
99
98
98
99
DTP1
98
98
98
97
96
99
98
99
97
97
86
DTP3
96
96
95
93
89
89
96
99
92
91
67
HepB3
96
96
95
93
89
95
98
99
...
...
...
Hib3
96
96
97
97
97
94
99
...
...
...
...
MCV
99
99
98
97
96
98
94
99
94
85
48
Pol3
99
99
99
99
99
99
98
95
94
88
99
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
169
169
100
100
12
85
91
88
93

...
100
below 50%
at 80% or above

98

year
2007
target age group
coverage (%)
12-24 y
97
BCG
DT
DTwP
DTwPHibHep
2 months
6 years
18 months
2, 4, 6 months
Influenza
MenBC
MMR
OPV
HepB birth
TT
Hib
Typhoid
18 months

3, 5 months
1, 6 years
<1, 1, 2, 9 years
15 years
10, 13, 16 years
45
Cyprus
2010
Births............................................................................................................................. 13,000
Gross national income per capita (PPP, US$)............................................................ 30160

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
98
98
98
98
98
98
97
82
59
DTP3
99
99
97
97
97
98
97
96
93
61
34
HepB3
96
96
93
93
93
88
89
68
...
...
...
Hib3
96
96
90
90
90
58
32
...
...
...
...
MCV
87
87
87
87
87
86
86
83
77
43
29
Pol3
99
99
97
97
97
98
97
96
94
61
35
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

83
83
83
83
33
17
100
100

...

year
2010
target age group
coverage (%)
1st grade
87
BCG

children with continuous

contact to contagious TB
DTaPHibHepIPV
DTaPHibIPV
2, 4 months
2, 4, 6, 15-18 months
DTaPIPV 2, 4, 6, 15-18 months; 4-6 years

HepA
universal in private sector;

high-risk groups in public sector
HepB
46
2, 4, 8-12 months
Hib
2, 4, 6, 12-18 months
IPV
2, 4, 6, 15-18 months; 4-6 years
MMR
13-15 months; 4-6 years
Pneumo_conj
2, 4, 6, 12-15 months
Pneumo_ps national
Rabies
Td
(if indicated)
14-16 years; +adult booster
Czech Republic
2010
Births........................................................................................................................... 115,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
98
99
99
99
99
98
95
...
...
...
DTP1
99
99
99
99
99
99
99
98
...
...
...
DTP3
99
99
99
99
98
97
98
96
...
...
...
HepB3
99
99
99
99
98
99
...
...
...
...
...
Hib3
99
99
99
99
97
97
...
...
...
...
...
MCV
98
98
97
98
98
97
98
96
...
...
...
Pol3
99
99
99
99
98
96
98
98
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

86
86
100
100
100
100
100
100

100
100
below 50%

at 80% or above

98

year
...
target age group
...
coverage (%)
...
DTaP
DTaPHibHepIPV

DTaPIPV
HepB
5 years
13, 17, 21 weeks;
18 months
10 years
12 years (3 doses)
Influenza
MMR
Pneumo_conj
Pneumo_ps
TT
>65 years
15, 21 months
4, 5, 6, 11-18 months
3, 4, 5 months
25 years
47
Denmark
2010
Births............................................................................................................................. 64,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
93
90
89
87
93
93
98
97
98
99
97
DTP3
90
89
88
87
93
93
97
90
90
90
88
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
90
89
88
87
93
93
95
78
...
...
...
MCV
85
84
87
89
90
95
99
88
84
...
...
Pol3
90
89
88
87
93
93
97
97
99
99
99
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

11
100
100
...
...
100
...
64
...

...
...
below 50%

at 80% or above

85

year
...
target age group
...
coverage (%)
...
DTaPHibIPV
DTaPIPV
HepB

48
3, 5, 12 months
5 years
birth; 1, 2, 12 months (children

residing wih carrier)
HPV 12 years; +2, +6 months (females)

MMR

Pneumo_conj
15 months; 4 years or
15 months; 12 years
3, 5,12 months
Djibouti
2010
Births............................................................................................................................. 26,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
90
90
90
90
88
80
34
51
81
37
...
DTP1
90
90
90
92
76
73
66
66
95
46
...
DTP3
88
89
89
88
72
71
46
41
85
22
...
HepB3
88
89
88
25
...
...
...
...
...
...
...
Hib3
88
89
89
25
...
...
...
...
...
...
...
MCV
85
84
73
74
67
65
50
41
85
27
...
Pol3
88
89
89
88
72
71
46
41
85
22
...
PAB
79
77
79
79
77
71
46
62
80
14
...

2010 2009

100
100
...
33
33
67
67
...
83
...
below 50%
at 80% or above


...

year
2008
target age group
coverage (%)
9 m-15 y
86
BCG birth
DTwP
DTwPHibHep
Measles
15 months
6, 10, 14 weeks
9-15 months
OPV


15 months
TT


+1, +1 year
Vitamin A
6, 12, 18, 24, 30, 36 months
49
Dominica
2010
Births................................................................................................................................... ...

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
98
90
99
98
99
99
99
90
65
DTP1
99
99
98
98
98
99
99
99
97
97
84
DTP3
98
99
96
96
95
98
99
99
92
91
63
HepB3
98
99
96
93
...
...
...
...
...
...
Hib3
98
99
96
93
...
...
...
...
...
...
MCV
99
99
99
96
97
98
99
99
88
93
...
Pol3
99
99
95
93
96
98
99
99
94
89
53
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

100
100
100
100
100
100

100
100
below 50%

at 80% or above

114

year
...
target age group
...
coverage (%)
...
BCG
birth-2 months
DT
3 years
DTwPHibHep
HepB
50
2, 4, 6 months
MMR
OPV
Td
12, 18 months
13 years
Dominican Republic
2010
Births........................................................................................................................... 216,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
96
92
92
95
96
90
90
70
51
29
DTP1
96
85
90
87
93
92
91
89
87
64
61
DTP3
88
82
85
87
89
87
78
72
69
39
36
HepB3
84
85
88
81
84
87
68
...
...
...
...
Hib3
81
77
79
65
77
87
...
...
...
...
...
MCV
79
79
79
79
79
81
84
78
70
54
30
Pol3
86
85
87
80
88
86
75
70
90
39
46
PAB
87
86
86
85
85
75
48
82
60
33
23

2010 2009
155
155
100
100
19
34
39
60
42
32
34

80
100
below 50%
at 80% or above

...

year
2010
target age group
1-8 y
coverage (%)
97
BCG birth
DTwP
2, 4, 6, 18 months; 3, 5 years
DTwPHibHep
2, 4, 6 months
HepB
birth; 1st contact; +1, +6 months

(high-risk groups)
Influenza
6, 12, 24 months; 18-65 years;

>65 years
MenACWY
high-risk groups
MM
suspected cases
MMR
1, 5 years
OPV
2, 4, 6, 18 months; 3, 5 years
Pneumo_conj
2, 4, 6, 12 months

(high-risk groups)
Pneumo_ps
65 years
Td
7, 10, 20, 30, 40, 50 years;

CBAW and pregnancy
Typhoid
high-risk groups
Varicella
1 year
Vitamin A
6, 12, 18, 24 months
Yellow fever
6 months (high-risk groups,
travellers)
51
Ecuador
2010
Births........................................................................................................................... 299,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
99
89
99
76
DTP1
99
99
99
99
99
98
96
94
87
66
31
DTP3
99
99
99
99
98
94
88
83
68
41
10
HepB3
98
98
98
98
98
94
38
...
...
...
...
Hib3
99
99
99
99
98
94
...
...
...
...
...
MCV
98
98
98
98
97
93
99
81
60
51
24
Pol3
99
99
99
99
97
93
84
82
67
39
19
PAB
74
73
73
72
72
65
42
33
82
14

2010 2009
170
170
100
100
14
10
86
89
77
82

98
83
below 50%
at 80% or above

91

year
target age group
coverage (%)
2009
12-23 m
7
BCG birth
DT
5 years
DTwP
18 months
DTwPHibHep
2, 4, 6 months
HepB

(high-risk groups)
Influenza
>65 years
MenAC
high-risk groups
MMR
1, 6 years
52
OPV
2, 4, 6, 18 months
Pneumo_conj
2, 4, 6 months
(subnational)
Pneumo_ps
65 years
Rotavirus
2, 4 months
Td

+1 year; +every 10 years
Varicella
6, 10 years
Yellow fever >1 year (high-risk areas)
Egypt
2010
Births........................................................................................................................ 1,881,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
98
98
98
99
98
98
93
89
80
50
DTP1
97
97
98
98
98
98
98
96
95
94
80
DTP3
97
97
97
98
98
98
98
88
87
84
57
HepB3
97
97
97
98
98
98
98
74
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
96
95
92
97
98
98
98
89
86
74
41
Pol3
97
97
97
98
98
98
98
90
87
84
67
PAB
86
85
85
85
86
85
80
76
74
...

2010 2009
273
271
100
100
below 50%

at 80% or above

98
100
95
93
100
100

97

year
2009
target age group
coverage (%)
2-11y
104
BCG birth
MMR
DTwP
2, 4, 6, 18 months
OPV
HepB
2, 4, 6 months
MenAC
6, 12, 15 years
Td
12, 18 months
2, 4, 6, 9, 12, 18 months
6, 10 years
53
El Salvador
2010
Births........................................................................................................................... 126,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
91
87
99
99
93
84
99
99
75
50
56
DTP1
97
97
99
99
98
96
99
99
93
78
69
DTP3
92
91
98
99
96
89
99
99
80
55
44
HepB3
92
91
98
99
96
89
99
...
...
...
...
Hib3
92
91
98
99
96
89
...
...
...
...
...
MCV
92
95
95
99
98
99
97
93
98
71
45
Pol3
92
91
98
99
96
89
98
94
80
54
42
PAB
88
87
87
87
91
92
83
67
37
26
23

2010 2009
262
262
100
100
27
11
71
85
50
65

90
96
below 50%
at 80% or above

81

year
2007
target age group
1-6 y
coverage (%)
99
BCG birth
MMR
DTwP
OPV
DTwPHibHep
1, 4 years
2, 4, 6 months
Pneumo_conj
HepB birth
Pneumo_ps
Influenza
Rotavirus
IPV
54
6-23 months; 60 years

high-risk groups
1, 4 years
2, 4, 6, 15-18 months
high-risk groups
2, 4 months
Td adults
Equatorial Guinea
2010
Births............................................................................................................................. 26,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
73
73
73
73
73
73
73
99
94
28
...
DTP1
65
65
65
65
65
65
65
94
96
21
...
DTP3
33
33
33
33
33
33
33
79
77
...
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
51
51
51
51
51
51
51
81
88
11
...
Pol3
39
39
39
39
39
39
39
79
75
...
PAB
75
75
69
62
59
59
61
75
58
14
...

2010 2009
18
18
94
100
78
17
17
61
22
28

22
below 50%

at 80% or above

...

year
2005
target age group
coverage (%)
9 m-15 y
44
BCG birth
DTwP
Measles

9 months
OPV


15 months
TT
1, 2, 6 months; 1, 2 years;
pregnancy
55
Eritrea
2010
Births........................................................................................................................... 191,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
89
68
...
...
...
DTP1
99
99
99
99
99
99
93
68
...
...
...
DTP3
99
99
99
96
96
96
81
58
...
...
...
HepB3
99
99
99
96
96
96
...
...
...
...
...
Hib3
99
99
99
...
...
...
...
...
...
...
...
MCV
99
95
95
95
95
95
76
58
...
...
...
Pol3
99
99
99
96
96
96
82
58
...
...
...
PAB
93
86
86
85
85
84
80
17
...
...
...

2010 2009

58
100
100
34
17
53
67
12
17
97
100
below 50%
at 80% or above


0

year
2009
target age group
coverage (%)
9-47 m
82
BCG birth
DTwPHibHep
Measles
OPV
56
6, 10, 14 weeks
9 months
TT


Vitamin A
6, 12, 18, 24, 30, 36 months
Estonia
2010
Births............................................................................................................................. 16,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
97
97
98
98
99
99
99
99
...
...
...
DTP1
96
97
97
98
98
99
96
94
...
...
...
DTP3
94
95
95
95
95
96
93
82
...
...
...
HepB3
94
95
94
95
95
95
...
...
...
...
...
Hib3
94
95
95
95
88
37
...
...
...
...
...
MCV
95
95
95
96
96
96
93
81
...
...
...
Pol3
94
95
95
95
95
96
93
80
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
16
16
...
...
...
...
...
...
...
...
...

...
...

below 50%
at 80% or above

95

year
...
target age group
...
coverage (%)
...
BCG
DT

1-5 days
3, 4.5, 6 months; 2, 6-7 years
DTaPHibIPV
DTaPIPV
HepB

3, 4.5, 6 months; 2 years

6-7 years
birth; 1, 6 months or 12 years;

+1, +6 months
Hib

3, 4.5 months; 2 years (pertussis

contraindication)
IPV

3, 4.5, 6 months; 2, 6-7 years

MMR
Rabies

Td
1, 13 years
first contact; +3, +7,
+14, +28 days
15-16 years; +every 10 years
57
Ethiopia
2010
Births........................................................................................................................ 2,613,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
69
76
81
72
72
67
76
61
64
11
...
DTP1
90
86
87
81
80
78
74
80
73
25
...
DTP3
86
79
81
73
72
69
56
57
49
...
HepB3
86
79
81
73
...
...
...
...
...
...
...
Hib3
86
79
81
73
...
...
...
...
...
...
...
MCV
81
75
74
65
63
59
52
38
38
12
Pol3
86
76
75
71
69
66
57
65
49
PAB
88
88
84
83
82
80
54
34
24
...

2010 2009
98
98
100
12
19
33
38
55
43
26
17

58
...

below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG birth
OPV
DTwPHibHep
TT

Measles
58
6, 10, 14 weeks
9 months
6, 10, 14 weeks
1st contact pregnancy; +1, +6
months; +1, +2, +3 years
Fiji
2010
Births............................................................................................................................. 19,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
98
96
99
99
99
95
DTP1
99
99
99
99
99
99
97
98
98
87
87
DTP3
99
99
99
99
98
96
90
97
97
69
68
HepB3
99
99
99
99
99
99
98
82
...
...
...
Hib3
99
99
99
99
99
99
98
...
...
...
...
MCV
94
94
94
94
92
90
81
94
84
57
32
Pol3
99
99
99
99
98
97
91
99
96
68
55
PAB
94
94
94
94
93
93
84
76
...
...

2010 2009

20
19
100
100
...
15
100
85
...
75
...

...
...
below 50%
at 80% or above

...

year
2006
target age group
coverage (%)
6 m-<6 y
98
BCG birth
MR
DTaPHibHep
OPV
6, 10, 14 weeks
HepB birth
HPV
TT

1, 6 years
+1 year
59
Finland
2010
Births............................................................................................................................. 61,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
98
98
99
99
91
83
90
DTP1
99
99
99
99
99
99
99
99
96
98
97
DTP3
99
99
99
99
97
97
99
99
90
96
92
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
98
98
98
97
98
98
96
94
...
...
...
MCV
98
98
97
98
97
97
96
98
97
85
...
Pol3
99
99
97
97
97
97
96
99
90
89
90
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
...
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG
children residing with carrier;

high-risk groups
DTaPHibIPV
3, 5, 12 months
DTaPIPV
4, 11-12 years
HepA
high-risk groups
HepAHepB
high-risk groups
HepB
high-risk groups
Influenza
6-35 months; 65 years;

high-risk groups
60
IPV travellers
MenACWY military
MMR
Pneumo_conj
3, 5, 12 months;

high-risk groups
Pneumo_ps
5 years (high-risk groups)
Rotavirus
3, 5, 12 months
TBE
>7 years (land Island)
Td
every 10 years
France
2010
Births........................................................................................................................... 793,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
84
84
84
83
83
74
82
80
DTP1
99
99
99
99
99
99
99
98
97
98
92
DTP3
99
99
98
98
98
98
97
96
94
95
79
HepB3
42
42
36
29
29
29
26
...
...
...
...
Hib3
97
97
87
87
87
87
86
...
...
...
...
MCV
90
90
87
87
87
87
84
83
71
35
...
Pol3
99
99
98
98
98
98
98
97
95
97
80
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
100
100
...
...
...
...
...
...
...
...
...

...
...

below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
aP
26-28 years
BCG
birth-15 years (high-risk
groups)
DT
6, 11-13 years
DTaPHibIPV
2, 3, 4, 16-18 months
DTaPIPV
11-13 years
HepB
2, 3, 16-18 months
HPV
14 years; +2, +6 months
(females)
IPV
6, 11-13 years
MenC_conj
1 year
MMR
12, 13-24 months
Pneumo_conj
2, 4, 12 months
Td
16-18, 26-28, 38, 48, 58,

68 years
Yellow fever 1, 11, 21, 31, 41, 51 years

(French Guiana)
61
Gabon
2010
Births............................................................................................................................. 41,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
89
89
89
89
89
89
89
90
96
80
...
DTP1
69
69
69
69
69
69
69
81
96
56
...
DTP3
45
45
45
45
45
45
45
70
78
48
...
HepB3
45
45
45
45
45
45
...
...
...
...
...
Hib3
45
...
...
...
...
...
...
...
...
...
...
MCV
55
55
55
55
55
55
55
57
76
58
...
Pol3
44
44
44
44
44
44
44
70
78
48
...
PAB
75
75
73
67
63
58
39
53
84
29
...

2010 2009

51
51
100
100
33
14
45
35
22
51

47
below 50%
at 80% or above

...

year
2007
target age group
coverage (%)
9-59 m
83
BCG birth
Measles
DTwP
OPV
6, 10, 14 weeks (subnational)
DTwPHibHep
HepB
6, 10, 14 weeks
6, 10, 14 weeks (subnational)
TT

Yellow fever
62
9 months
9 months
Gambia
2010
Births............................................................................................................................. 66,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
95
97
98
98
99
99
99
99
98
92
85
DTP1
99
99
99
95
97
98
98
99
98
90
89
DTP3
98
99
97
95
95
95
86
96
92
78
63
HepB3
94
95
96
96
95
95
91
87
...
...
...
Hib3
98
99
97
95
95
95
90
...
...
...
...
MCV
97
99
96
90
91
91
89
91
86
75
69
Pol3
96
96
96
93
94
94
90
98
94
62
53
PAB
91
91
91
90
94
89
92
92
85
85
...

2010 2009

100
100
100
100
83
100

...
100
below 50%

at 80% or above

...

year
2007
target age group
coverage (%)
9-59 m
96
BCG birth
OPV
DTwP
Pneumo_conj
1 year after 3rd dose (booster)
DTwPHibHep
2, 3, 4 months
HepB birth
Measles
9 months
TT

birth; 2, 3, 4, 9, 18 months
2, 3, 4 months

+1, +2 years
Vitamin A
Yellow fever
6, 12, 18, 24, 36, 42 months

9 months
63
Georgia
2010
Births............................................................................................................................. 52,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
96
95
95
96
95
95
95
70
...
...
...
DTP1
99
99
99
99
99
94
89
91
...
...
...
DTP3
91
88
92
98
87
84
80
79
...
...
...
HepB3
95
54
89
94
83
74
55
...
...
...
...
Hib3
67
...
...
...
...
...
...
...
...
...
...
MCV
94
83
96
97
95
92
73
61
...
...
...
Pol3
88
93
90
88
88
84
81
82
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
65
65
97
...
12
15
85
85
75
31

60
57
below 50%
at 80% or above

84

year
2008
target age group
1-5 y
coverage (%)
...
BCG
DT
DTwP
DTwPHibHep
64
birth-5 days
5 years
18 months
2, 3, 4 months
HepB birth
MMR
OPV
Td
1, 5 years
14 years
Germany
2010
Births........................................................................................................................... 695,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
97
97
97
97
97
97
96
92
93
93
...
DTP3
93
93
93
93
93
93
90
78
80
80
...
HepB3
90
90
90
90
90
90
84
45
...
...
...
Hib3
94
94
94
94
94
94
94
85
...
...
...
MCV
96
96
96
96
96
96
92
92
75
50
25
Pol3
95
95
95
95
95
95
94
95
80
85
80
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

412
423
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

90

year
...
target age group
...
coverage (%)
...
DTaPHibHepIPV
2, 3, 4, 11-14 months
MMRV
11-14, 15-23 months
DTaPHibIPV
2, 3, 4, 11-14 months
Pneumo_conj
2, 3, 4, 11-14 months
HepB
HPV
2, 4, 11-14 months
12-17 years (females, 3 doses)
Influenza
MenC_conj
MMR

Pneumo_ps
Tdap
>60 years
>60 years (annually)
TdapIPV
9-17 years
11-14 months
Varicella
11-14, 15-23 months
11-14, 15-23 months;

adults born after 1970
65
Ghana
2010
Births........................................................................................................................... 770,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
87
71
41
...
DTP1
96
96
96
96
87
88
98
88
80
46
27
DTP3
94
94
93
94
84
84
95
70
58
22
HepB3
94
94
93
94
84
84
...
...
...
...
...
Hib3
94
94
93
94
84
84
...
...
...
...
...
MCV
93
93
86
95
85
83
98
70
61
21
16
Pol3
94
94
92
94
84
85
94
71
57
18
PAB
86
86
86
86
85
83
69
68
60
34

2010 2009
170
170
100
100
21
10
79
90
54
69

82
...
below 50%
at 80% or above

...

year
2010
target age group
coverage (%)
9-59 m
93
BCG birth
DTwPHibHep
Measles
OPV
66
6, 10, 14 weeks
9 months
6, 10, 14 weeks
TT


Vitamin A
6, 12, 18, 24, 30, 36 months
Yellow fever
9 months
Greece
2010
Births........................................................................................................................... 118,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
91
91
91
91
91
90
88
50
86
65
95
DTP1
99
99
99
99
99
98
96
96
77
77
89
DTP3
99
99
99
99
98
96
89
90
54
54
72
HepB3
95
95
95
95
94
93
89
12
...
...
...
Hib3
83
83
83
83
84
84
87
19
...
...
...
MCV
99
99
99
99
98
96
89
70
76
77
...
Pol3
99
99
99
99
98
96
89
95
96
96
90
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

54
54
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG
6 years
DTaP
2, 4, 6, 15-18 months;

4-6 years
HepA
>1 year; +6 months
HepB
2, 4, 6-18 months
Hib
2, 4, 6, 12-15 months
HPV
IPV
2, 4, 6-18 months; 4-6 years
MenC_conj
2, 4, 15-18 months
MMR
Pneumo_conj
2, 4, 6, 12-18 months
Pneumo_ps 2-60 years (high-risk groups);

60 years
Td
10 years after DTaP;

+every 10 years
Tdap
11-12 years
Varicella
67
Grenada
2010
Births............................................................................................................................... 2,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
98
97
99
99
98
93
82
50
DTP3
97
99
99
96
91
99
97
95
80
61
25
HepB3
97
99
99
96
91
99
...
...
...
...
...
Hib3
97
99
99
96
91
99
33
...
...
...
...
MCV
95
98
99
98
98
99
92
88
85
49
...
Pol3
94
99
99
96
91
99
97
77
69
77
32
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%
100
100
100
100
57
43

...
...
at 80% or above

86

year
...
target age group
...
coverage (%)
...
DT
DTwP
DTwPHibHep
HepB

68
4-5 years
18 months
6, 16-20, 24-28 weeks
>18 years (high-risk
groups, 3 doses)
Influenza
MMR
OPV

Td
6, 7 months
12, 18 months; adults
6-8, 16-20, 24-28 weeks;
18 months; 4.5, >14 years
>7 years (2 doses)
Guatemala
2010
Births........................................................................................................................... 467,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
93
99
88
96
96
95
79
62
30
36
DTP1
96
94
99
88
95
95
94
91
86
45
68
DTP3
94
92
95
85
89
87
81
77
66
21
43
HepB3
94
92
95
85
89
87
...
...
...
...
...
Hib3
94
92
95
85
89
87
...
...
...
...
...
MCV
93
92
96
86
95
93
86
83
68
23
23
Pol3
94
92
96
85
90
87
80
80
74
42
43
PAB
85
71
71
71
70
70
67
55
44

2010 2009
332
333
100
100
19
20
80
79
64
62

83
84
below 50%
at 80% or above

...

year
2007
target age group
coverage (%)
9-39 y
99
BCG birth
OPV
DTwP
Rotavirus
DTwPHibHep
18 months; 4 years
2, 4, 6 months
HepB birth
Influenza
MMR
50 years; health workers
Td

2, 4, 6 months
1st contact; +1, +6 months; +1,

+1 year or +10, +10 years
Vitamin A

6, 12, 18, 24, 30,

36 months
1 year
69
Guinea
2010
Births........................................................................................................................... 390,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
81
81
81
81
81
80
81
78
50
18
...
DTP1
75
75
75
75
75
75
61
77
40
37
...
DTP3
57
57
57
57
57
59
47
54
17
15
...
HepB3
57
57
57
57
...
...
...
...
...
...
...
Hib3
57
57
...
...
...
...
...
...
...
...
...
MCV
51
51
51
51
51
51
42
61
35
29
...
Pol3
53
53
53
53
53
59
47
54
18
16
...
PAB
90
96
96
95
95
90
79
68
27
...
...

2010 2009
38
38
97
100
26
37
71
63
39
45

...
84
below 50%
at 80% or above

...

year
2006
target age group
coverage (%)
9-59 m
97
BCG birth
TT
DTwPHibHep
Vitamin A
Measles
OPV
70
6, 10, 14 weeks
9 months
Yellow fever

6, 12 months
9 months
Guinea-Bissau
2010
Births............................................................................................................................. 58,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
93
93
92
91
90
89
77
92
90
56
...
DTP1
92
92
91
89
88
86
71
70
82
57
...
DTP3
76
76
74
72
70
68
49
45
61
18
...
HepB3
76
76
...
...
...
...
...
...
...
...
...
Hib3
76
76
...
...
...
...
...
...
...
...
...
MCV
61
61
65
69
72
76
71
45
53
35
...
Pol3
73
73
73
73
72
72
52
45
60
18
...
PAB
78
94
94
92
69
65
49
68
40
10
...

2010 2009


below 50%

at 80% or above

11
11
100
100
45
91
55
36
45
73

...

year
2009
target age group
coverage (%)
unknown
101
BCG birth
DTwPHibHep
Measles
OPV
6, 10, 12 weeks
9 months
TT


+1, +1 year
Vitamin A
Yellow fever
6 months (2 doses)
9 months
71
Guyana
2010
Births............................................................................................................................. 14,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
98
96
97
96
96
93
93
85
98
68
DTP1
99
99
94
96
95
93
97
95
94
91
60
DTP3
95
98
93
94
93
93
88
86
83
75
35
HepB3
95
98
93
94
93
93
...
...
...
...
...
Hib3
95
98
93
94
93
93
...
...
...
...
...
MCV
95
97
95
96
90
92
86
77
73
40
...
Pol3
95
97
93
94
92
93
79
87
79
77
42
PAB
97
90
90
91
92
91
82
71
56
...
...

2010 2009


below 50%
13
13
100
...
...
...
100
...
77

...
...
at 80% or above

82

year
2007
target age group
coverage (%)
0-59 m
95
BCG birth
OPV
DT pregnancy
Pneumo_conj
2, 4, 6 months
(immunocompromised,
subnational)
DTwPHibHep
2, 4, 6 months
IPV
2, 4, 6, 18, 45 months
(immunocompromised)
Rotavirus
2, 4, 6, 18, 45 months
2, 4, 6 months
MenACW
high-risk groups
(subnational)
Tdap
high-risk groups
(subnational)
MMR
Yellow fever
72
12, 45 months
1 year
Haiti
2010
Births........................................................................................................................... 266,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
75
75
75
75
75
75
72
74
72
71
...
DTP1
83
83
83
83
83
83
77
75
66
42
21
DTP3
59
59
59
59
59
59
49
42
41
19
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
59
59
59
59
59
59
55
49
31
21
...
Pol3
59
59
59
59
59
59
50
42
40
19
PAB
70
70
50
43
31
37
41
41
39
36
14

2010 2009
133
140
100
100
12
29
20
26
68
44
46

...
76
below 50%
at 80% or above

...

year
2006
target age group
1-4 y
coverage (%)
40
BCG birth
DTwP
MR
OPV
6, 10, 14 weeks
9 months
<15 days; 6, 10, 14 weeks
Td

Vitamin A


+1, +5 years (females
15-49 years)
6, 10, 14, 18, 30,
42 months
73
Honduras
2010
Births........................................................................................................................... 198,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
97
98
99
97
70
65
25
DTP1
99
99
96
94
95
99
98
97
94
80
53
DTP3
98
98
93
94
95
98
94
94
84
58
28
HepB3
98
98
93
94
95
98
94
...
...
...
...
Hib3
98
98
93
94
95
98
94
...
...
...
...
MCV
99
99
95
96
97
96
98
89
90
53
31
Pol3
98
98
93
94
94
98
88
94
87
58
31
PAB
94
94
94
94
94
90
93
77
60
27

2010 2009
298
298
100
100
below 50%
94
96
82
82

84
90
at 80% or above

...

year
2008
target age group
1-4 y
coverage (%)
97
BCG birth
DT
4, 6, 18 months; 4 years (pertussis
contraindication)
DTwP
DTwPHibHep
HepB

Influenza

74
18 months; 4 years
2, 4, 6 months
birth; 1st contact;
+1, +6 months
6-35 months; >60 years
(high-risk groups)
IPV
2, 4, 6, 18, months
(immunocompromised)
MMR
OPV
Rotavirus
Td
Vitamin A

Yellow fever
1 year
2, 4, 6, 18 months
2, 4 months
11 years; pregnancy
6, 12, 18, 24, 30,
36 months
>1 year (travellers)
Hungary
2010
Births............................................................................................................................. 99,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
99
99
99
99
DTP1
99
99
99
99
99
99
99
99
99
99
99
DTP3
99
99
99
99
99
99
99
99
99
99
99
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
99
99
99
99
99
99
99
...
...
...
...
MCV
99
99
99
99
99
99
99
99
99
99
99
Pol3
99
99
99
99
99
99
99
99
99
99
98
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

81
81
100
100
100
100
100
100

100
100
below 50%

at 80% or above

96

year
...
target age group
...
coverage (%)
...
BCG birth
MMR
DTaPHibIPV
Pneumo_conj
DTaPIPV
HepB
2, 3, 4 months
18 months; 6 years
Tdap
15 months; 11 years
2, 4, 15 months
11 years
13 years (2 doses)
75
Iceland
2010
Births............................................................................................................................... 5,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
98
99
99
97
97
95
99
99
99
99
99
DTP3
96
96
98
97
97
95
98
99
99
99
99
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
96
96
98
97
97
95
98
99
...
...
...
MCV
93
92
96
95
95
90
91
99
99
96
...
Pol3
96
96
98
97
97
95
98
99
99
99
99
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

59
59
100
100
100
100
100
100
...
...

...
year
...
target age group
...
coverage (%)
...
DTaP
DTaPHibIPV
5 years
3, 5, 12 months
DTaPIPV
14 years
Influenza
60 years
76
MenC_conj
MMR
Pneumo_ps
6, 8 months
18 months; 12 years
60 years
India
2010
Births...................................................................................................................... 27,165,000
Surviving infants.................................................................................................. 25,804,000
Total population.............................................................................................. 1,224,614,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
87
87
87
87
87
81
74
81
66
...
DTP1
83
83
83
87
83
78
72
88
88
41
25
DTP3
72
72
72
70
66
67
62
71
70
18
HepB3
37
29
21
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
74
74
74
74
70
64
55
72
56
...
Pol3
70
70
70
69
67
55
64
71
66
14
PAB
87
86
86
86
86
86
85
83
81
49
20

2010 2009

644
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG birth
Measles
DTwP

6, 10, 14 weeks; 16-24

months; 5 years
OPV

HepB


(subnational)
JE
16-24 months (subnational)
9-12, 16-24 months

16-24 months
TT
10, 16 years; pregnancy
Vitamin A
9, 18, 24, 30, 36 months
77
Indonesia
2010
Births........................................................................................................................ 4,372,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
97
93
89
90
88
85
80
77
74
65
61
DTP1
94
89
86
89
86
85
85
87
82
52
...
DTP3
83
82
77
81
72
72
71
69
60
27
...
HepB3
83
82
78
72
66
65
65
50
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
89
82
83
83
79
77
74
63
58
26
...
Pol3
93
89
91
81
78
79
75
71
60
13
...
PAB
85
85
79
83
83
83
82
74
64
29

2010 2009
495
475
100
100
17
17
79
80
56
55

86
87
below 50%
at 80% or above

89

year
...
target age group
...
coverage (%)
...
BCG
DT
DTwPHep
HepB
IPV
78
1 month
school entrance
2, 3, 4 months
birth-7 days
Measles
9 months; 7 years
OPV
TT
1, 2, 3, 4 months
schoolchildren grades 2 and 3
Vitamin A
6-11, 12-59 months
Iran (Islamic Republic of)

2010
Births........................................................................................................................ 1,267,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
96
95
79
DTP1
99
99
99
99
98
97
99
98
97
75
57
DTP3
99
99
99
99
98
95
99
98
91
51
32
HepB3
99
99
99
97
98
94
99
59
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
99
99
98
97
99
94
99
95
85
62
39
Pol3
99
99
99
98
99
95
99
97
90
63
38
PAB
95
83
83
83
83
83
82
66
71
26

2010 2009
360
356
100
100
100
100
100
100

100
100
below 50%

at 80% or above

99

year
2003
target age group
coverage (%)
5-25 y
102
BCG birth
MMR
DTwP
2, 4, 6, 12, 18 months; 6 years
OPV
HepB

birth; 2, 6 months;
high-risk groups
Td

12, 18 months
birth; 2, 4, 6, 18 months; 6 years
military; pregnancy;
+every 10 years
MenAC military
79
Iraq
2010
Births........................................................................................................................ 1,125,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
80
80
80
87
87
92
93
97
96
94
76
DTP1
81
88
81
68
76
84
92
86
93
98
36
DTP3
65
67
61
51
57
65
78
74
83
86
14
HepB3
64
66
59
50
55
62
67
57
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
MCV
73
80
75
64
62
69
87
80
75
70
Pol3
69
72
66
71
62
69
84
73
83
86
16
PAB
80
69
69
69
70
71
75
81
70
31

2010 2009
125
121
100
100
42
36
58
60
42
53

50
31
below 50%
at 80% or above

91

year
target age group
coverage (%)
2010
6-36 m
97
BCG birth
DT
2 (2 doses), 6, 18 months; 4-6 years
DTwP
2, 4, 6, 18 months; 4-6 years
HepA
2, 3 years (high-risk groups)
HepB
birth; 2, 6 months
Influenza
pilgrims; high-risk groups
IPV
2, 4, 6, 18 months (immunocompromised)
Measles
9 months
MenACWY
7, 12 years (high-risk groups,

subnational); travellers
MMR
80
OPV
birth; 2, 4, 6, 18 months; 4-6 years
Pneumo_ps
2 years (high-risk groups)
Rabies
birth; 4, 7, 14, 28, 90 days

(post-exposure and high-risk

groups, subnational)
Td
>6-7 years
TT
CBAW and first contact pregnancy;

+1, +6 months;+1, +2 years
Typhoid
4 years (high-risk groups,
subnational)
Vitamin A
9, 15 months; 4-6 years
Yellow fever
4 years; travellers
Ireland
2010
Births............................................................................................................................. 72,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
96
95
94
93
93
93
90
87
84
80
...
DTP1
98
98
97
97
97
96
95
90
85
70
59
DTP3
94
94
93
92
91
90
86
73
65
45
34
HepB3
94
...
...
...
...
...
...
...
...
...
...
Hib3
94
94
93
92
91
90
85
...
...
...
...
MCV
90
90
89
87
86
84
79
77
78
63
...
Pol3
94
94
93
92
91
90
86
77
81
90
72
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

100
100
100
100
63
88

...
...
below 50%

at 80% or above

...

year
2009
target age group
coverage (%)
15-18 y
...
BCG birth
Influenza
DTaPHibHepIPV
MenC_conj
DTaPIPV
HepB

Hib
HPV

2, 4, 6 months
4-5 years

(high-risk groups)
13 months
(females)
MMR

high-risk groups
4, 6, 13 months
1, 4-5 years; health workers
(if indicated)
Pneumo_conj
2, 6, 12 months
Pneumo_ps
2 years (high-risk
groups)
Td
11-14 years
81
Israel
2010
Births........................................................................................................................... 154,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
75
DTP1
96
96
96
96
96
93
96
98
97
95
94
DTP3
96
96
96
96
96
93
96
96
93
85
84
HepB3
96
96
96
97
94
96
97
93
...
...
...
Hib3
93
93
93
93
93
93
94
93
...
...
...
MCV
98
98
98
97
96
94
97
93
91
85
81
Pol3
94
94
94
96
94
95
92
96
93
86
85
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%
15
15
100
100
100
100
100
100

100
100
at 80% or above

92

year
...
target age group
...
coverage (%)
...
BCG
high-risk groups
DT
2, 4, 6, 12 months (pertussis contraindication)
DTaPHibIPV
2, 4, 6, 12 months
DTaPIPV
7 years
HepA
18, 24 months; high-risk groups
HepAHepB
high-risk groups
HepB
Hib
high-risk groups
HPV
9-45 years; +2, +6 months (10-49 years;

+1, +6 months if CERVARIX)
Influenza
high-risk groups
IPV
high-risk groups
JE travellers
82
MenACWY
high-risk groups
MMRV
1, 6 years; high-risk groups
MR
>12 years (high-risk groups)
Pneumo_conj
2, 4, 12 months
Pneumo_ps
Rotavirus
2, 4, 6 months
TBE travellers
Td
>7 years; +every 10 years
Tdap
14 years
Typhoid travellers
TyphoidHepA travellers
Varicella
high-risk groups
Yellow fever
travellers
Italy
2010
Births........................................................................................................................... 559,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
98
98
98
99
98
98
95
98
94
33
...
DTP3
96
96
96
97
96
95
87
95
83
12
...
HepB3
96
96
96
97
96
96
94
95
95
...
...
Hib3
95
96
96
96
96
95
55
...
...
...
...
MCV
90
90
90
90
88
87
74
50
43
12
...
Pol3
96
96
96
97
97
97
97
98
98
92
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

21
21
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
aP

BCG
Dip

HepA
HepB

Hib
HPV
Influenza
3, 5, 11-12 months; 5-6 years,

11-12 years
health workers at high-risk
3, 5, 11-12 months;
5-6, 11-15 years
high-risk groups (recommended)
3, 5, 11-12 months;
high-risk groups
3, 5, 11-12 months
12 years; +1, +6 months (females)
high-risk groups
IPV
Measles
MenC_conj

MMR

Pneumo_conj

Pneumo_ps
Rubella
Td
3, 5, 11-12 months; 5-6 years

12-15 months; 5 or 12 years
3, 5, 11-12 months; health
workers (recommended)
12-15 months; 5-12 years; health
workers (recommended)
3, 5, 11-12 months; high-risk
groups (recommended)
high-risk groups
females (recommended)
83
Jamaica
2010
Births............................................................................................................................. 51,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
95
94
92
87
90
95
94
98
98
51
38
DTP1
99
99
99
99
99
99
97
96
95
82
48
DTP3
99
99
99
99
99
99
93
90
86
60
24
HepB3
99
99
99
99
99
99
...
...
...
...
...
Hib3
99
99
99
99
99
99
...
...
...
...
...
MCV
88
88
88
76
87
84
88
90
74
64
...
Pol3
99
99
99
99
99
98
93
91
87
58
34
PAB
80
62
58
54
53
51
51
...
...
...
...

2010 2009


below 50%
13
13
100
100
15
85
100
46
46
100
100
at 80% or above


56

year
target age group
coverage (%)
2006
12-72 m
21
BCG
birth-6 weeks
DT
6 weeks; 3, 5-6, 18 months;

4-6 years (pertussis
contraindication)
DTwP
DTwPHibHep
6 weeks; 3, 5-6 months
HepB
6 weeks; 3, 6 months or

1st contact; +1,

+6 months (high-risk groups)
Hib
6 weeks; 3, 6 months

Influenza
health workers; high-risk groups
84
IPV
6 weeks; 3, 5-6, 18 months; 4-6 years
(immunocompromised)
MMR
post-partum
OPV
6 weeks; 3, 5-6, 18 months;

4-6 years
Pneumo_conj
2, 4, 6 months (children with

sickle cell diseases)
Td

+1, +1 year (>7 years)
Yellow fever
travellers
Japan
2010
Births........................................................................................................................ 1,077,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
94
90
94
...
...
...
...
85
85
...
DTP1
99
99
99
99
99
99
88
90
96
94
82
DTP3
98
98
98
98
98
98
85
74
90
83
60
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
94
94
95
96
97
98
96
93
73
73
69
Pol3
98
99
98
97
95
95
98
97
90
95
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
1,724
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

97

year
...
target age group
...
coverage (%)
...
BCG
DT
DTaP
Influenza
JE
6 months
11-12 years
3, 4.5, 6, 18 months
65 years
Measles
1-2, 5-7 years
MR
1-2, 5-7 years
OPV
Rubella
6 months; 1 year
1-2, 5-7 years
85
Jordan
2010
Births........................................................................................................................... 153,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
95
95
95
90
95
89
...
...
...
...
...
DTP1
98
98
98
99
99
98
91
99
97
95
55
DTP3
98
98
97
98
98
95
91
95
92
85
30
HepB3
98
98
97
98
98
95
93
54
...
...
...
Hib3
98
98
97
98
98
95
...
...
...
...
...
MCV
98
95
95
95
99
95
94
92
87
73
29
Pol3
98
98
98
98
98
95
94
95
92
84
32
PAB
87
87
87
87
86
67
44
47
49
52
...

2010 2009


below 50%
12
21
100
100
100
100
100
100

100
...
at 80% or above

94

year
target age group
coverage (%)
2005
8-16 y
87
BCG
birth-6 years
DT
DTaPHibIPV
3, 4, 5 months
DTwP
18 months
DTwPHib
5 months
DTwPHibHep
3, 4 months
HepB
3, 4, 5 months
Influenza
health workers; pilgrims;

high-risk groups
IPV
3, 4 months
86
Measles
9 months
MenACWY
>2 years; pilgrims; high-risk
groups
MMR
12, 18 months
OPV
Pneumo_conj
Td
6, 16 years
TT

+1 year, +1 year
Typhoid travellers
Kazakhstan
2010
Births........................................................................................................................... 344,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
96
96
97
99
99
69
98
90
...
...
...
DTP1
99
98
99
97
99
99
97
97
...
...
...
DTP3
99
98
99
93
99
98
97
93
...
...
...
HepB3
99
99
99
94
99
94
99
...
...
...
...
Hib3
96
97
49
...
...
...
...
...
...
...
...
MCV
99
99
99
99
99
99
99
95
...
...
...
Pol3
98
99
99
94
99
99
96
94
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
204
204
100
100
below 50%

at 80% or above

100
100
100
100
96
98

100

year
2005
target age group
coverage (%)
15-25 y
99
BCG
Dip
DT
DTwPHib
DTwPHibHep
HepA
birth; 6 years
12 years
6 years
Influenza
IPV
MenACW pilgrims
3, 18 months
MMR
2, 4 months
OPV
2 years
HepB birth
high-risk groups
pertussis contraindication
Td
Typhoid
1, 6 years
2, 3, 4, 12 months
high-risk groups
87
Kenya
2010
Births........................................................................................................................ 1,529,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
97
95
92
92
85
91
97
92
82
...
DTP1
93
92
90
89
90
85
73
96
92
88
...
DTP3
83
84
85
81
80
76
79
94
84
70
...
HepB3
83
84
85
81
80
76
...
...
...
...
...
Hib3
83
84
85
81
80
76
...
...
...
...
...
MCV
86
88
90
80
77
69
75
83
78
63
...
Pol3
83
84
85
76
77
70
77
94
84
70
...
PAB
78
78
78
74
74
73
68
61
60
36
...

2010 2009
149
149
100
99
11
34
46
59
42
44
21

58
66
below 50%
at 80% or above

0

year
2009
target age group
coverage (%)
unknown
...
BCG birth
DTwPHibHep
Measles
OPV
6, 10, 14 weeks
9 months
Rabies post-exposure
88
TT

1st contact pregnancy; +1 month;

+next pregnancy (up to 4th)
Vitamin A
6, 12, 18, 24, 30, 36 months
Yellow fever
Kiribati
2010
Births................................................................................................................................... ...

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
87
76
83
90
91
93
80
47
93
62
66
DTP1
97
90
97
99
98
93
95
82
98
62
68
DTP3
91
86
82
94
86
79
90
60
97
37
43
HepB3
91
86
83
96
88
50
90
36
73
...
...
Hib3
91
86
83
...
...
...
...
...
...
...
...
MCV
89
82
72
93
61
85
80
47
75
...
Pol3
95
84
74
93
86
74
90
58
97
15
10
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

24
100
100
21
17
33
83
46
33
42

...
63
below 50%
at 80% or above

21

year
target age group
coverage (%)
2009
12-59 m
106
BCG birth
MR
DTwP
OPV
DTwPHibHep
6 years
6, 10, 14 weeks
TT
1, 6 years
6, 10, 14 weeks
6, 13 years
HepB birth
89
Korea, Democratic Peoples Republic of

2010
Births........................................................................................................................... 348,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
98
97
96
96
94
78
82
99
51
50
DTP1
94
94
93
93
91
83
75
84
98
78
74
DTP3
93
93
92
92
89
79
56
64
98
55
50
HepB3
93
93
92
92
96
92
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
99
98
98
99
96
96
78
67
98
38
29
Pol3
99
98
98
99
98
97
93
88
99
65
50
PAB
91
91
91
91
90
90
81
90
90
...
...

2010 2009
208
208
100
100
below 50%

at 80% or above

100
100
100
100
...
...

99

year
2007
target age group
coverage (%)
6 m-45 y
100
BCG birth
OPV
DTwPHep
TT
6, 10, 14 weeks
HepB birth
Measles
90
9, 15 months
Vitamin A
6, 10, 14 weeks
3, 4 months
Korea, Republic of
2010
Births........................................................................................................................... 478,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
96
96
96
96
98
97
73
93
72
47
...
DTP1
96
96
95
95
98
98
97
99
90
91
...
DTP3
94
94
94
91
98
96
97
99
74
76
...
HepB3
94
94
94
91
99
99
93
99
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
MCV
98
93
92
92
99
99
95
93
93
89
Pol3
95
95
92
91
98
96
99
99
74
80
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%
230
270
100
...
...
...
100
...
100

...
...
at 80% or above

96

year
2009
target age group
7y
coverage (%)
100
BCG
birth-1 month
DTaP

2, 4, 6, 15-18 months;
4-6 years
HepB
birth; 1, 6 months
HFRS

1st contact; +1 month; +1 year

(high-risk groups)
Influenza
IPV
high-risk groups
2, 4, 6-18 months; 4-6 years
JE

MMR
Td
Tdap
12-23 months; +1-2 weeks;

+1 year; 6, 12 years
11-12 years
11-12 years
Typhoid
high-risk groups
Varicella
12-15 months
91
Kuwait
2010
Births............................................................................................................................. 49,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
99
99
94
84
...
...
...
...
...
...
DTP1
98
99
99
99
99
99
99
99
88
96
86
DTP3
98
99
99
99
99
99
98
99
71
90
67
HepB3
99
99
99
99
99
99
95
99
...
...
...
Hib3
98
99
99
99
99
99
98
...
...
...
...
MCV
98
99
99
99
99
99
99
98
66
91
48
Pol3
98
99
99
99
99
99
94
99
71
91
70
PAB
95
84
84
83
82
81
77
37
51
13

2010 2009

109
...
...
...
...
...
...
...
...
...
...
100
...
below 50%
at 80% or above


99

year
2010
target age group
1-7 y
coverage (%)
...
BCG
3 months
DT
high-risk groups (subnational)
DTwP
3.5 years
DTwPHibHep
2, 4, 6, 18 months
HepB birth
Influenza
high-risk groups
IPV
2 months; high-risk groups
MenAC
high-risk groups
MenACWY
2 years; pilgrims; travellers
MMR
1, 2, 12 years; female students
92
OPV
4, 6, 12, 18 months
Pneumo_conj
2, 4, 6, 18 months
Pneumo_ps
high-risk groups
(subnational)
Td
10-18 years
TT
pregnancy; high-risk groups
(subnational)
Typhoid
food handlers (subnational)
Yellow fever
travellers
Kyrgyzstan
2010
Births........................................................................................................................... 130,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
98
99
98
99
96
96
96
...
...
...
DTP1
99
98
99
98
96
98
99
97
...
...
...
DTP3
96
95
95
94
92
98
99
93
...
...
...
HepB3
96
96
97
94
90
97
44
...
...
...
...
Hib3
96
...
...
...
...
...
...
...
...
...
...
MCV
99
99
99
99
97
99
98
97
...
...
...
Pol3
88
96
95
94
93
98
99
96
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
42
52
100
...
...
...
...
...
...
...
100
...

100
100

below 50%
at 80% or above

98

year
2001
target age group
coverage (%)
7-25 y
99
BCG birth
MMR
DT
6 years
MR
DTwP
2 years
OPV
DTwPHibHep
2, 3.5, 5 months
Td
1 year
6 years
birth; 2, 3.5, 5 months
11, 16, 26, 36, 46, 56 years
HepB birth
93
Lao Peoples Democratic Republic

2010
Births........................................................................................................................... 141,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
72
67
68
56
61
65
69
62
26
...
DTP1
81
76
73
59
68
68
83
77
41
22
...
DTP3
74
67
61
50
57
49
53
54
18
...
HepB3
74
67
61
50
57
49
...
...
...
...
...
Hib3
74
...
...
...
...
...
...
...
...
...
...
MCV
64
59
52
40
48
41
42
68
32
...
Pol3
76
67
60
46
56
50
57
64
26
...
PAB
80
47
47
47
52
50
58
44
12
...

2010 2009
143
141
100
100
10
17
51
53
38
30
10
10

56
51
below 50%
at 80% or above

...

year
2007
target age group
coverage (%)
9 m-14 y
96
BCG birth
OPV
DTwPHibHep
TT


+1, +1 year
Vitamin A
6, 12, 18, 24, 30, 36 months
6, 10, 14 weeks
HepB birth
Measles
94
9 months
6, 10, 14 weeks
Latvia
2010
Births............................................................................................................................. 24,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
92
99
99
99
99
99
99
99
...
...
...
DTP1
97
97
98
98
99
99
99
99
...
...
...
DTP3
89
95
97
98
98
99
96
98
...
...
...
HepB3
89
94
96
97
97
98
95
...
...
...
...
Hib3
88
95
96
97
99
94
79
58
...
...
...
MCV
93
96
97
97
95
95
97
81
...
...
...
Pol3
89
96
97
98
98
99
96
98
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%
33
33
100
100
...
18
82
97
70
...

88
...
at 80% or above

94

year
...
target age group
...
coverage (%)
...
BCG
2-5 days
DTaPHibHepIPV
2, 4, 6, 12-15
months
DTaPHibIPV
DTaPIPV
HepB

2, 4, 6 months
7 years
birth; 1, 2, 12-15 months;
high-risk groups
HPV
12 years (females, 3 doses)
MMR
7 years
MMRV
12-15 months
Pneumo_conj
2, 4, 6 months
TdIPV
14 years
95
Lebanon
2010
Births............................................................................................................................. 65,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
83
83
83
83
83
83
90
97
94
40
17
DTP3
74
74
74
74
74
74
83
93
82
17
HepB3
74
74
74
74
74
74
83
...
...
...
...
Hib3
74
74
74
74
74
74
...
...
...
...
...
MCV
53
53
53
53
53
53
71
85
61
23
Pol3
74
74
74
74
74
74
83
93
82
17
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

26
26
100
96
...
...
96
...
77
96

...
...
below 50%

at 80% or above

89

year
2000
target age group
coverage (%)
1-15 y
93
DTwP
DTwPHib
DTwPHibHep
4-5 years
18 months
2, 3, 4 months
HepB birth
Measles
MMR
OPV

Td
96
9 months
1, 4-5 years
2, 3, 4, 18 months; 4-5,
10-18 years
10-12 years
Lesotho
2010
Births............................................................................................................................. 60,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
95
95
95
95
95
96
88
96
89
91
81
DTP1
93
93
93
93
94
94
87
95
91
92
75
DTP3
83
83
83
84
86
87
83
88
82
82
56
HepB3
83
83
83
86
90
87
...
...
...
...
...
Hib3
83
83
...
...
...
...
...
...
...
...
...
MCV
85
85
85
85
85
85
74
83
80
73
49
Pol3
91
91
91
91
91
90
82
88
82
80
56
PAB
83
83
83
82
80
79
73
61
...
...
...

2010 2009
10
10
100
...
20
80
50
20
30
10

70
100

below 50%
at 80% or above

0

year
2010
target age group
coverage (%)
6 m-15 y
91
BCG birth
Measles
DT
OPV
DTwPHibHep
18 months
6, 10, 14 weeks
HPV
9-13 years (females, 3 doses,
subnational)
TT
9, 18 months
6, 10, 14 weeks
1st contact; +1 month; +1 year
Vitamin A
6, 12, 18, 24, 30, 36 months
97
Liberia
2010
Births........................................................................................................................... 154,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
80
80
80
74
77
76
78
...
...
...
...
DTP1
75
75
84
81
75
75
80
...
...
...
...
DTP3
64
64
64
60
60
60
46
...
...
...
...
HepB3
64
64
63
...
...
...
...
...
...
...
...
Hib3
64
64
63
...
...
...
...
...
...
...
...
MCV
64
64
64
64
63
63
63
...
...
...
...
Pol3
71
71
71
63
66
66
56
...
...
...
...
PAB
91
91
91
90
73
60
51
55
33
18
...

2010 2009

15
15
100
100
53
13
47
87
13
67

27
60
below 50%
at 80% or above

...

year
2010
target age group
coverage (%)
unknown
100
BCG birth
DTwPHibHep
Measles
OPV
98
6, 10, 14 weeks
9 months
TT

Vitamin A
Yellow fever

+1, +1 year
6, 12 months
9 months
Libya
2010
Births........................................................................................................................... 145,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
98
99
90
87
88
DTP1
98
98
98
98
98
98
97
98
94
93
82
DTP3
98
98
98
98
98
98
94
95
84
81
60
HepB3
98
98
98
98
98
97
92
92
...
...
...
Hib3
98
98
98
56
...
...
...
...
...
...
...
MCV
98
98
98
98
98
97
93
92
89
75
61
Pol3
98
98
98
98
98
98
94
95
84
81
60
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
23
...
100
...
below 50%
...
...
100
...
100

...
100
at 80% or above

...

year
2009
target age group
1-6 y
coverage (%)
98
BCG birth
MenACWY
DT
MMR
DTwP
DTwPHibHep
6 years
18 months
OPV
6 years; pilgrims
12, 18 months
birth; 2, 4, 6, 18 months; 6 years
2, 4, 6 months
Td
HepB birth
TT
Influenza seasonal
Yellow fever
15 years
15 years
travellers
99
Lithuania
2010
Births............................................................................................................................. 35,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
97
...
...
...
DTP1
98
98
96
99
98
98
99
96
...
...
...
DTP3
95
98
96
95
94
94
94
90
...
...
...
HepB3
94
95
96
96
95
95
98
...
...
...
...
Hib3
95
98
96
95
94
61
...
...
...
...
MCV
96
96
97
97
97
97
97
94
...
...
...
Pol3
95
98
96
95
94
93
92
89
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

52
52
100
100
100
100
94
100

94
...
below 50%

at 80% or above

95

year
...
target age group
...
coverage (%)
...
BCG birth
MMR
DTaPHibIPV
Rabies

post-exposure; +3, +7,

+14, +28 days
DTaPIPV
HepB

100
3, 4.5, 6, 18 months
6 years
birth; 1, 6 months or
12 years (3 doses)
Td
15 years
Luxembourg
2010
Births............................................................................................................................... 6,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
99
99
99
99
98
96
91
...
DTP3
99
99
99
99
99
99
98
97
90
77
...
HepB3
94
95
94
87
91
95
49
...
...
...
...
Hib3
98
99
98
99
99
98
91
...
...
...
...
MCV
96
96
96
96
96
95
91
88
80
58
...
Pol3
99
99
99
99
99
99
98
96
90
90
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
...
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
DTaPHibHepIPV
2, 3, 13 months
DTaPHibIPV
4 months
DTaPIPV
5-6, 15-16 years; +every 10 years
HepB
2-3, 3-4, 11-12 months

or 12 years (catch up)
HPV
Influenza
65 years
IPV
every 10 years (if indicated)
MenC_conj
13 months
MMR
12, 15-23 months
MMRV
12, 15-23 months
Mumps
12, 15-23 months
Pneumo_conj
2, 3, 4, 12 months
Pneumo_ps
60 years
Rotavirus
2, 3 months
Typhoid travellers
Varicella
13 years
Yellow fever
travellers
101
Madagascar
2010
Births........................................................................................................................... 732,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
67
73
83
94
90
80
72
72
67
31
21
DTP1
78
80
84
92
91
84
72
80
71
47
...
DTP3
74
78
77
84
82
81
57
57
46
23
...
HepB3
74
78
77
84
82
81
...
...
...
...
...
Hib3
74
78
52
...
...
...
...
...
...
...
...
MCV
67
64
70
81
65
61
55
55
47
...
Pol3
72
76
77
83
78
72
60
56
46
21
...
PAB
76
76
76
72
71
66
58
38
45
26
...

2010 2009
111
111
100
100
37
30
59
68
58
35

47
60
below 50%
at 80% or above

...

year
2008
target age group
coverage (%)
9-59 m
...
BCG birth
OPV
DTwPHibHep
TT

Measles
102
6, 10, 14 weeks
9 months
6, 10, 14 weeks
Malawi
2010
Births........................................................................................................................... 663,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
97
95
97
95
99
99
83
97
97
87
...
DTP1
97
97
97
96
99
99
98
96
95
78
80
DTP3
93
93
91
87
99
93
75
89
87
55
58
HepB3
93
93
91
87
99
93
...
...
...
...
...
Hib3
93
93
91
87
99
93
...
...
...
...
...
MCV
93
92
88
83
85
82
73
90
81
49
49
Pol3
86
93
92
88
99
94
73
90
93
55
28
PAB
87
87
87
86
88
86
84
87
81
26
...

2010 2009

28
28
100
100
100
96
68
50

82
100
below 50%

at 80% or above

...

year
2010
target age group
coverage (%)
9 m-15 y
107
BCG birth
DTwPHibHep
Measles
OPV
6, 10, 14 weeks
9 months
TT


+1, +1 year
Vitamin A 6, 12, 18, 24, 30, 36 months;

post-partum
6, 10, 14 weeks
103
Malaysia
2010
Births........................................................................................................................... 576,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
98
98
90
99
99
99
99
99
95
94
DTP1
98
95
96
90
96
96
95
93
95
68
86
DTP3
94
95
96
90
90
95
95
94
90
57
67
HepB3
95
95
95
90
87
92
94
91
86
...
...
Hib3
94
95
95
90
89
85
...
...
...
...
...
MCV
96
95
94
95
90
90
88
86
70
20
...
Pol3
94
95
96
90
96
94
95
94
90
56
67
PAB
87
87
87
87
88
88
88
84
82
52
20

2010 2009
141
139
100
100
below 50%

at 80% or above

12
91
86
63
65
...
...

98

year
target age group
coverage (%)
2004
7-15 y
96
BCG birth
DT
7 years
DTaPHibIPV
2, 3, 5, 18 months
DTwP
18 months
HepB
birth; 1, 6 months
HPV
Influenza
high-risk groups
JE
9, 10, 18 months; 5, 8,

104
Measles
MenACWY pilgrims
MMR
1, 7 years
OPV
18 months; 7 years
Rubella females
Tdap
15 years
Typhoid
food handlers
Maldives
2010
Births............................................................................................................................... 5,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
97
99
99
99
99
99
99
99
99
45
DTP1
97
99
99
99
99
99
99
99
97
53
22
DTP3
96
98
98
98
98
98
98
94
94
28
HepB3
97
98
98
98
98
98
96
80
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
97
98
97
97
97
97
99
96
96
47
...
Pol3
97
98
98
98
98
98
98
97
94
28
PAB
95
95
95
94
94
94
95
92
86
25

2010 2009

20
20
100
100
100
100
100
100

100
...
below 50%

at 80% or above

...

year
2007
target age group
4-6 y
coverage (%)
56
BCG birth
Cholera
>18 years (subnational);
travellers
DT
5 years (catch up)
DTwP
6, 10, 14 weeks
HepB
birth; 1, 3 months
H1N1 seasonal
Influenza
pilgrims
Measles
9 months
MenAC
pilgrims
MMR
18 months
OPV
TT
CBAW; +1, +6 months;

+1, +1 year
Vitamin A
6, 12, 18, 24 months
Yellow fever
travellers
105
Mali
2010
Births........................................................................................................................... 714,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
86
86
86
85
86
83
69
76
82
33
...
DTP1
90
89
85
89
91
87
61
73
67
28
...
DTP3
76
73
74
73
77
77
43
49
42
...
HepB3
76
73
74
74
90
83
...
...
...
...
...
Hib3
77
74
74
44
16
...
...
...
...
...
MCV
63
60
71
66
68
73
55
52
43
19
...
Pol3
73
70
74
74
77
78
54
49
42
...
PAB
85
92
92
90
89
86
50
36
45
...

2010 2009

59
59
100
100
22
14
71
81
41
69

25
98
below 50%
at 80% or above

...

year
2007
target age group
coverage (%)
9-59 m
101
BCG birth
OPV
DTwPHibHep
TT

Measles
6, 10, 14 weeks
9 months
Yellow fever
106

9 months
Malta
2010
Births............................................................................................................................... 4,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
92
77
65
...
DTP1
97
91
88
84
85
94
97
97
84
62
...
DTP3
76
73
72
74
85
92
94
92
63
37
...
HepB3
86
86
86
82
86
85
...
...
...
...
...
Hib3
76
73
72
72
83
83
93
...
...
...
...
MCV
73
82
78
79
94
86
74
51
80
10
...
Pol3
76
73
72
76
83
94
94
92
86
84
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

97

year
...
target age group
...
coverage (%)
...
BCG
DTaPHibIPV
12-13 years (high-risk groups)

6 weeks; 3, 4, 18 months
HepA

1st contact; +6 months

(high-risk groups)
HepB
12, 13, 18 months
Hib

Influenza

(high-risk groups)
high-risk groups
IPV
MenACWY
MMR
OPV
high-risk groups
high-risk groups
Rabies
high-risk groups
Typhoid
high-risk groups
Varicella
high-risk groups
Yellow fever
high-risk groups
107
Marshall Islands
2010
Births................................................................................................................................... ...

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
98
95
92
92
93
89
71
49
...
...
DTP1
99
99
99
99
90
89
64
88
97
...
...
DTP3
94
96
95
93
74
77
39
70
92
...
...
HepB3
97
99
97
93
97
89
38
47
10
...
...
Hib3
92
99
92
83
60
69
45
...
...
...
...
MCV
97
78
86
94
96
86
94
57
52
...
...
Pol3
95
99
96
91
95
88
36
64
89
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
100
...
below 50%
...
...
100
...
...

...
...
at 80% or above

90

year
target age group
coverage (%)
2003
6 m-40 y
...
BCG birth
DTaP
2, 4, 6, 12 months; 4-6 years
DTaPHepIPV
2, 4, 6 months
DTaPHibIPV
2, 4, 6 months
HepB
birth; 2, 6 months; adolescents
Hib
2, 4, 12 months
HPV

(females)
Influenza
high-risk groups
108
IPV
2, 4, 6 months
MenC_conj
11-12 years
MMR
12, 15 months
OPV
Pneumo_conj
2, 4, 6, 12 months
Rotavirus
2, 4, 6 months
Td
every 10 years
Tdap
1-12 years (subnational)
Vitamin A
6-59 months
Mauritania
2010
Births........................................................................................................................... 117,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
85
81
89
92
86
87
75
80
79
74
...
DTP1
82
79
88
92
85
85
70
93
69
52
...
DTP3
64
64
74
75
68
71
53
55
33
27
...
HepB3
64
64
74
74
68
42
...
...
...
...
...
Hib3
64
64
...
...
...
...
...
...
...
...
...
MCV
67
59
65
67
62
61
62
67
38
41
...
Pol3
63
63
73
75
68
71
61
56
33
16
...
PAB
87
87
77
77
62
59
44
43
24
17
...

2010 2009

53
53
100
100
32
25
51
64
17
11
26
28
below 50%
at 80% or above


...

year
2004
target age group
coverage (%)
9 m-14 y
102
BCG birth
OPV
DTwPHibHep
TT

Measles
6, 10, 14 weeks
9 months

1st contact or pregnancy;
+1 month; +1, +1, +1 year
109
Mauritius
2010
Births............................................................................................................................. 17,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
95
96
98
97
99
88
86
87
87
89
DTP1
99
99
99
97
99
99
88
97
95
96
96
DTP3
99
99
99
97
97
97
88
93
85
88
89
HepB3
99
99
99
97
97
97
88
...
...
...
...
Hib3
99
99
99
96
96
...
...
...
...
...
...
MCV
99
99
98
98
99
98
84
89
76
67
...
Pol3
99
99
99
96
98
97
88
93
86
91
90
PAB
95
87
87
86
85
86
79
78
61
18

2010 2009


below 50%

at 80% or above

10
10
100
100
100
100
50
100
100
100

88

year
...
target age group
...
coverage (%)
...
BCG
DT
1 month
18 months; 5 years
DTwPHib

6, 10, 14 weeks;
18 months
HepB

6, 10, 14 weeks;
high-risk groups
Influenza
110
60 years
MenACWY travellers
MMR
OPV
1, 5 years
TT
pregnancy; post-injury
Typhoid travellers
Yellow fever
travellers
Mexico
2010
Births........................................................................................................................ 2,217,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
99
99
99
99
99
99
98
67
16
48
DTP1
96
98
98
99
99
99
99
97
77
65
69
DTP3
95
95
96
98
98
98
97
91
53
40
44
HepB3
93
95
97
98
98
98
97
...
...
...
...
Hib3
95
95
96
98
98
98
97
...
...
...
...
MCV
95
96
96
96
96
96
96
90
75
64
35
Pol3
95
95
96
98
98
98
97
92
66
67
91
PAB
88
87
87
87
87
86
81
71
59
36

2010 2009
2,438 2,438
0
100
...
...
...
89
...
92

...
...
below 50%
at 80% or above

91

year
2010
target age group
6-7 y
coverage (%)
91
BCG birth
DTaP
2, 4 years
DTaPHibIPV
2, 4, 6, 18 months
HepB
birth; 2, 6 months; >12 years

(2 doses)
HPV
12 years (females, subnational,

2 doses); 15 years
Influenza
6-35 months (2 doses);

>60 years
MMR
1, 6 years
MR
>12 years; 13-39 years
OPV
>6 months; <5 years (6 doses)
Pneumo_conj
2, 4, 12 months
Pneumo_ps
65 years
Rotavirus
2, 4 months
Td
11-12 years (2 doses); >12 years

(4 doses); pregnancy
Vitamin A
<5 years (2 doses,
subnational)
111
Micronesia (Federated States of)

2010
Births............................................................................................................................... 3,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
70
75
79
82
55
70
24
50
12
...
...
DTP1
90
97
95
92
85
98
95
94
95
...
...
DTP3
85
91
85
79
67
94
85
83
85
...
...
HepB3
88
89
89
90
84
91
87
82
56
...
...
Hib3
70
73
73
79
59
74
75
...
...
...
...
MCV
80
86
86
92
83
96
85
90
81
...
...
Pol3
85
81
88
79
81
94
85
81
85
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
100
...
...
...
100
...
50
...

...

below 50%

at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG birth
Pneumo_conj
DTaP
Rotavirus
HepB
birth; 2, 6 months
Hib
HPV
2, 4, 12 months
females (3 doses)
MMR
12, 13 months
OPV

2, 4, 6 months;
1, 4 years
112
Td
Tdap
TT
Vitamin A

2, 4, 6, 13 months
2, 4, 6 months
>10 years
7 years
every 10 years
6, 12, 18, 24, 30,
36 months
Moldova
2010
Births............................................................................................................................. 44,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
96
99
99
99
99
99
95
...
...
...
DTP1
93
88
96
97
97
98
98
98
...
...
...
DTP3
90
85
95
96
97
98
95
96
...
...
...
HepB3
98
89
98
98
99
99
92
19
...
...
...
Hib3
63
47
...
...
...
...
...
...
...
...
...
MCV
97
90
94
95
97
97
89
91
...
...
...
Pol3
97
87
97
97
98
99
97
97
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

44
44
100
100
11
91
86
93
82

95
86
below 50%

at 80% or above

90

year
2002
target age group
coverage (%)
20-23 y
...
BCG
DT
DTwP
DTwPHib
HepB
2 days; 7 years
7 years
22 months
2, 4, 6 months
birth; 1, 6 months
Influenza seasonal
MMR
OPV
Td

1, 7 years
15, 20, 25, 30, 35, 40,
50, 60 years
113
Monaco
2010
Births................................................................................................................................... ...

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
89
89
89
89
89
89
97
90
99
...
...
DTP1
99
99
99
99
99
99
99
99
99
...
...
DTP3
99
99
99
99
99
99
99
99
99
...
...
HepB3
99
99
99
99
99
99
99
...
...
...
...
Hib3
99
99
99
99
99
99
99
...
...
...
...
MCV
99
99
99
99
99
99
99
99
99
...
...
Pol3
99
99
99
99
99
99
99
99
99
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
...
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG birth
HepB
DTaPHibHepIPV
MenC_conj
HepA

2 months
5 months; 1 year;
high-risk groups
MMR
Pneumo_ps
114
5 months; 1 year
2 years
1, 3-6 years
2 months
Mongolia
2010
Births............................................................................................................................. 65,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
98
98
99
98
99
97
94
81
52
51
DTP1
98
95
98
95
99
99
95
96
94
93
91
DTP3
96
95
96
95
99
99
94
88
84
80
76
HepB3
96
97
96
98
98
98
93
88
...
...
...
Hib3
96
97
96
78
56
28
...
...
...
...
...
MCV
97
94
97
98
99
97
92
85
92
18
17
Pol3
96
96
95
99
98
99
94
86
87
86
86
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
340
338
100
100
100
100
98
96

91
94
below 50%

at 80% or above

92

year
2007
target age group
coverage (%)
2-10 y
97
BCG birth
HepB birth
DT
MMR
DTwPHibHep
7, 15 years
2, 3, 4 months
OPV
8 months; 2 years
115
Montenegro
2010
Births............................................................................................................................... 8,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
95
95
98
98
98
...
...
...
...
...
...
DTP1
97
96
98
98
95
...
...
...
...
...
...
DTP3
94
92
95
92
90
...
...
...
...
...
...
HepB3
90
87
93
90
90
...
...
...
...
...
...
Hib3
90
87
93
89
90
...
...
...
...
...
...
MCV
90
86
89
90
90
...
...
...
...
...
...
Pol3
93
91
95
92
90
...
...
...
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

21
21
100
100
100
100
71
43
100
...

...
year
...
target age group
...
coverage (%)
...
BCG birth
IPV
DT
MMR
6 years
DTwP
HepB
9, 13 weeks; 1 year
Hib
Influenza seasonal
116
OPV

9, 17, 23 weeks
1, 6, 12 years
6, 14 years
Td
14 years
TT
18 years
Morocco
2010
Births........................................................................................................................... 623,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
96
95
95
97
96
96
77
...
DTP1
99
99
99
98
99
99
98
94
93
75
...
DTP3
99
99
99
95
97
98
95
90
81
51
...
HepB3
98
98
97
95
95
96
43
...
...
...
...
Hib3
99
99
99
90
...
...
...
...
...
...
...
MCV
98
98
96
95
95
97
93
88
79
45
...
Pol3
99
99
99
95
97
98
95
90
81
51
...
PAB
89
87
90
88
87
89
86
80
66
...
...

2010 2009


below 50%

at 80% or above

68
68
100
100
100
100
94
85
100
100

...

year
2008
target age group
coverage (%)
9 m-14 y
99
BCG birth
DTwP
DTwPHiB
HepB
Measles
MR
18 months; 5 years
6, 10, 14 weeks
birth; 6 weeks; 9 months
9 months
6 years
OPV


18 months; 5 years
Pneumo_conj
Rotavirus
TT

Vitamin A
2, 4, 12 months
2, 3 months

+1, +1 year
6, 12, 18 months
117
Mozambique
2010
Births........................................................................................................................... 883,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
90
90
89
88
88
88
84
78
59
47
...
DTP1
77
90
89
88
88
88
84
75
71
54
...
DTP3
74
76
78
79
78
78
70
57
46
29
...
HepB3
74
76
78
79
78
78
...
...
...
...
...
Hib3
74
74
...
...
...
...
...
...
...
...
...
MCV
70
67
71
74
75
75
71
71
59
39
...
Pol3
73
76
77
78
78
77
69
57
46
25
...
PAB
83
83
83
82
81
77
75
53
37
49
...

2010 2009

144
144
44
100
18
30
82
58
60

...
52
below 50%

at 80% or above

...

year
2008
target age group
coverage (%)
9-59 m
103
BCG birth
OPV
DTwPHibHep
TT

Measles
6, 10, 14 weeks
9 months
Vitamin A
118

+1, +1 year
6 months; +6 months
Myanmar
2010
Births........................................................................................................................... 830,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
93
93
88
89
85
76
88
90
95
45
DTP1
93
93
88
89
86
76
87
94
96
39
22
DTP3
90
90
85
86
82
73
82
84
88
16
HepB3
90
90
84
85
75
62
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
88
87
82
81
78
72
84
82
68
...
...
Pol3
90
90
85
84
82
73
86
84
88
...
PAB
93
93
93
93
92
89
79
80
62
24

2010 2009

325
325
98
99
10
87
89
54
49

94
93
below 50%
at 80% or above

75

year
2007
target age group
coverage (%)
9 m-5 y
94
BCG
6 weeks
DTwP
6, 10, 14 weeks
HepB
Measles
OPV
TT

9, 18 months
6, 10, 14 weeks
1st contact pregnancy;
+1 month
119
Namibia
2010
Births............................................................................................................................. 60,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
88
85
88
95
88
95
77
92
...
...
...
DTP1
87
87
88
88
91
93
90
90
...
...
...
DTP3
83
83
83
86
86
86
79
74
...
...
...
HepB3
83
...
...
...
...
...
...
...
...
...
...
Hib3
83
...
...
...
...
...
...
...
...
...
...
MCV
75
76
73
69
63
73
69
68
...
...
...
Pol3
83
83
83
81
74
86
80
73
...
...
...
PAB
83
82
82
82
81
80
74
40
...
...
...

2010 2009

34
34
100
100
32
38
68
62
21
15

...
...
below 50%
at 80% or above

...

year
2009
target age group
coverage (%)
9-59 m
104
BCG birth
DT
DTwPHibHep
Measles
120
5, 10 years
6, 10, 14 weeks
9 months
OPV

TT
Vitamin A

5, 10 years
15-49 years
9 months
Nauru
2010
Births................................................................................................................................... ...

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
90
93
78
93
81
...
DTP1
99
99
99
99
98
90
85
79
90
86
...
DTP3
99
99
99
99
72
80
44
56
74
67
...
HepB3
99
99
99
99
99
80
58
57
...
...
...
Hib3
99
99
...
...
...
...
...
...
...
...
...
MCV
99
99
99
99
99
79
...
...
...
...
Pol3
99
99
99
99
45
80
27
56
74
73
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

14
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

100

year
2001
target age group
coverage (%)
12-59 m
...
BCG birth
MR
DTwPHibHep
OPV

6, 10, 14 weeks
HepB birth
12, 15 months
4 years
TT
(pregnancy)
121
Nepal
2010
Births........................................................................................................................... 724,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
94
94
87
89
93
87
84
76
74
67
22
DTP1
85
94
96
93
97
81
91
77
68
57
28
DTP3
82
89
96
91
94
75
80
54
43
32
HepB3
82
89
82
82
69
41
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
86
90
90
89
88
74
77
56
57
34
...
Pol3
83
93
96
91
96
78
72
50
42
20
...
PAB
81
81
81
84
86
88
67
48
35
18

2010 2009

75
75
100
100
53
51
44
47
40

79
95
below 50%
at 80% or above

...

year
target age group
coverage (%)
2008
9 m-5 y
93
BCG birth
OPV
DTwPHibHep
TT pregnancy
JE
Measles
122
6, 10, 14 weeks
9 months
Vitamin A
6, 10, 14 weeks
6-59 months
Netherlands
2010
Births........................................................................................................................... 183,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
98
98
99
99
98
98
98
98
DTP3
97
97
97
96
96
98
97
97
97
97
96
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
97
97
97
96
96
97
96
...
...
...
...
MCV
96
96
96
96
95
96
96
94
94
92
91
Pol3
97
97
97
96
96
98
97
97
97
97
96
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

12
12
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

92

year
...
target age group
...
coverage (%)
...
DTaPHibHepIPV

2, 3, 4, 11 months
(high-risk groups)
HPV
(females)
DTaPHibIPV
2, 3, 4, 11 months
MenC_conj
DTaPIPV
4 years
MMR
DTIPV
9 years
Pneumo_conj
HepB

14 months
14 months; 9 years
2, 3, 4, 11 months
birth; <2 days after birth

(children of carriers)
123
New Zealand
2010
Births............................................................................................................................. 64,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
95
94
91
91
92
92
96
96
96
89
91
DTP3
93
92
89
88
89
89
90
89
90
72
76
HepB3
90
93
90
88
87
87
90
88
...
...
...
Hib3
89
98
86
78
80
80
90
...
...
...
...
MCV
91
89
86
79
82
82
85
84
90
64
80
Pol3
93
92
89
88
89
89
82
87
90
84
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
20
...
...
...
...
...
...
...
...
...
...

...
...

below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG
DTaPHibHepIPV
DTaPIPV
HepB
Hib
HPV
Influenza

124
high-risk groups
4 years
high-risk groups
15 months
12 years (females)
<5 years; >64 years;
high-risk groups
IPV
high-risk groups
MenACWY
high-risk groups
MMR
15 months; 4 years
Pneumo_conj

Pneumo_ps
Td
Tdap
6 weeks; 3, 5,
15 months
high-risk groups
45, 65 years
Nicaragua
2010
Births........................................................................................................................... 138,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
98
98
98
98
93
96
93
84
99
34
DTP1
99
99
98
96
94
92
97
93
88
64
39
DTP3
98
98
96
92
87
88
83
80
70
39
16
HepB3
98
98
96
92
87
88
83
...
...
...
...
Hib3
98
98
96
92
87
88
83
...
...
...
...
MCV
99
99
99
99
99
95
86
85
82
59
15
Pol3
99
99
96
92
88
87
85
83
90
88
21
PAB
81
80
80
80
85
87
83
68
39
21
...

2010 2009
153
153
100
100
91
92
74
72

86
86
below 50%

at 80% or above

...

year
2008
target age group
1-4 y
coverage (%)
100
BCG birth
MMR
DTwP
OPV
18 months; 6 years
DTwPHibHep
HepB

2, 4, 6 months

health workers; adolescents
Influenza 6 months-4 years; 65 years

(high-risk groups)
Pneumo_ps
Rotavirus
Td
Vitamin A
Yellow fever
1 year
2, 4, 6 months
50 years
2, 4, 6 months
10, 20 years; CBAW
6 months; 1, 2, 3, 4 years
travellers
125
Niger
2010
Births........................................................................................................................... 755,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
83
84
78
73
69
64
50
53
50
28
...
DTP1
80
81
76
68
63
58
46
42
46
22
...
DTP3
70
71
67
57
51
45
34
23
22
...
HepB3
70
71
...
...
...
...
...
...
...
...
...
Hib3
70
71
...
...
...
...
...
...
...
...
...
MCV
71
69
66
60
53
47
37
40
25
27
...
Pol3
75
71
68
57
52
46
41
23
22
...
PAB
84
84
84
79
73
69
63
57
17
...

2010 2009

42
42
100
100
10
90
95
45
43

79
74
below 50%
at 80% or above

0

year
2008
target age group
coverage (%)
9-59 m
100
BCG birth
DTwPHibHep
Measles
OPV
126
6, 10, 14 weeks
9 months
TT

1st contact or pregnancy; +1,

+6 months; +1, +1 years
Vitamin A
Yellow fever
6, 11 months
9 months
Nigeria
2010
Births........................................................................................................................ 6,332,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
76
68
61
53
52
49
41
42
80
28
...
DTP1
77
73
63
52
49
48
42
59
79
39
...
DTP3
69
63
53
42
40
36
29
34
56
16
...
HepB3
66
63
41
42
27
18
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
71
64
53
41
44
41
33
44
54
17
...
Pol3
79
70
62
54
46
45
26
31
55
16
...
PAB
69
67
64
63
63
62
57
44
32
11
...

2010 2009
774
774
100
100
10
10
50
37
40
52
38
45

52
46
below 50%
at 80% or above

...

year
target age group
coverage (%)
2008
9-59 m
97
BCG birth
OPV
DTwP
6, 10, 14 weeks
TT pregnancy
HepB
Measles
Yellow fever
6, 10, 14 weeks
9 months
9 months
127
Niue
2010
Births................................................................................................................................... ...

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
98
99
96
99
92
99
41
85
DTP1
99
99
99
99
99
94
99
99
99
83
27
DTP3
99
99
99
98
99
84
99
99
99
62
HepB3
99
99
99
98
99
85
99
90
...
...
...
Hib3
99
99
99
99
99
99
99
...
...
...
...
MCV
99
99
99
98
99
99
99
34
99
52
77
Pol3
99
99
99
98
99
85
99
99
99
62
76
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

100
100
100
100
100
100

100
100
below 50%

at 80% or above

100

year
2001
target age group
coverage (%)
12-59 m
...
BCG birth
MMR
DTaPHibHepIPV

Pneumo_conj

DTaPIPV
Hib
128
6 weeks; 3,
5 months
4 years
15 months
Tdap
15 months; 4 years
6 weeks; 3, 5,
15 months
11 years
Norway
2010
Births............................................................................................................................. 60,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
99
99
99
99
98
95
95
...
DTP3
93
92
94
93
93
91
90
97
86
85
...
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
94
94
94
95
94
93
93
...
...
...
...
MCV
93
92
93
92
91
89
88
92
87
90
...
Pol3
93
92
94
93
93
91
91
92
84
90
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

19
19
100
95
100
95
95
89

...
...
below 50%

at 80% or above

97

year
...
target age group
...
coverage (%)
...
BCG
DTaPHibIPV
DTaPIPV
HepB

HPV

3, 5, 12 months
7 years
birth; 1, 2 months;
high-risk groups
Influenza
IPV
MMR
Pneumo_conj
Td
high-risk groups
15 years
15 months; 12 years
3, 5, 12 months
11 years
129
occupied Palestinian territory

2010
Births........................................................................................................................... 134,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
92
91
...
...
...
DTP1
98
98
98
99
98
99
95
99
...
...
...
DTP3
96
96
96
99
96
96
93
99
...
...
...
HepB3
95
95
95
98
96
99
94
93
...
...
...
Hib3
96
96
96
96
...
...
...
...
...
...
...
MCV
98
97
96
98
99
98
93
73
...
...
...
Pol3
97
97
97
99
97
99
93
96
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

17
17
100
100
100
100
100
100

100
100
below 50%

at 80% or above

94

year
...
target age group
...
coverage (%)
...
BCG birth
Measles
DT
MMR
DTP
DTPHib
HepB
IPV
130
6 years
18 months
2, 4, 6 months
birth; 1, 6 months
1, 2 months
OPV
Pneumo_conj
Rubella
Td
9 months
12, 18 months
2, 4, 6, 18 months; 1 year
2, 4, 12 months
1 year
15 years
Oman
2010
Births............................................................................................................................. 50,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
98
98
96
96
93
51
DTP1
99
99
99
99
98
99
99
99
98
82
41
DTP3
99
98
99
99
98
99
99
99
98
60
18
HepB3
98
97
98
99
98
98
99
99
...
...
...
Hib3
99
98
99
99
98
99
...
...
...
...
...
MCV
97
97
97
97
96
98
99
98
98
65
22
Pol3
99
96
97
97
98
99
99
99
98
60
18
PAB
91
91
91
95
94
94
94
80
93
82
35

2010 2009

61
61
100
100
100
100
100
100

100
100
below 50%

at 80% or above

99

year
...
target age group
...
coverage (%)
...
BCG birth
DT
6 years
DTwP
18 months
DTwPHibHep
2, 4, 6 months
HepB birth
Influenza seasonal
IPV
9 weeks
MenACWY pilgrims
MMR
12, 18 months
OPV
4, 6, 18 months; 6, 18 years
Pneumo_conj
Rabies
Rubella
Td
TT
Typhoid
Varicella
Vitamin A
Yellow fever
2, 4, 6 months
high-risk groups
15-49 years; post-partum
12, 17 years
pregnancy; post-injury
food handlers
1 year
9, 18 months; post-partum
travellers
131
Pakistan
2010
Births........................................................................................................................ 4,741,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
95
90
90
89
89
82
74
73
80
62
DTP1
90
90
85
90
90
82
72
73
77
55
20
DTP3
88
85
73
83
83
80
62
58
54
30
HepB3
88
85
73
83
83
73
...
...
...
...
...
Hib3
88
85
...
...
...
...
...
...
...
...
...
MCV
86
80
85
80
80
78
59
47
50
38
Pol3
88
85
81
83
83
81
65
58
54
30
PAB
84
84
80
78
80
78
71
63
50
12
...

2010 2009
139
135
100
100
11
22
27
72
61
49
40

59
44
below 50%
at 80% or above

51

year
...
target age group
...
coverage (%)
...
BCG birth
OPV
DTwPHibHep
TT

Measles
132
6, 10, 14 weeks
9, 15 months

Palau
2010
Births................................................................................................................................... ...

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
99
98
98
98
99
99
...
...
DTP3
49
49
92
94
98
98
96
99
99
...
...
HepB3
80
69
92
91
98
98
96
99
...
...
...
Hib3
66
48
92
95
98
98
96
...
...
...
...
MCV
75
75
97
91
98
98
83
99
98
...
...
Pol3
48
48
92
94
98
98
96
99
99
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
...
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
DTaP
IPV
DTaPHepIPV
MMR
HepB birth
Pneumo_conj
Hib
Pneumo_ps
6 weeks; 4, 6, 12 months
HPV
(females)
Influenza
high-risk groups
Rotavirus
Tdap
4-6 years
12, 15 months
3, 5, 7, 15 months
65 years
5-10 years
133
Panama
2010
Births............................................................................................................................. 70,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
97
97
97
97
98
99
99
99
97
94
99
DTP1
98
95
93
97
98
98
99
95
95
90
72
DTP3
94
85
86
85
88
92
98
86
86
73
47
HepB3
94
85
86
85
88
92
...
...
...
...
...
Hib3
94
85
86
85
88
92
...
...
...
...
...
MCV
95
95
95
95
95
99
97
84
73
84
71
Pol3
94
84
85
83
97
87
98
86
86
71
70
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

76
77
100
100
...
26
100
74
99
48

84
47
below 50%

at 80% or above

73

year
2010
target age group
<5 y
coverage (%)
16
BCG birth
DT
<5 years (pertussis contraindication)
DTwP
5 years
DTwPHib
18 months
DTwPHibHep
2, 4, 6 months
H1N1 seasonal
HepA
12, 18 months
HepB
birth; health workers; adolescents
HPV
10 years; +1, +6 months (females)
Influenza
6, 7-11 months; >60 years; health workers;

high-risk groups
IPV
2, 4, 6, 15-18 months; 4-5 years (high-risk groups)
134
MMR
MR
OPV
Pneumo_conj

Pneumo_ps
Rotavirus
Td
Tdap
Vitamin A
Yellow fever

1, 4 years
>19 years; CBAW; health workers
2, 4, 6, 12-15 months
(subnational); high-risk groups
2, 4 months
>6 years; CBAW; health workers
6, 12, 18 months
1 year (subnational); +every
10 years (high-risk areas)
Papua New Guinea

2010
Births........................................................................................................................... 207,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
79
79
68
67
75
73
81
91
92
66
62
DTP1
80
80
70
76
85
80
84
97
97
65
57
DTP3
56
62
52
60
61
61
59
62
68
40
32
HepB3
56
62
56
59
70
63
57
23
20
...
...
Hib3
56
62
...
...
...
...
...
...
...
...
...
MCV
55
55
54
58
65
63
62
42
67
33
...
Pol3
61
68
65
61
56
50
47
68
68
34
29
PAB
61
61
61
60
57
53
24
60
78
25
45

2010 2009
89
89
98
93
44
61
31
20
22
12
12

21
24
below 50%
at 80% or above

...

year
target age group
coverage (%)
2010
6-35 m
72
BCG birth
OPV
DTwPHibHep
TT

1, 2, 3 months
HepB birth
Measles
6, 9 months
1, 2, 3 months
7, 13 years; 1st contact pregnancy;
+1, +6 months; +1 year
Vitamin A
6, 12 months
135
Paraguay
2010
Births........................................................................................................................... 156,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
92
91
94
96
98
97
85
82
75
68
31
DTP1
96
94
96
98
99
97
95
87
86
80
40
DTP3
90
86
90
92
96
94
86
68
67
57
17
HepB3
98
94
95
92
96
95
...
...
...
...
...
Hib3
98
94
94
92
93
91
...
...
...
...
...
MCV
94
91
91
91
91
91
92
75
69
48
19
Pol3
88
83
88
90
94
93
86
68
64
99
14
PAB
85
74
74
74
81
78
47
75
66
42
26

2010 2009

241
234
99
100
13
12
50
56
36
32
22
15

88
86
below 50%
at 80% or above

64

year
2009
target age group
1-4 y
coverage (%)
79
BCG birth
DTwP
18 months; 4 years
DTwPHibHep
2, 4, 6 months
HepB

(high-risk groups)
Influenza
6-35 years (2 doses); >60 years;

high-risk groups
IPV
2, 4, 6, 18 months

(high-risk groups)
MenAC
high-risk groups
MMR
1, 4 years
136
MR
>5 years (high-risk groups)
OPV
Pneumo_ps
high-risk groups
Rotavirus
2, 4 months;
Td
1st contact; +1 month; +1, +1, +1 year

(>7 years and high-risk groups)
Typhoid travellers
Varicella
high-risk groups
Yellow fever
1 year
Peru
2010
Births........................................................................................................................... 594,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
95
97
98
99
99
93
93
94
83
63
57
DTP1
97
99
99
98
99
99
99
96
89
72
39
DTP3
93
93
99
97
94
89
98
90
72
48
16
HepB3
93
93
99
93
94
89
...
...
...
...
...
Hib3
93
93
99
93
94
89
38
...
...
...
...
MCV
94
91
90
95
99
80
97
98
64
53
23
Pol3
92
92
98
96
95
85
93
89
73
47
16
PAB
85
67
67
67
66
65
66
50
19
...

2010 2009
1,834 1,834
100
100
15
14
33
32
52
54
46
40

79
71
below 50%
at 80% or above

56

year
2009
target age group
<5 y
coverage (%)
45
BCG birth
DT
4, 6 months (pertussis
contraindication)
DTwP
18 months; 4 years
DTwPHibHep
2, 4, 6 months
HepB
birth; adults (when requested)
Hib
2, 4 months (pertussis
contraindication)
Influenza
1st contact (high-risk adults)
IPV
2, 4, 6 months (HIV-exposed)
MMR
1, 4 years
MR
<5 years; high-risk groups
OPV
2, 4, 6 months
Pneumo_conj
3, 5, 12 months
Rotavirus
2, 4 months
Td
Vitamin A
>6 months (subnational)
Yellow fever 15 months (high-risk areas)
137
Philippines
2010
Births........................................................................................................................ 2,344,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
90
90
93
90
91
91
92
82
96
76
56
DTP1
89
89
94
90
90
91
93
76
96
81
72
DTP3
87
87
91
87
88
89
79
70
88
59
47
HepB3
85
85
88
87
77
49
38
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
MCV
88
88
92
92
92
92
80
72
85
49
...
Pol3
86
86
91
87
88
90
75
67
88
58
50
PAB
75
68
58
58
61
57
55
54
57
28

2010 2009

217
179
81
98
40
25
37
72
18
43

92
89
below 50%
at 80% or above

...

year
target age group
coverage (%)
2007
9-48 m
95
BCG birth
MMR
DTwP
OPV
6, 10, 14 weeks
1 year
6, 10, 14 weeks
DTwPHibHep subnational
TT pregnancy
HepB
Vitamin A

Measles
138
birth; 6, 14 weeks
9 months
6, 12, 18, 24, 30,

36 months
Poland
2010
Births........................................................................................................................... 405,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
94
94
94
93
94
94
96
98
97
95
93
DTP1
99
99
99
99
99
99
99
98
98
97
98
DTP3
99
99
99
99
99
99
98
96
96
94
96
HepB3
98
98
98
98
98
98
99
23
...
...
...
Hib3
99
99
94
88
31
22
...
...
...
...
...
MCV
98
98
98
98
99
98
97
96
95
92
92
Pol3
96
96
98
99
99
99
98
96
96
94
96
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

379
379
100
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

94

year
...
target age group
...
coverage (%)
...
BCG birth
IPV
DTwP

7-8 weeks; 3-4, 5-6,

16-18 months
MMR
HepB

birth; 2, 7 months or 14 years;

+1, +6 months (catch up)
Hib
2, 3-4, 5-6, 16-18 months
OPV
Td
Tdap
3-4, 5-6, 16-18 months

6 years
14, 19 years
6 years
139
Portugal
2010
Births............................................................................................................................. 99,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
96
98
98
98
99
89
82
94
88
82
...
DTP1
99
97
99
99
99
94
99
97
96
89
90
DTP3
98
96
97
97
97
93
96
93
89
72
73
HepB3
97
96
97
97
97
94
58
...
...
...
Hib3
97
96
97
97
97
93
86
...
...
...
...
MCV
96
95
97
95
97
93
87
94
85
70
54
Pol3
97
96
97
96
97
93
96
96
89
29
18
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

below 50%
20
100
...
...
...
100
...
100
...

100
100
at 80% or above

...

year
2010
target age group
coverage (%)
travellers
BCG birth
DTaPHib
DTaPHibIPV
DTaPIPV
HepB
140
18 months
2, 4, 6 months
5-6 years
birth; 2, 4 months
HPV
(females)
MenC_conj
MMR
Td
3, 5, 15 months
Qatar
2010
Births............................................................................................................................. 21,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
98
97
96
99
99
99
96
97
76
DTP1
98
99
98
96
99
99
92
97
94
88
82
DTP3
97
99
97
94
96
97
80
92
82
71
61
HepB3
97
99
97
94
96
97
89
90
...
...
...
Hib3
97
99
97
94
96
97
80
...
...
...
...
MCV
99
99
96
92
99
99
91
87
79
62
26
Pol3
98
98
98
97
95
98
91
92
82
71
61
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
...
100
...
...
...
100
...
100

...
...
below 50%
at 80% or above

99

year
2007
target age group
coverage (%)
12-59 m
93
BCG birth
DT
4-6 years
DTaPHib
DTaPHibHepIPV
2 months
DTwPHibHep
4, 6 months
HepA
12, 18 months
HepB
Influenza
pilgrims; health workers
IPV
2 months
MenACWY
>2 years (+every 3 years);

pilgrims; travellers
MMR
OPV
Pneumo_conj
Pneumo_ps
Rotavirus
Td
TT
Typhoid
Yellow fever

2, 4, 6, 18 months; 4-6 years
2, 4, 6, 15 months
high-risk groups
2, 6 months
13-16 years
0, 1, 6 months (post-injury)
food handlers; travellers
travellers
141
Romania
2010
Births........................................................................................................................... 221,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
98
99
99
90
...
...
DTP1
99
99
99
99
99
99
99
98
98
98
...
DTP3
97
97
97
97
97
97
99
98
96
95
...
HepB3
98
95
97
99
99
98
98
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
95
96
96
97
95
97
98
93
92
88
...
Pol3
96
96
96
96
97
97
99
94
92
92
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

42
42
...
100
...
...
...
100
...
98

...
...
below 50%
at 80% or above

93

year
...
target age group
...
coverage (%)
...
BCG birth
IPV
DTaP
MMR
DTaPHibIPV
HepA
HepB
HPV
Influenza
142
4 years
2, 4, 6, 12 months
outbreaks (subnational)
birth; 2, 6 months
high-risk groups
Td
9 years
1, 7 years
TT post-injury
Typhoid
Yellow fever
(if indicated)
travellers (subnational)
Russian Federation
2010
Births........................................................................................................................ 1,682,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
96
96
98
96
97
97
96
92
...
...
...
DTP1
99
99
99
99
99
99
97
92
...
...
...
DTP3
97
98
98
98
99
98
96
78
...
...
...
HepB3
97
98
98
98
98
97
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
98
98
99
99
99
99
97
85
...
...
...
Pol3
98
98
98
99
99
98
97
77
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

83
83
100
100
100
100
100
100
...
100

97

year
target age group
coverage (%)
2008
18-35 y
101
BCG
3 days; 7, 14 years
Dip
every 10 years
DT
3, 4.5, 12 months
DTwP
3, 4.5, 6, 18 months
DTwPHep
3, 6 months
HepB
1 day; 3, 6 months
Influenza seasonal
IPV
3, 4.5, 6 months
Measles
1, 6 years
MenACWY
pilgrims (subnational)
MM
1, 6 years
MMR
1, 6 years (subnational)
Mumps
1, 6 years
OPV
Rubella
1, 6 years
Td
6-7, 14 years; +every 10 years
143
Rwanda
2010
Births........................................................................................................................... 438,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
75
85
93
89
98
91
81
89
92
83
...
DTP1
92
90
99
99
99
95
93
94
94
74
...
DTP3
80
90
97
97
99
95
90
83
84
50
...
HepB3
80
90
97
97
99
95
...
...
...
...
...
Hib3
80
90
97
96
99
95
...
...
...
...
...
MCV
82
93
92
94
95
89
74
84
83
52
...
Pol3
80
90
97
98
99
95
90
84
83
56
...
PAB
85
85
85
82
82
79
81
89
85
28
...

2010 2009
30
...
...
...
...
...
...
...
...
...
...

...
...

below 50%
at 80% or above

...

year
2008
target age group
coverage (%)
9-11 m
59
BCG birth
OPV
DT

Pneumo_conj
DTwPHibHep
Measles
144
1 month; +2, +6 months;

+1, +1 year; pregnancy
6, 10, 14 weeks
9 months
TT


6, 10, 14 weeks

Saint Kitts and Nevis

2010
Births................................................................................................................................... ...

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
91
93
95
97
99
99
99
94
80
...
...
DTP1
98
99
99
99
99
99
99
99
99
97
79
DTP3
95
97
98
99
99
99
98
99
99
92
56
HepB3
96
97
98
99
99
99
99
...
...
...
...
Hib3
96
97
97
99
99
99
12
...
...
...
...
MCV
99
99
99
99
99
99
99
99
99
91
...
Pol3
90
94
97
99
98
99
98
99
99
89
76
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

17
17
100
100
100
100
100
100
...
100

121

year
...
target age group
...
coverage (%)
...
BCG
birth-4 weeks
DTwP

3, 4, 5, 18 months;
4-5 years
DTwPHibHep
HepB

2, 4, 6 months
2, 4, 7 months; 1st contact;

+1, +7 months (adults)
IPV

2, 4, 6, 18 months; 4-5, 16 years

(high-risk groups)
MMR
OPV

Td
Yellow fever
1, 2 years
2, 4, 6, 18 months;
4-5, 16 years
11, 16, 26 years
travellers
145
Saint Lucia
2010
Births............................................................................................................................... 3,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
97
97
99
99
94
97
91
98
94
99
27
DTP1
98
99
99
99
94
99
76
98
96
95
79
DTP3
97
95
96
99
85
95
70
98
89
87
56
HepB3
97
95
96
99
85
95
...
...
...
...
...
Hib3
97
95
96
99
85
95
...
...
...
...
...
MCV
95
99
99
94
94
94
88
94
82
68
...
Pol3
97
95
96
99
85
95
70
98
90
44
58
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

100
100
22
33
78
67
56
78

89
...
below 50%
at 80% or above

74

year
...
target age group
...
coverage (%)
...
BCG
DT
DTwP
DTwPHibHep
6 weeks
5 years
18 months
3, 5, 7 months
IPV
3, 5, 7, 18 months; 5, 11 years
(immunocompromised)
MMR
OPV
HepB
high-risk groups
Td
Influenza
high-risk groups
Varicella
1, 5, 11 years
3, 5, 7, 18 months; 5, 11 years
Yellow fever
146
11 years
high-risk groups
travellers
Saint Vincent and the Grenadines

2010
Births............................................................................................................................... 2,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
90
80
87
93
99
95
99
99
99
84
...
DTP1
99
99
99
99
99
99
99
98
98
96
51
DTP3
99
99
99
99
99
98
97
97
98
90
26
HepB3
99
99
99
99
99
99
...
...
...
...
...
Hib3
99
99
99
99
99
99
...
...
...
...
...
MCV
99
99
99
99
99
96
95
99
96
74
...
Pol3
99
99
99
98
98
92
99
97
92
89
26
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

100
100
100
100
67
100
100
100

89

year
...
target age group
...
coverage (%)
...
BCG
birth-1 year
DT
4-5, 10-15 years
DTwP
18 months
DTwPHibHep
2, 4, 6 months
HepB
birth; adults (hepatitis
B-exposed)
Hib
6 months (if given HepB at birth)
IPV

MMR
OPV

2, 4, 6, 18 months;
4-5 years (HIV-exposed)
1, 4-5 years
2, 4, 6, 18 months;
4-5 years
Td
>10 years
Yellow fever
travellers
147
Samoa
2010
Births............................................................................................................................... 5,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
91
94
99
91
84
86
97
96
97
97
72
DTP1
97
91
50
85
80
86
99
97
96
96
54
DTP3
87
72
46
71
56
64
99
94
90
89
29
HepB3
87
72
38
69
56
60
96
96
...
...
...
Hib3
87
72
32
...
...
...
...
...
...
...
...
MCV
61
49
45
63
54
57
93
96
89
81
...
Pol3
86
72
78
71
57
73
99
94
88
92
29
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

100
100
11
...
33
33
56
67
22
22

67
33
below 50%
at 80% or above

45

year
2009
target age group
coverage (%)
6-59 m
76
BCG birth
MMR
12, 15 months
DTaP
OPV
6, 10, 14 weeks
DTwPHibHep
5 years
6, 10, 14 weeks
HepB birth
148
Td


+1 year
San Marino
2010
Births................................................................................................................................... ...

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
95
95
89
92
98
98
97
99
99
99
...
DTP3
92
92
87
92
95
95
96
99
99
99
...
HepB3
92
92
87
92
95
95
94
98
...
...
...
Hib3
92
92
87
92
95
94
92
80
...
...
...
MCV
93
93
73
92
94
94
74
97
...
...
...
Pol3
92
92
87
92
95
95
96
98
99
99
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
DTaPHibHepIPV
2-3, 4-5, 11-12
months
DTaPIPV
HPV

5-6 years
11 years (females,
3 doses)
MMR
15 months; 5 years
Td
15-16 years
Tdap
25-26 years
149
Sao Tome and Principe

2010
Births............................................................................................................................... 5,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
98
98
98
81
95
99
75
...
DTP1
98
99
99
99
99
99
93
92
97
72
...
DTP3
98
98
99
97
97
97
82
79
92
48
...
HepB3
98
98
99
87
75
96
...
...
...
...
...
Hib3
98
...
...
...
...
...
...
...
...
...
...
MCV
92
90
93
86
85
88
69
74
71
35
...
Pol3
98
99
99
98
97
97
87
79
90
48
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

100
100
100
100
57
57
100
...

...

year
2007
target age group
coverage (%)
9 m-14 y
101
BCG birth
DTwPHibHep
6, 10, 14 weeks
HepB
6, 10, 14 weeks
Measles
9 months
OPV


17 months
TT


+1, +2 years
Vitamin A
6, 12, 18, 24, 30, 36 months
Yellow fever
150
9 months
Saudi Arabia
2010
Births........................................................................................................................... 595,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
98
98
96
95
96
94
94
90
89
33
DTP1
98
98
98
97
97
97
95
98
97
93
66
DTP3
98
98
98
96
96
96
95
96
92
81
41
HepB3
98
98
98
96
96
97
93
93
66
...
...
Hib3
98
98
98
96
96
96
...
...
...
...
...
MCV
98
98
97
96
95
97
94
94
88
79
Pol3
98
98
98
96
96
96
95
96
92
81
41
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

20
20
100
100
100
100
100
100

100
100
below 50%

at 80% or above

98

year
target age group
coverage (%)
2007
6 m-18 y
98
BCG birth
DT
<7 years (pertussis contraindication)
DTwP
18 months
DTwPHib
18 months
DTwPHibHep
2, 4, 6 months
HepA
18 months; 2 years
HepB birth
Hib
contraindication)
Influenza seasonal
IPV
2 months
Measles
9 months
MMR
1, 4-6 years
OPV
4, 6, 12, 18 months; 4-6 years
Pneumo_conj
2, 4, 6, 12 months
Pneumo_ps
high-risk groups
Td
7 years
Typhoid
(if indicated)
Varicella
1, 4-6 years
Yellow fever
travellers
151
Senegal
2010
Births........................................................................................................................... 465,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
80
97
98
96
94
92
89
91
90
...
...
DTP1
80
94
94
98
99
97
79
93
75
...
...
DTP3
70
86
88
94
89
84
52
80
51
...
...
HepB3
70
86
88
94
89
84
...
...
...
...
...
Hib3
70
86
88
94
89
18
...
...
...
...
...
MCV
60
79
77
84
80
74
48
80
51
...
...
Pol3
70
83
87
93
89
84
49
80
53
...
...
PAB
88
88
88
85
86
80
62
54
45
...

2010 2009
65
65
95
100
below 50%

at 80% or above

62
29
28
71
18
80
68

0

year
target age group
coverage (%)
2006
9-59 m
99
BCG birth
TT CBAW
DTwPHibHep
Vitamin A 6, 12, 18, 24, 30, 36 months;

post-partum
Measles
6, 10, 14 weeks
9 months
Yellow fever
OPV
152
9 months
Serbia
2010
Births........................................................................................................................... 111,000

2010 2009 2008 2007 2006*

2005 2000 1995 1990 1985 1980
BCG
99
98
99
98
99
98
85
97
...
...
...
DTP1
97
98
98
98
97
99
98
96
...
...
...
DTP3
91
95
95
94
92
98
95
89
...
...
...
HepB3
89
93
93
99
93
65
...
...
...
...
...
Hib3
91
94
98
89
42
...
...
...
...
...
...
MCV
95
95
92
95
88
96
89
86
...
...
...
Pol3
91
97
95
93
97
98
98
90
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

25
25
100
100
100
100
100
92
...
...

98

year
...
target age group
...
coverage (%)
...
BCG birth
MenAC
DT
MMR
7 years
DTwP
HepA travellers
OPV

HepB
Pneumo_ps
Hib
Influenza
IPV
8, 14, 20 weeks
>1 year (immunocompromised)
high-risk groups; travellers

1, 7 years
7, 14 years
Td
high-risk groups
14 years
Typhoid travellers
Yellow fever
*All data prior to 2006 pertain to the pre-cession Serbia and Montenegro.
travellers
153
Seychelles
2010
Births................................................................................................................................... ...

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
96
99
99
99
99
99
99
98
92
...
DTP1
99
99
99
99
99
99
99
98
99
95
...
DTP3
99
99
99
99
99
99
98
97
99
86
...
HepB3
99
99
99
99
99
99
98
99
...
...
...
Hib3
99
...
...
...
...
...
...
...
...
...
...
MCV
99
97
99
99
99
99
97
97
86
90
...
Pol3
99
99
99
99
99
99
98
97
99
86
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
16

below 50%
16
100
...
...
...
100
...
100
...

100
...
at 80% or above

98

year
...
target age group
...
coverage (%)
...
BCG
DT
DTwP
birth; 6 years
6 years
3, 4, 5, 18 month
DTwPHibHep
3, 4, 5 months
HepB
3, 4, 9 months
154
MMR
15 months; 6 years
OPV

3, 4, 5, 18 months;
6, 15 years
TT
Yellow fever
15, 25, 35 years

1 year; travellers
Sierra Leone
2010
Births........................................................................................................................... 226,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
96
88
82
83
85
74
...
...
...
...
DTP1
96
98
84
77
79
80
64
...
...
...
...
DTP3
90
86
77
64
64
65
44
...
...
...
...
HepB3
90
86
77
63
...
...
...
...
...
...
...
Hib3
90
86
77
63
...
...
...
...
...
...
...
MCV
82
78
69
60
65
71
37
...
...
...
...
Pol3
89
86
76
63
65
67
46
...
...
...
...
PAB
85
97
97
94
85
83
53
76
85
38

2010 2009

14
13
100
100
21
14
79
86
36
71

14
43
below 50%
at 80% or above

...

year
2009
target age group
coverage (%)
9-59 m
101
BCG birth
DTwPHibHep
Measles
OPV
6, 10, 14 weeks
9 months
TT


+1, +1 year
Vitamin A
Yellow fever
6, 9 months
9 months
155
Singapore
2010
Births............................................................................................................................. 45,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
98
98
98
99
98
99
93
85
DTP1
98
98
98
97
96
96
98
98
95
92
94
DTP3
97
97
97
96
95
96
98
98
85
78
84
HepB3
96
97
96
95
94
96
97
96
74
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
95
95
95
95
93
96
96
97
84
75
47
Pol3
97
97
97
96
95
96
98
98
85
81
83
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above
...

94

year
...
target age group
...
coverage (%)
...
BCG birth
MMR
DTaP
3, 4, 5, 18 months
HepB
birth; 1, 5-6 months
OPV

HPV

9-26 years (females,

3 doses)
Influenza
6 months-5 years
(recommended)
156
Pneumo_conj

Pneumo_ps
Tdap
1-2, 6-7 years

3, 4, 5, 18 months;
6-7, 10-11 years
3, 5 months;
1-2 years
high-risk groups
10-11 years
Slovakia
2010
Births............................................................................................................................. 57,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
97
98
98
98
98
94
92
...
...
...
DTP1
99
99
99
99
99
99
99
99
...
...
...
DTP3
99
99
99
99
99
99
99
99
...
...
...
HepB3
99
99
99
99
99
99
98
...
...
...
...
Hib3
99
99
99
99
99
99
59
...
...
...
...
MCV
98
99
99
99
98
98
98
99
...
...
...
Pol3
99
99
99
99
99
99
98
98
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

79
79
100
100
100
100
100
100
...
...

99

year
...
target age group
...
coverage (%)
...
BCG
3 days; 10 years (if tuberculin
negative)
DTaPHibHepIPV
DTaPIPV
HepB
2, 4, 10 months
5, 12 years
Influenza
MMR
Pneumo_conj
high-risk groups
14 months; 10 years
2, 4, 10 months
birth; children of carriers
157
Slovenia
2010
Births............................................................................................................................. 20,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
98
99
...
...
...
DTP1
98
98
99
99
99
98
96
98
...
...
...
DTP3
96
96
97
97
97
95
91
98
...
...
...
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
96
96
97
97
97
95
...
...
...
...
...
MCV
95
95
96
96
96
94
95
93
...
...
...
Pol3
96
96
97
97
97
95
93
98
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

100
100
100
100
100
100
...
100

...
year
...
target age group
...
coverage (%)
...
BCG
Dip
DTaPHibIPV
HepA
HepB
Hib
HPV
Influenza
IPV
Measles
MenACWY
MenC_conj
158

(if indicated)
3, 4.5, 6, 18 months
(if indicated)
5 (2 doses), 6 years
high-risk groups
(if indicated)
(if indicated)
high-risk groups
high-risk groups
MMR
1, 5 years
Pneumo_conj
high-risk groups
Pneumo_ps
high-risk groups
Rabies
Rubella
(if indicated)
TBE
Td
9 years
Tdap
9 years
TT
18 years
Typhoid
(if indicated)
Varicella
high-risk groups
Solomon Islands
2010
Births............................................................................................................................. 17,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
85
58
81
84
84
78
92
77
87
50
65
DTP1
85
93
78
84
96
81
90
87
91
63
71
DTP3
79
81
78
79
91
78
82
69
77
38
46
HepB3
79
81
77
79
93
73
77
68
...
...
...
Hib3
79
77
77
...
...
...
...
...
...
...
...
MCV
68
60
60
78
84
70
85
68
70
...
...
Pol3
78
82
78
77
91
74
82
69
75
36
43
PAB
85
85
85
84
74
74
75
81
71
27
...

2010 2009

10
50
100
98
50
50
70
...
below 50%
at 80% or above


0

year
2009
target age group
1-4 y
coverage (%)
90
BCG birth
Measles
DTwPHibHep
OPV
6, 10, 14 weeks
HepB birth
TT

1 year
6, 10, 14 weeks; 5 years
5 years; 1st and
2nd pregnancy
159
Somalia
2010
Births........................................................................................................................... 408,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
29
29
36
38
40
50
69
46
31
30
DTP1*
55
52
40
59
40
50
57
46
42
46
...
DTP3*
45
42
31
40
26
35
33
22
19
22
...
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV*
46
43
34
35
35
35
24
34
30
35
Pol3
49
41
40
40
26
35
37
22
18
22
PAB
64
64
49
50
51
47
47
48
49
16
...

2010 2009

98
113
100
100
64
77
15
23
20
16

23
below 50%
at 80% or above

...

year
2010
target age group
coverage (%)
9-59 m
70
BCG birth
OPV
DTwP
TT
6, 10, 14 weeks
Measles
160
9 months
Vitamin A

16, 20 weeks; pregnancy
9 months
*Since 2008, Somalia supplements routine services with DTP and MCV administered
through Child Health Days. The estimates are based solely on routine doses.
South Africa
2010
Births........................................................................................................................ 1,059,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
86
86
86
86
85
84
89
95
57
70
...
DTP1
73
73
73
73
74
75
85
89
89
91
...
DTP3
63
63
63
63
65
66
73
72
72
75
...
HepB3
56
56
56
56
60
64
73
...
...
...
...
Hib3
45
45
45
45
51
56
71
...
...
...
...
MCV
65
65
65
65
64
64
72
76
79
70
...
Pol3
67
67
67
67
68
69
71
72
76
77
...
PAB
77
75
75
72
74
59
68
29
...
...
...

2010 2009

52
52
100
...
...
27
...
69
...
48
...

71
...
below 50%
at 80% or above

83

year
2010
target age group
coverage (%)
6 m-15 y
98
BCG birth
OPV
DTaPHibIPV

6, 10, 14 weeks;
18 months
Pneumo_conj

6, 14 weeks;
9 months
HepB
6, 10, 14 weeks
Rotavirus
6, 14 weeks
Influenza
Measles
birth; 6 weeks
high-risk groups
Td
6, 12 years
9, 18 months
TT
161
Spain
2010
Births........................................................................................................................... 498,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
98
99
98
99
98
98
96
95
92
...
DTP3
97
96
97
96
98
96
95
90
86
79
...
HepB3
97
96
97
96
81
81
77
...
...
...
...
Hib3
97
96
97
96
98
96
92
...
...
...
...
MCV
95
98
98
97
97
97
94
90
99
79
...
Pol3
97
96
97
96
98
96
95
88
94
73
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
19
19
95
79
...
...
95
79
89
79

...
...
below 50%

at 80% or above

92

year
...
target age group
...
coverage (%)
...
DTaP
4-6 years
Influenza
DTaPHibHepIPV
2, 4, 6, 15-18 months
(subnational)
MenC_conj
DTaPHibIPV
2, 4, 6, 15-18 months
(subnational)
Pneumo_conj

HepB

HPV
162
birth; 2, 6 months or 1, 2,
MMR
Pneumo_ps
>65 years
2, 6, 15-18 months
2, 4, 6, 15-18 months;
high-risk groups
Td
14-16 years
Varicella
10-14 years
Sri Lanka
2010
Births........................................................................................................................... 378,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
98
90
84
71
61
DTP1
99
97
99
99
99
99
99
97
95
88
71
DTP3
99
97
98
98
98
99
99
93
86
70
46
HepB3
99
97
98
98
98
99
...
...
...
...
...
Hib3
99
...
...
...
...
...
...
...
...
...
...
MCV
99
97
98
98
99
99
99
87
80
20
...
Pol3
99
97
98
98
98
99
99
92
86
71
46
PAB
86
93
93
91
90
87
92
81
72
50
45

2010 2009


below 50%

at 80% or above

26
26
100
92
...
...
100
92
92
92
100
...

95

year
...
target age group
...
coverage (%)
...
BCG birth
DT
DTwP
DTwPHibHep
JE
Measles
MR
5 years
18 months
2, 4, 6 months
9 months
OPV

2, 4, 6, 18 months;
5 years
Rubella
13 years
(recommended)
Td
12 years
TT

pregnancy (2 doses
for 1st pregnancy)
3 years
163
Sudan
2010
Births........................................................................................................................ 1,429,000

2010*
2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
90
82
88
83
77
72
56
63
77
12
DTP1
99
92
96
95
91
88
75
72
83
28
18
DTP3
90
81
86
84
78
78
62
48
62
HepB3
75
72
78
78
60
22
...
...
...
...
...
Hib3
75
72
78
...
...
...
...
...
...
...
...
MCV
90
82
79
79
73
69
58
51
57
...
Pol3
90
81
85
84
77
78
62
48
62
PAB
74
74
70
72
70
68
61
76
72
...

2010 2009
157
143
100
99
10
13
89
81
40
24

69
66
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG birth
DTwP

6, 10, 14 weeks
(subnational, South Sudan)
DTwPHibHep
6, 10, 14 weeks

(subnational, North Sudan)
Measles
MenAC

164
9 months
OPV

TT

birth (South Sudan);

6, 10, 14 weeks
+1, +1 year
Yellow fever

>2 years (subnational,

South Sudan)
>2 years (subnational,

South Sudan)
*All data up to and including 2010 pertain to the pre-cession Republic of Sudan.
Suriname
2010
Births............................................................................................................................. 10,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
91
95
96
94
94
88
94
94
94
50
DTP3
88
87
85
84
84
83
71
84
83
84
25
HepB3
88
87
84
84
84
83
...
...
...
...
...
Hib3
86
87
84
84
84
83
...
...
...
...
...
MCV
89
88
86
85
83
91
84
85
65
73
...
Pol3
88
85
85
84
84
84
70
81
81
85
24
PAB
93
93
93
93
93
92
92
92
92
...
...

2010 2009

10
10
100
100
...
10
...
90
...
70
100
...
below 50%
at 80% or above


...

year
2005
target age group
1-5 y
coverage (%)
87
DT
2, 4, 6, 18 months
MMR
DTwP

2, 4, 6, 18 months;
5 years
OPV

DTwPHibHep
HepB
Influenza

2, 4, 6 months
Td
Yellow fever
1, 5 years
2, 4, 6, 18 months;
5 years
7 years
6 months-2 years;
12 years
165
Swaziland
2010
Births............................................................................................................................. 35,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
98
98
99
99
99
90
99
96
79
...
DTP1
95
95
96
96
97
97
95
94
96
82
...
DTP3
89
90
91
93
94
95
87
82
89
61
...
HepB3
89
90
91
93
94
95
83
...
...
...
...
Hib3
89
89
...
...
...
...
...
...
...
...
...
MCV
94
94
95
95
94
92
92
94
85
54
...
Pol3
89
90
92
93
95
96
90
81
89
59
...
PAB
86
86
86
85
85
82
80
77
63
...
...

2010 2009


below 50%

at 80% or above

100
100
100
100
75

77

year
target age group
coverage (%)
2009
9-47 m
96
BCG birth
DT
5 years
DTwPHibHep
Measles
OPV

166
6, 10, 14 weeks
9, 18 months

5 years
TT

CBAW and 1st contact pregnancy;

+1, +6 months; +1, +1 year
Vitamin A 6, 12, 18, 24, 30, 36 months

Yellow fever every 10 years; travellers
Sweden
2010
Births........................................................................................................................... 112,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
23
23
23
23
21
20
16
14
13
16
DTP1
99
99
99
99
99
99
99
99
99
99
99
DTP3
98
98
98
98
98
98
99
99
99
99
99
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
98
98
98
98
98
98
98
99
...
...
...
MCV
96
96
96
96
97
96
91
97
96
94
88
Pol3
98
98
98
98
98
98
99
99
99
98
97
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
290
290
100
100
100
100
99
97

...
...
below 50%

at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG
birth-6 months (high-risk
groups)
DTaP
10 years (catch up)
DTaPHibHepIPV
3, 5, 12 months

(high-risk groups)
DTaPHibIPV
3, 5, 12 months
DTaPIPV
5-6 years
HepB
birth; +1; +2 or 6, +12 (if +6

given) months (children

of carrieries)
HPV
MMR
18 months; 6-8 years or

12 years (catch up)
Pneumo_conj
3, 5, 12 months
Pneumo_ps
>65 years; high-risk

groups (subnational)
Tdap
14-16 years (if indicated)
167
Switzerland
2010
Births............................................................................................................................. 76,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
98
95
95
95
95
95
95
93
96
...
...
DTP3
96
95
95
94
94
94
88
89
90
...
...
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
94
95
95
92
92
93
86
...
...
...
...
MCV
90
90
90
87
87
87
81
83
90
...
...
Pol3
95
95
95
95
95
95
92
95
98
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

26
26
92
...
...
...
92
...
23

...
...
below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
DTaPHibIPV
DTaPIPV
HepB
HPV

Influenza
2, 4, 6, 15-24 months
4-7 years
11-15 years; +6 months
(females)
1 month
MenC_conj

MMR
Pneumo_conj
Pneumo_ps
Td
Varicella
168
12-15 months;
11-15 years
12, 15-24 months
2, 4, 12 months
>65 years
11-15 years; +10 years
>11 years; +1 month
Syrian Arab Republic

2010
Births........................................................................................................................... 465,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
90
90
89
90
90
90
91
91
92
53
35
DTP1
89
89
88
88
88
88
90
96
93
54
35
DTP3
80
80
79
80
80
80
84
89
91
29
13
HepB3
84
84
83
83
83
83
79
74
...
...
...
Hib3
80
80
79
80
80
80
...
...
...
...
...
MCV
82
82
81
81
81
81
84
85
87
27
13
Pol3
83
83
82
83
83
83
86
89
91
29
13
PAB
94
94
94
92
93
92
90
76
63

2010 2009

75
71
100
100
100
100
100
...

100
100
below 50%

at 80% or above

99

year
2008
target age group
coverage (%)
11-15 y
100
BCG birth
MMR
DT
OPV
DTwPHib
DTwPHibHep
HepB
IPV
MenACWY
6 years
12, 18 months
5, 7, 12, 18 months
4, 5, 18 months
Td
12 years
3 months
TT


+1, +1 year
birth; 7 months
3, 4 months
Vitamin A
12, 18 months
6 years (school entrance)
169
Tajikistan
2010
Births........................................................................................................................... 192,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
82
82
89
83
93
97
98
96
...
...
...
DTP1
95
96
92
88
92
92
88
86
...
...
...
DTP3
93
93
86
86
83
84
83
80
...
...
...
HepB3
93
93
86
84
88
81
...
...
...
...
...
Hib3
93
93
92
...
...
...
...
...
...
...
...
MCV
94
89
86
85
82
85
88
70
...
...
...
Pol3
95
93
87
85
76
79
86
69
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

65
65
100
100
100
100
94
100

...
100
below 50%

at 80% or above

81

year
2009
target age group
coverage (%)
12 m-14 y
98
BCG
DT
3-5 days
6 years
HepB birth
MR
DTwP
16-23 months
OPV
DTwPHibHep
2, 3, 4 months
Vitamin A
170
1, 6 years
birth; 2, 3, 4, 12 months
0-59 months
Tanzania, United Republic of

2010
Births........................................................................................................................ 1,862,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
93
89
89
90
91
86
96
85
90
72
DTP1
98
90
88
89
94
95
92
93
92
86
81
DTP3
91
85
86
83
90
90
79
81
78
67
59
HepB3
91
85
86
83
90
90
...
...
...
...
...
Hib3
91
85
...
...
...
...
...
...
...
...
...
MCV
92
91
88
90
93
91
78
78
80
66
46
Pol3
94
88
89
88
91
91
64
79
78
64
57
PAB
83
90
81
81
81
81
79
85
77
51
37

2010 2009
129
129
100
100
21
27
79
71
54
60

78
81
below 50%
at 80% or above

...

year
2005
target age group
coverage (%)
9-59 m
90
BCG birth
DTwPHibHep

Measles
4, 8, 12 weeks or 6, 10,
12 weeks (Zanzibar)
9 months
OPV

TT

birth; 4, 8, 12 weeks or 6, 10,

12 weeks (Zanzibar)
+1, +1 year
171
Thailand
2010
Births........................................................................................................................... 838,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
98
99
80
68
DTP1
99
99
99
99
99
99
98
98
97
83
73
DTP3
99
99
99
98
98
98
97
96
92
62
49
HepB3
98
98
98
96
96
96
95
93
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
MCV
98
98
98
96
96
96
94
91
80
26
...
Pol3
99
99
99
98
98
98
97
96
92
61
19
PAB
91
91
91
89
88
88
85
87
75
41
25

2010 2009
926
926
...
...
...
...
...
...
...
...
...

...
...

below 50%
at 80% or above

...
year
...
target age group
...
coverage (%)
...
BCG birth
MenACWY
DTwP
1.5-2, 4-5 years
MMR
2, 4, 6 months
OPV
DTwPHep
HepB birth
Influenza >65 years (subnational); health

workers; high-risk groups
JE
172
1.5-2 years (2 doses); 2.5-3 years
Td

pilgrims (subnational)
9 months; school entrance
2, 4, 6, 18 months; 4-5 years

(schoolchilden grade 6; pregnancy)
Yellow fever
travellers (subnational)
The former Yugoslav Republic of Macedonia

2010
Births............................................................................................................................. 22,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
98
94
95
92
99
97
95
...
...
...
DTP1
98
98
98
98
95
99
98
98
...
...
...
DTP3
95
96
95
95
93
97
95
95
...
...
...
HepB3
90
95
97
96
89
53
...
...
...
...
...
Hib3
89
82
13
...
...
...
...
...
...
...
...
MCV
98
96
98
96
94
96
97
97
...
...
...
Pol3
95
96
96
96
92
98
96
95
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

31
31
100
100
100
100
100
97
...
...

99

year
target age group
coverage (%)
2009
13m-26 y
...
BCG
birth; 7 years
MMR
1, 6 years
DTwP
HepB
birth; 2, 6 months
Rubella
Hib
2, 3, 5, 18 months
Tdap
HPV 12 years; +2, +6 months (females)
OPV
TT
2, 3.5, 5, 18 months; 7, 14 years

14 years (females)
7, 14 years
18 years
173
Timor-Leste
2010
Births............................................................................................................................. 44,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
71
71
85
74
74
70
...
...
...
...
...
DTP1
75
76
85
76
71
64
...
...
...
...
...
DTP3
72
72
79
70
63
55
...
...
...
...
...
HepB3
72
72
79
...
...
...
...
...
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
66
70
73
63
61
48
...
...
...
...
...
Pol3
72
78
79
70
62
55
...
...
...
...
...
PAB
81
81
66
59
63
59
...
...
...
...
...

2010 2009

13
13
100
100
77
54
23
46
15
23

...
100
below 50%
at 80% or above

...

year
2009
target age group
coverage (%)
9-59 m
76
BCG
DTwPHep
Measles
birth-1 year
6, 10, 14 weeks
9 months
OPV
TT

birth-2 weeks; 6, 10, 14 weeks

Vitamin A 6, 12, 18, 24, 30, 36 months
174
Togo
2010
Births........................................................................................................................... 193,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
94
91
92
91
96
96
84
83
99
54
...
DTP1
97
93
92
94
91
91
80
74
90
48
...
DTP3
92
89
89
88
87
82
64
58
77
24
...
HepB3
92
89
24
...
...
...
...
...
...
...
...
Hib3
92
89
24
...
...
...
...
...
...
...
...
MCV
84
84
77
80
83
70
58
53
73
27
...
Pol3
92
89
88
78
87
80
63
59
76
23
...
PAB
81
81
81
82
81
81
63
52
47
...
...

2010 2009
35
35
97
100
11
17
89
83
43
37

97
94
below 50%
at 80% or above

0

year
2008
target age group
coverage (%)
9-59 m
98
BCG birth
DTwP
6, 10, 14 weeks
DTwPHibHep
6, 10, 14 weeks
Measles
OPV
9 months
TT


Vitamin A 6, 10, 14 weeks; 9 months;

post-partum
Yellow fever
9 months
175
Tonga
2010
Births............................................................................................................................... 3,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
99
99
99
99
DTP1
99
99
99
99
99
99
99
98
97
97
65
DTP3
99
99
99
99
99
99
95
95
94
92
40
HepB3
99
99
98
99
99
99
97
91
94
...
...
Hib3
99
99
99
99
99
99
...
...
...
...
...
MCV
99
99
99
99
99
99
95
94
86
81
...
Pol3
99
99
99
99
99
99
95
93
93
81
20
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

100
100
100
100
100
100

100
100
below 50%

at 80% or above

98

year
target age group
coverage (%)
2001
12-59 m
...
BCG birth
MR
12, 18 months
DTwP
OPV
6, 10, 14 weeks
DTwPHibHep
18 months; 5 years
6, 10, 14 weeks
HepB birth
176
Td
16 years
Trinidad and Tobago

2010
Births............................................................................................................................. 20,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
96
95
91
90
93
98
90
96
94
91
51
DTP3
90
90
90
88
92
95
90
89
82
75
26
HepB3
90
90
90
89
89
95
...
...
...
...
...
Hib3
90
90
90
88
89
95
74
...
...
...
...
MCV
92
94
91
91
89
93
90
84
70
32
...
Pol3
91
90
91
90
89
95
90
90
87
74
38
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

100
100
11
89
100
67
78

...
100
below 50%
at 80% or above

107

year
...
target age group
...
coverage (%)
...
DT

DTwP
18, 48-60 months
DTwPHibHep
2, 4, 6 months
HepB
>10 years (3 doses)
Hib
3, 4, 6 months (high-risk groups)
Influenza seasonal
IPV
2, 4, 5, 18 months: 4-5 years
(immunocompromised)
MenC_conj
3 years
MMR
1, 4-5 years
OPV
2, 4, 6, 18 months;

4-5 years
Pneumo_conj
2, 4, 6 months (high-risk
groups)
Pneumo_ps
2 years
Td
10 years
Yellow fever
1, 11 years
177
Tunisia
2010
Births........................................................................................................................... 179,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
98
99
99
99
98
95
97
96
90
...
DTP1
98
99
99
99
99
98
99
97
97
88
...
DTP3
98
99
99
98
99
98
97
94
93
70
...
HepB3
98
99
99
98
99
97
94
...
...
...
...
Hib3
...
...
...
...
...
80
...
...
...
...
...
MCV
97
98
98
98
98
96
95
91
93
65
...
Pol3
98
99
99
98
99
98
97
94
93
70
...
PAB
96
96
96
96
89
90
68
58
40

2010 2009
225
225
100
100
below 50%

at 80% or above

100
100
92
95
100
100

98

year
2005
target age group
coverage (%)
13-18 y
91
BCG birth
DTwP

2, 3, 6, 18 months;
6, 12, 18 years
HepB
birth; 2, 6 months
Measles
178
15 months; 6 years
OPV

2, 3, 6, 18 months;
6, 12, 18 years
Rubella
12 years (females)
Td
7, 12, 18 years; CBAW
Turkey
2010
Births........................................................................................................................ 1,298,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
96
96
96
94
88
88
96
90
93
76
...
DTP1
97
97
97
98
92
92
92
86
94
78
67
DTP3
96
96
96
96
90
90
85
67
84
55
42
HepB3
94
94
92
96
82
85
71
...
...
...
...
Hib3
96
96
96
76
...
...
...
...
...
...
...
MCV
97
97
97
96
98
91
87
65
78
61
27
Pol3
96
96
96
96
90
90
85
67
84
55
63
PAB
90
71
71
70
68
62
50
42
20
...
...

2010 2009

81
81
100
100
100
100
96
98

...
100
below 50%

at 80% or above

...

year
2003
target age group
coverage (%)
6-14 y
97
BCG
2 months
MMR
DTaPHibIPV
2, 4, 6, 18 months
OPV
HepB
birth; 1, 6 months
Pneumo_conj
Influenza
high-risk groups
Td
1, 6 years
2, 4, 6, 12 months
6, 14 years
179
Turkmenistan
2010
Births........................................................................................................................... 109,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
93
...
...
...
DTP1
99
98
98
99
99
99
97
97
...
...
...
DTP3
96
96
96
98
98
99
97
93
...
...
...
HepB3
96
97
96
98
98
99
...
...
...
...
...
Hib3
58
...
...
...
...
...
...
...
...
...
...
MCV
99
99
99
99
99
99
96
92
...
...
...
Pol3
96
97
96
98
98
99
98
96
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

64
64
100
100
100
100
100
100
...
100

99

year
...
target age group
...
coverage (%)
...
BCG
DT
DTwP
DTwPHibHep
180
2-3 days; 14 years

6 years
18 months
2, 3, 4 months
HepB birth
MMR
OPV
Td

2-3 days; 2, 3, 4, 18 months
15, 25 years
Tuvalu
2010
Births................................................................................................................................... ...

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
88
96
90
99
DTP1
99
97
99
99
99
99
93
95
99
76
61
DTP3
89
88
99
97
97
93
82
87
99
52
36
HepB3
89
91
99
97
97
79
81
49
...
...
...
Hib3
89
84
...
...
...
...
...
...
...
...
...
MCV
85
90
93
95
84
62
81
94
95
92
...
Pol3
89
85
99
97
97
99
82
85
84
97
23
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009


below 50%

at 80% or above

100
...
...
...
100
...
38
100
100
100

70

year
2010
target age group
coverage (%)
12-71 m
79
BCG birth
MR
12, 18 months
DTwP
6, 10, 14 weeks
OPV
6, 10, 14 weeks
DTwPHibHep
6, 10, 14 weeks
TT
1st contact; +1, + 6 months
HepB birth
181
Uganda
2010
Births........................................................................................................................ 1,514,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
84
88
84
87
83
90
82
83
75
37
...
DTP1
83
92
85
91
85
90
80
81
72
36
...
DTP3
60
63
59
65
60
64
52
59
45
14
...
HepB3
60
63
59
65
60
64
...
...
...
...
...
Hib3
60
63
59
65
60
64
...
...
...
...
...
MCV
55
63
59
68
71
68
57
57
52
17
...
Pol3
55
59
55
60
57
59
55
58
45
13
...
PAB
85
89
85
85
83
85
70
82
41
12
...

2010 2009

80
80
100
100
...
...
38
...
59
18
26

56
46
below 50%
at 80% or above

...

year
2009
target age group
coverage (%)
unknown
104
BCG birth
OPV
DTwPHibHep
TT

HPV

Measles
182
6, 10, 14 weeks

(females, subnational)
9 months
Vitamin A


CBAW (15-49 years); +1,
6 months; 1, 1.5, 2, 2.5,
3 years
Ukraine
2010
Births........................................................................................................................... 493,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
95
95
95
98
97
96
98
95
...
...
...
DTP1
96
96
96
99
98
98
99
98
...
...
...
DTP3
90
90
90
98
98
96
99
98
...
...
...
HepB3
84
84
84
92
96
97
...
...
...
...
Hib3
81
81
81
46
11
...
...
...
...
...
...
MCV
94
94
94
97
98
96
99
97
...
...
...
Pol3
91
91
91
98
99
95
99
97
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
...
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above

...

year
2008
target age group
coverage (%)
15-29 y
...
BCG
3 days; 7, 14 years
Dip
23 years
DT
6 years
DTaP
DTaPHibIPV
DTwPHib
HepB
Hib
18 months
3 months
IPV
MMR
Mumps
OPV
Rubella
3, 4 months
1, 6 years
15 years
5, 18 months; 6, 14 years
15 years
4, 5 months
Td
14, 18 years
1 day; 1, 6 months
TT
60 years
4, 5, 18 months
183
United Arab Emirates

2010
Births............................................................................................................................. 92,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
98
98
98
98
98
98
98
98
96
60
15
DTP1
94
96
97
97
97
97
96
96
95
91
32
DTP3
94
93
92
92
92
94
94
90
85
76
11
HepB3
94
93
92
92
92
92
92
90
...
...
...
Hib3
94
93
92
92
92
94
92
...
...
...
...
MCV
94
93
92
92
92
92
94
90
80
60
34
Pol3
94
94
94
94
94
94
94
90
85
74
11
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above
...

94

year
2001
target age group
coverage (%)
9 m-18 y
94
BCG birth
DT
5-6 years
DTwPHib
18 months
DTwPHibHep
2, 4, 6 months
HepB
Hib
18 months
Influenza
pilgrims; high-risk groups
IPV
2 months
MenACWY pilgrims
184
MMR
OPV
Pneumo_conj
Pneumo_ps
Rubella
Td
Typhoid
Varicella
Yellow fever
1, 5-6 years
2, 4, 6 months
high-risk groups
15-16 years
high-risk groups
high-risk groups
travellers
United Kingdom
2010
Births........................................................................................................................... 757,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
98
97
97
97
97
97
97
97
94
85
66
DTP3
96
93
92
92
92
91
91
94
84
65
41
HepB3
...
...
...
...
...
...
...
...
...
...
...
Hib3
97
94
93
93
93
92
92
94
...
...
...
MCV
93
86
86
86
85
82
88
92
87
68
53
Pol3
98
93
92
92
92
92
91
96
92
95
81
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009

177
173
98
100
100
96
53
22

...
...
below 50%

at 80% or above

84

year
...
target age group
...
coverage (%)
...
BCG
DTaPHibIPV
DTaPIPV
HepB

MenACWY
2, 3, 4 months
MenC_conj
3-5 years
(high-risk groups)
HibMenC
HPV

1 year
12-13 or up to 18 years (catch up);

+1, +6 months (females)
Influenza
2 months (high-risk groups)
MMR
Pneumo_conj
Pneumo_ps
TdIPV
Varicella

3, 4 months
2, 4, 12 months
13-18 years
1st contact; +1-2 months
(if indicated)
185
United States
2010
Births........................................................................................................................ 4,301,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
...
...
...
...
...
...
...
...
...
...
...
DTP1
99
99
99
99
99
99
99
98
96
98
98
DTP3
95
95
95
95
95
96
94
95
90
96
96
HepB3
92
92
92
92
92
92
90
68
...
...
...
Hib3
93
93
93
93
93
94
93
91
...
...
...
MCV
92
92
92
92
92
93
91
88
90
97
86
Pol3
93
93
93
93
93
92
90
88
85
96
95
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
...
...
...
...
...
...
...
...
...
...
...

...
...
below 50%
at 80% or above
...

...
year
...
target age group
...
coverage (%)
...
DTaP

HepA

HepB

Hib

HPV
Influenza

186
2, 4, 6, 15-18 months; 4-6 years

(or in combination vaccine)
12-23 months (2 doses);
high-risk groups
birth; 1-2, 6-18 months (or in
combination vaccine)
2, 4, 6, 12-15 months (or in
combination vaccine)
6-59 months; >50 years;
high-risk groups
IPV
MenC_conj
MMR
Pneumo_conj

Pneumo_ps
Rotavirus
Tdap
Varicella

2, 4, 6-18 months; 4-6 years

11-12 years; high-risk groups
2, 4, 6, 12-15 months; >15
months (h0igh-risk groups)
2, 4, 6 months or 2, 4 months
11-12 years
high-risk groups
Uruguay
2010
Births............................................................................................................................. 50,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
99
99
99
99
99
99
99
92
56
DTP1
98
99
98
98
99
99
92
97
98
84
77
DTP3
95
95
94
94
95
96
90
91
97
63
53
HepB3
95
95
94
94
95
96
92
...
...
...
...
Hib3
95
95
94
94
95
96
88
...
...
...
...
MCV
95
94
95
96
94
95
89
90
97
59
50
Pol3
95
95
94
94
95
96
92
91
97
58
59
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
275
275
100
100
100
100
100
100

100
100
below 50%

at 80% or above

...

year
2003
target age group
1-4 y
coverage (%)
94
BCG birth
DT
DTwP
5 years
DTwPHibHep
2, 4, 6, 15 months
H1N1
6 months-4 years;

pregnancy; high-risk groups
HepA
15, 21 months; travellers
HepB

high-risk groups
Hib
Influenza
>55 years
IPV
MMR
OPV
Pneumo_conj

Pneumo_ps
Rabies
Td
Varicella
Yellow fever
OPV contraindication
1, 5 years
2, 4, 6, 12 months
2, 4, 12 months; <5 years
(catch up)
high-risk groups; post-exposure
1 year
travellers
187
Uzbekistan
2010
Births........................................................................................................................... 587,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
99
99
96
99
99
93
98
99
...
...
...
DTP1
99
99
99
98
96
99
99
96
...
...
...
DTP3
99
98
98
96
96
99
99
87
...
...
...
HepB3
99
98
91
99
98
99
...
...
...
...
...
Hib3
99
98
...
...
...
...
...
...
...
...
...
MCV
98
95
98
98
98
99
99
91
...
...
...
Pol3
99
99
98
98
94
99
99
99
...
...
...
PAB
...
...
...
...
...
...
...
...
...
...
...

2010 2009
199
199
100
100
below 50%

at 80% or above

100
100
100
89
...
100

...
year
...
target age group
...
coverage (%)
...
BCG
DTwP
DTwPHibHep
188
3-5 days
16 months
2, 3, 4 months
HepB birth
MMR
OPV

1, 6 years
3-5 days; 2, 3, 4, 16 months;
7 years
Vanuatu
2010
Births............................................................................................................................... 7,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
81
81
81
81
81
81
79
67
96
83
...
DTP1
78
78
78
78
78
79
85
90
91
55
...
DTP3
68
68
68
68
68
68
71
73
76
30
...
HepB3
59
59
59
59
59
61
70
66
...
...
...
Hib3
...
...
...
...
...
...
...
...
...
...
...
MCV
52
52
52
52
52
53
61
60
66
26
...
Pol3
67
67
67
67
67
67
67
74
78
27
...
PAB
73
73
73
73
88
84
86
33
47
19
...

2010 2009
100
33
33
67
67
33
67
below 50%
at 80% or above


...

year
2006
target age group
coverage (%)
1-12 y
99
BCG birth
OPV
DTaP
6, 10, 14 weeks
Td
6, 7 years
HepB
birth; 6, 14 weeks
TT


+1, +1 year
Measles
1 year
6, 10, 14 weeks; 6, 12 years
189
Venezuela (Bolivarian Republic of)

2010
Births........................................................................................................................... 598,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
92
91
90
82
83
95
99
91
82
89
72
DTP1
90
86
87
70
79
98
92
87
84
73
79
DTP3
78
84
50
62
71
87
77
68
63
49
56
HepB3
78
84
53
62
71
88
...
...
...
...
Hib3
78
84
51
62
71
87
...
...
...
...
MCV
79
87
93
87
82
76
84
47
61
56
50
Pol3
74
75
76
67
73
80
86
85
72
59
95
PAB
50
50
52
51
49
51
...
...
...
...
...

2010 2009
367
367
100
100
46
44
45
47
25
30

52
72
below 50%
at 80% or above

31

year
2009
target age group
2-5 y
coverage (%)
23
BCG birth
MenC_conj
DT
MMR
0, +1, +6 months; +1, +1 year
DTwP
5 years
DTwPHibHep
HepB

Influenza

190
2, 4, 6, 18 months
birth; 1st contact; +2, +4 months

(high-risk groups)
6, 7 months; >50 years;
high-risk groups
OPV
Pneumo_ps
Rotavirus
Td

Yellow fever
high-risk groups
1, 5 years
>60 years
2, 4 months
+1, +1 year
1 year; travellers
Viet Nam
2010
Births........................................................................................................................ 1,467,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
94
97
92
94
95
95
98
96
90
50
...
DTP1
93
97
97
92
94
98
97
97
96
67
...
DTP3
93
96
93
92
94
95
96
93
88
42
...
HepB3
88
94
87
67
93
94
...
...
...
...
...
Hib3
63
...
...
...
...
...
...
...
...
...
...
MCV
98
97
92
83
93
95
97
95
88
19
...
Pol3
94
97
93
92
94
94
96
94
88
62
...
PAB
87
87
84
86
87
86
86
80
24
...
...

2010 2009
695
690
100
100
95
97
94
94

92
96
below 50%

at 80% or above

98

year
2010
target age group
coverage (%)
1-5 yrs
96
BCG birth
Measles
DTwP
2, 3, 4 months
OPV
DTwPHibHep
2, 3, 4 months
TT

HepB
birth; 2, 4 months
JE
1 year; + 2 weeks; + 2 years
(subnational)
Typhoid
Vitamin A

9 months; 6 years
2, 3, 4 months
pregnancy; +1, +6 months;
+1, +1 year
6-11, 12-17, 18-23, 24-29,
30-36 months
191
Yemen
2010
Births........................................................................................................................... 919,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
65
58
60
64
67
66
82
60
95
20
DTP1
94
92
93
94
92
95
88
69
94
33
18
DTP3
87
86
87
87
85
85
76
44
84
12
HepB3
87
86
87
87
85
86
15
...
...
...
...
Hib3
87
86
87
87
85
55
...
...
...
...
...
MCV
73
69
73
74
68
76
71
40
69
13
Pol3
88
86
87
87
85
86
76
44
84
12
PAB
66
66
63
52
56
59
54
30
17
...

2010 2009

333
333
99
100
17
26
75
68
12

69
68
below 50%
at 80% or above

49

year
2009
target age group
coverage (%)
9-59 m
96
BCG birth
Measles
DT
6, 10, 14 weeks
OPV
DTwPHibHep
6, 10, 14 weeks
TT

HepB
6, 10, 14 weeks
(subnational)
192
Vitamin A
9, 18 months
+1, +1 year
9, 18 months
Zambia
2010
Births........................................................................................................................... 600,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
89
89
89
89
92
92
94
97
97
92
...
DTP1
99
92
92
90
92
92
94
97
97
86
...
DTP3
82
82
79
76
81
82
85
86
91
66
...
HepB3
82
82
79
76
81
82
...
...
...
...
...
Hib3
82
82
79
76
81
82
...
...
...
...
...
MCV
91
87
84
92
85
85
85
86
90
58
...
Pol3
66
82
83
74
83
84
85
84
90
61
...
PAB
90
90
90
89
90
91
78
85
62
...
...

2010 2009

72
72
100
100
29
13
68
86
68
56

72
63
below 50%
at 80% or above

...

year
2007
target age group
coverage (%)
9-59 m
109
BCG birth
OPV
DTwPHibHep
TT

Measles
6, 10, 14 weeks
9 months
6, 10, 14 weeks
1st contact pregnancy; +1, +1,
Vitamin A 6, 12, 18, 24, 30, 36 months
193
Zimbabwe
2010
Births........................................................................................................................... 374,000

2010 2009 2008 2007 2006 2005 2000 1995 1990 1985 1980
BCG
90
90
91
86
81
76
85
96
91
76
...
DTP1
94
87
89
85
81
77
85
96
96
84
...
DTP3
83
73
75
72
68
65
79
88
88
63
...
HepB3
83
73
75
72
68
65
79
...
...
...
Hib3
83
73
75
...
...
...
...
...
...
...
...
MCV
84
76
70
69
67
66
75
87
87
78
...
Pol3
84
69
75
72
70
67
79
88
89
63
...
PAB
76
76
76
78
78
77
76
42
57
44
...

2010 2009

60
60
100
98
38
52
58
45
47
22

15
20
below 50%
at 80% or above

...

year
2010
target age group
coverage (%)
6 m-14 y
97
BCG birth
OPV
DT
Pneumo_conj
DTwP
DTwPHibHep
Measles
194
5 years
18 months
3, 4, 5 months
9 months
3, 4, 5 months
TT


+1, +1 year
Vitamin A
6, 12, 18, 24, 30, 36 months
GLOSSARY OF ACRONYMS
Note: Compound acronyms denote vaccine combinations.
DTPHibHepIPV, for example, denotes DTP, Hib, HepB and IPV
vaccines combined.
AMC
advanced market commitment
aP
acellular pertussis vaccine
BCG
bacille Calmette-Gurin (vaccine against

tuberculosis)
CBAW
childbearing-aged women; refers to ages 15-45

unless otherwise noted
Dip
diphtheria toxoid vaccine
DT
diphtheria toxoid
DTaP
diphtheria and tetanus toxoid with acellular

pertussis vaccine
DTP
diphtheria and tetanus toxoid with pertussis vaccine
DTP1
first dose of diphtheria and tetanus toxoid with

pertussis vaccine
DTP3
third dose of diphtheria and tetanus toxoid with

pertussis vaccine
DTwP
diphtheria and tetanus toxoid with whole-cell

pertussis vaccine
EPI
Expanded Programme on Immunization
GAVI
Global Alliance for Vaccines and Immunisation
GNI
gross national income (US$)
H1N1
monovalent vaccine against the 2009 influenza A

(H1N1) virus
HepA
hepatitis A vaccine
HepB
hepatitis B vaccine
HepB3
third dose of hepatitis B vaccine
HFRS
hemorrhagic fever with renal syndrome (hantavirus)

vaccine
Hib
Haemophilus influenzae type b vaccine
Hib3
third dose of Haemophilus influenzae type b

vaccine
HPV
human papilloma virus vaccine
IPV
inactivated polio vaccine
JE
Japanese encephalitis
MCV
measles-containing vaccine
MCV2
second dose of measles-containing vaccine
195
Glossary of acronyms, continued

MenA
meningococcal A vaccine; this monovalent vaccine

protects against meningitis serogroup A
MenAC
meningococcal AC vaccine; this bivalent vaccine

protects against meningitis serogroups A and C
MenACW
meningococcal ACW vaccine; this trivalent vaccine

protects against meningitis serogroups A, C and
W-135
MenACWY
meningococcal ACWY vaccine; this quadrivalent

vaccine protects against meningitis serogroups A,
C, Y and W-135
MenBC
meningococcal BC vaccine; this bivalent vaccine

protects against meningitis serogroups B and C
MenC
meningococcal C vaccine; this monovalent vaccine

protects against meningitis serogroup C
MenC_conj
meningococcal C conjugate vaccine
MM
measles and mumps vaccine
MMR
measles-mumps-rubella vaccine
MMRV
measles-mumps-rubella-varicella vaccine
MR
measles and rubella vaccine
OPV
oral polio vaccine
PAB
protected at birth against tetanus
Pneumo_conj
pneumococcal conjugate vaccine
Pneumo_ps
pneumococcal polisaccharide vaccine
Pol3
third dose of poliomyelitis vaccine
PPP
purchasing power parity
Pw
whole-cell pertussis vaccine
TBE
tick-borne encephalitis vaccine
TBD
to be determined
Td
tetanus toxoid with reduced amount of diphtheria

toxoid
Tdap
tetanus toxoid vaccine (full dose) with acellular

pertussis vaccine (reduced dose)
TT
tetanus toxoid
UNICEF
United Nations Childrens Fund
WHO
World Health Organization
196
Immunization Summary for 2010 data jointly produced

by the United Nations Childrens Fund (UNICEF) and the
World Health Organization (WHO) presents detailed statistics on the performance of national and local immunization systems in 194 countries and territories.
The attached CD-ROM complements the print version and
provides such reports and forms as:
Excel worksheets containing WHO/UNICEF coverage estimates with data for all years since 1980, plus
reported data that include district-level performance
indicators, supply and safety indicators, survey data
and national immunization schedules for 20092010.
Samples of the WHO/UNICEF Joint Reporting Form
on Immunization in English, French and Spanish.
National Immunization Coverage Final Report (PDF)
for each country or territory.
Full-text version of Immunization Summary: A Statistical Reference containing data through 2010.
Minimum technical requirements:
Microsoft Office (Microsoft Excel and Word)
Adobe Acrobat (for PDF downloads)
Further information on the publication

can be obtained from:
UNICEF Statistics and Monitoring Section

Division of Policy and Practice
3 United Nations Plaza
New York, NY 10017, USA
immunization@unicef.org
www.unicef.org
Tel: +1-212-326-7000
World Health Organization (WHO)

20 Avenue Appia
CH-1211 Geneva 27, Switzerland
info@who.int
www.who.int
Tel: +41-22-791-2111
The United Nations Childrens Fund (UNICEF) January 2012

UNICEF 2012ed Immunization Summary (English)

Hochgeladen von

Dokumentinformationen

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

UNICEF 2012ed Immunization Summary (English)

Hochgeladen von

Copyright:

Verfügbare Formate

IMMUNIZATION SUMMARY

A statistical reference containing

A statistical reference containing

See inside back cover

Glossary of acronyms............................................... 195

Measles control activities, including coverage

Table 1: Indicative budget prices for

Recommended budget price, 2012

Table 2: Indicative budget price for

Device (box of 100,

BCG autodisable syringe, 0.1 ml

Autodisable syringe, 0.5 ml

Reconstitution syringe, 2 ml, with needle

Re-use prevention feature syringe, 2 ml,

Reconstitution syringe, 5 ml, with needle

Re-use prevention feature syringe, 5 ml,

Re-use prevention feature syringe with SIP,

Reconstitution syringe, 10 ml, with needle

Re-use prevention feature syringe with SIP,

Safety box, 5 litre (box of 25)

Note: The list of countries and territories in MDG regions appears

MAPS: GLOBAL INDICATORS

Source: WHO/UNICEF coverage estimates,

90% (126 countries or 65%)

80-89% (24 countries or 12%)

50-79% (41 countries or 21%)

<50% (2 countries or 1%)

Map 1: Immunization coverage with measles-containing vaccines in infants, 2010

*155 developing countries and economies

Source: WHO/UNICEF coverage estimates,

Not applicable (32 countries)

(DTP3 estimated coverage for 2010

No data (20 countries or 13%)

No (89 countries or 57%)

Yes (46 countries or 30%)

National coverage rates (WHO/UNICEF estimates)

BCG bacille Calmette-Gurin (vaccine against tuberculosis)

District coverage (as reported)

Measles control activities (as reported)

National coverage rates (%) (WHO/UNICEF estimates, 2010)

District coverage (as reported)

Number of districts in country

DTP3: proportion of districts with coverage (%) between 50-79%

MCV: proportion of districts with coverage at 90% or above (%)

DTP1DTP3 drop-out rate: proportion of districts that

Measles control activities (as reported)

MCV2 routine coverage in 2010 (%)

Most recent national measles campaign

target age group

birth; 6, 10, 14 weeks;

National coverage rates (%) (WHO/UNICEF estimates, 2010)

District coverage (as reported)

Number of districts in country

MCV: proportion of districts with coverage at 90% or above (%)

DTP1DTP3 drop-out rate: proportion of districts that

DTP3: proportion of districts with coverage (%) between 50-79%

Measles control activities (as reported)

MCV2 routine coverage in 2010 (%)

Most recent national measles campaign

target age group

1st contact; +1 month

National coverage rates (%) (WHO/UNICEF estimates, 2010)

District coverage (as reported)

Number of districts in country